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Abstract
Interactions between diet, microbiota and host response are important for intestinal 
health. Dietary fibers are known to promote intestinal health. Dietary fibers are edible 
plant-derived food components that encompass complex carbohydrates and lignin, resist 
the digestion in the small intestine of which some are degraded and fermented by gut 
microbiota in the large intestine, i.e. cecum and colon. The beneficial health effects of 
dietary fiber are suggested to be mediated by short-chain fatty acids (SCFA), which are 
produced by gut microbial fermentation. The underlying mechanisms of the interaction 
between dietary fiber, SCFA, and the host, however, are not in detail known.
The objective of the research described in this thesis was to investigate the molecular 
effects and mechanisms underlying the effects of dietary fiber and its fermentation 
products, SCFA, in the large intestine. 
Firstly, the colonic transcriptional response to the main SCFA, acetate, propionate and 
butyrate, was investigated. SCFA were administered by rectal infusion in C57BL/6 mice fed 
a low fat/high carbohydrate (LFD) or high fat/low carbohydrate diet (HFD) and whole-genome 
gene expression analysis was performed on colonic scrapings by microarray technology. 
The analysis revealed specific and overlapping genes regulated between acetate, propionate 
and butyrate. In addition, gene response to SCFA was dependent on the diet, in particular 
for propionate. A set of propionate-regulated genes was activated on LFD while suppressed 
on a HFD and vice versa, indicating that diet composition is important factor in colonic 
response to SCFA. 
Secondly, the molecular effects of different dietary fibers and a control diet on the large 
intestine were investigated. Five different dietary fibers (inulin, fructo-oligosaccharide, 
arabinoxylan, guar gum, resistant starch) and a control diet were fed to C57BL/6 mice (10 
days). The transcriptional response to the fermentable fibers was comparable in gene 
expression, microbiota composition, and luminal SCFA level in colon. In common for all 
fermented dietary fibers, the transcriptional regulator Pparg was identified as potential 
upstream regulator for the mucosal gene expression response. Moreover, bacteria mainly 
belonging to Clostridium cluster XIVa were found to correlate with mucosal genes related 
to metabolic, energy-generating processes. 
Next to common responses, analysis of the transcriptome revealed distinct responses of 
different dietary fibers. With respect to the cecal metatranscriptome, we identified distinct 
activities of bacterial families in the fermentation of dietary fiber. Moreover, using 
multivariate statistical analysis, we found correlations of the mucosal transcriptome with 
both the microbiota composition and metatranscriptome. 
In addition, we showed that SCFA, particularly butyrate and to a lesser extend propionate, 
transactivate PPARg and regulate the PPARg target gene Angptl4 in colonic cells.  
Thirdly, we tested the hypothesis that epithelial Pparg plays an important role in the 
fermentation of dietary fibers in the gut. Mice with an intestine-specific knock out (KO) of 
Pparg (cre-villin) and wild type (WT) mice were fed inulin (10 days). Whole-genome gene 
expression analysis of the colon revealed that diet had a larger effect than genotype on 
colonic, luminal microbiota composition, metabolome and mucosal transcriptome. We 
identified genes that were regulated by inulin in Pparg-dependent manner. In addition, 
we also identified genes regulated by butyrate in Pparg-dependent manner in organoids 
grown from colonic crypt cells derived from KO or WT mice. 
In conclusion, we identified distinct mucosal gene expression responses to the main 
fermentation products of dietary fiber, SCFA, on both low fat/high carbohydrate and high 
fat/low carbohydrate diet backgrounds. Dietary fibers induce common and specific 
effects in colon. Epithelial Pparg partially governs the response to fermentation of dietary 
fiber in colon. Next to the commonalties of dietary fiber for intestinal physiology, specific 
and differential effects were identified for microbial gene activity and composition as well 
as mucosal transcriptome response indicating that omics tools are useful in elucidating 
and dissecting effects of dietary fiber.   
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Chapter 1
General Introduction
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The intestinal tract in mammals consists of small and large intestine. Its main function is 
the digestion and absorption of food and nutrients, which mainly takes place in the small 
intestine, whereas the large intestine is necessary for reabsorption of salts and water, 
elimination of waste products from the body, microbiota-associated synthesis of vitamins 
and fermentation thereby contributing to energy extraction from otherwise undigested 
food components such as dietary fiber. 
“All disease begins in the gut” (Hippocrates). The gut can be regarded as gatekeeper of 
body homeostasis with the factors diet, microbiota and host (Figure 1). Beneficial interactions 
between these factors are essential for maintaining homeostasis. The underlying molecular 
mechanisms of this interaction, however, are largely unknown. One of the important 
dietary constituents required for keeping the balance are dietary fibers, that are in particular 
rich in plant food rich diets that are mainly fermented in the large intestine.
Figure 1  Model explaining the intestine as gatekeeper of body homeostasis [1]
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Dietary fiber 
In general, the term dietary fiber encompasses carbohydrates that are not digested in the 
small intestine and have health benefits. In more detail, these food components are quite 
diverse, in terms of physicochemical properties and in terms of health effects, hence the 
definition of dietary fiber has been rather challenging. Internationally recognized, the 
Codex Alimentarius Commission (CAC) adopted a definition from 2009:
Dietary fibre means carbohydrate polymers1 with ten or more monomeric units2, which are not 
hydrolysed by the endogenous enzymes in the small intestine of humans and belong to the 
following categories:
•  Edible carbohydrate polymers naturally occurring in the food as consumed,
•  carbohydrate polymers, which have been obtained from food raw material by physical, 
enzymatic or chemical means and which have been shown to have a physiological effect of 
benefit to health as demonstrated by generally accepted scientific evidence to competent 
authorities,
•  synthetic carbohydrate polymers which have been shown to have a physiological effect of 
benefit to health as demonstrated by generally accepted scientific evidence to competent 
authorities 
1   When derived from a plant origin, dietary fibre may include fractions of lignin and/or other 
compounds when associated with polysaccharides in the plant cell walls and if these 
compounds are quantified by the AOAC gravimetric analytical method (...). However, when 
extracted or even re-introduced into a food containing non digestible polysaccharides, they 
cannot be defined as dietary fibre. 
2   Decision on whether to include carbohydrates from 3 to 9 monomeric units should be left to 
national authorities
Inclusion of dietary fibers in the daily diet is getting more and more attention because 
they are associated with the prevention of type 2 diabetes, obesity, colon cancer, 
cardiovascular health, body weight and appetite control, and promote intestinal health 
[2]. Dietary fibers are traditionally classified according to solubility in water. High soluble 
dietary fibers are generally linked to beneficial effects for prevention of gastrointestinal 
disorders and cardiovascular diseases [3], while insoluble fibers are generally attributed to 
laxative effects by increasing stool weight. The physiological effects linked to the term 
solubility are, however, not consistent and this classification might hence not be suitable 
for understanding physiological effects of dietary fibers [2,4]. Other physicochemical 
properties by which dietary fibers can be classified are water holding capacity, viscosity, 
binding of organic molecules and fermentability [5].
Fermentable dietary fibers are degraded by the intestinal microbiota and lead to the 
production of microbial metabolites such as short-chain fatty acids (SCFA). The health 
benefits of dietary fibers are generally attributed to the increased availability of SCFA. 
Different highly fermentable dietary fibers lead to different ratios of microbial metabolites 
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(SCFA) [6], which have in turn also different effects on the colon. Dietary fibers are complex 
food components, which have in addition to common also unique physicochemical 
properties and hence can be expected to have unique effects on the gut. Properties such 
as fermentability are dependent on the composition of the intestinal microbiota, which is 
an important player in the health effects mediated by diet to the host and hence cannot 
be ignored when studying dietary fibers. 
Intestinal Microbiota 
The human body is said to consist of approximately 1013 eukaryotic animal cells and is 
outnumbered by bacteria by a factor of 10 [7] of which the highest density is found in the 
gastrointestinal tract with up to 1012/g of bacteria. The fact that certain bacteria influence 
health or cause disease has long been proposed and in recent years the importance of the 
complex ecosystem of intestinal bacteria as environmental factor for host (metabolic) 
health is becoming evident. First evidence came from studies with gnotobiotic mice, i.e. 
mice with a defined microbiota composition, including germ-free mice. Fed a chow diet 
(a diet high in carbohydrates), germ-free mice did not gain as much body fat as conven-
tionalized mice [8], i.e. mice harboring microbiota and were protected from diet-induced 
obesity (with a high-fat, high-sugar diet) [9]. In addition, studies with transplantations of 
intestinal microbiota demonstrated the crucial role of microbiota for host health. For 
example, transplantation of microbiota from obese to non-obese gnotobiotic mice 
induced a phenotype in the recipient similar to that of the donor [10] Similarly, transferring 
microbiota from twins discordant for obesity into germ-free mice resulted in a phenotype 
similar to that of the donor [11], which further supports the important role of microbiota 
for determining host metabolic phenotype. Moreover, in humans it was demonstrated 
that fecal transplantations by infusion of small intestinal microbiota from a lean donor into 
subjects with metabolic syndrome improved glucose handling in these subjects [12]. 
The composition of the intestinal microbiota thus plays an important role for health, 
because changes in microbiota community can influence its function for the host in 
harvesting energy, providing nutrients, shaping immunity and organ development [13]. A 
dysfunction between microbiota composition and host is associated with a variety of 
disorders not only restricted to the intestine (e.g. Crohn’s disease [14]), but were also linked 
to metabolic syndrome [16] and psychological disorders (e.g. autism [15]). Hence, the 
intestinal microbiota is important for the gut as gatekeeper of whole body homeostasis 
[1]. It is well known that diet also plays an important role for whole body homeostasis and 
diet has a large impact on microbiota composition [17], [18], [19]. For example, microbiota 
composition was seen to be more different between mice fed a different diet than mice 
with different genotype status [20]. Animal-based diets have a high impact on composition 
shifts with higher abundance in bile acid-tolerant bacteria (e.g. Bacteroides) and decreased 
abundance of saccharolytic (carbohydrate fermenting) Firmicutes such as Roseburia, 
Eubacterium rectale and Ruminococcus bromii [18]. Saccharolytic bacteria can degrade 
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carbohydrates to produce microbial metabolites such as pyruvate and others, which can 
be used to form SCFA. Hence, SCFA potentially mediate the effect of microbiota and diet 
on whole body homeostasis. 
Short-chain fatty acids (SCFA) - from microbiota to host 
After degradation and fermentation of dietary fibers by intestinal microbiota, short-chain 
fatty acids (SCFA) are produced. SCFA, also known as volatile fatty acids, are organic acids 
of carbon chain length C1-6. The most abundant SCFA that are formed are acetate C2, 
propionate C3 and butyrate C4 (in total ca. 90% of SCFA), while valerate C5, hexanoate C6 
and the branched-chain SCFA iso-butyrate C4 and iso-valerate C5 are present in lower 
amounts in colon [21]. SCFA are absorbed by the small intestine [22] and large intestinal 
epithelium [23]. Uptake across epithelial intestinal membrane takes place either via 
diffusion of the protonated SCFA or via active transport when dissociated. Next to 
bicarbonate exchange, monocarboxylate transport (via MCT1) and sodium-dependent 
monocarboxylate transport (via SMCT1) have been described as modes of transport [24]. 
All three SCFA are found in hepatic, portal and venous blood, with propionate being 
mainly taken up by the liver [25]. Propionate was found to affect cholesterol, fatty acid 
synthesis [26] and glucose metabolism [27], whereas acetate induces cholesterol synthesis 
[28]. Butyrate is mainly used by colonic epithelium where it serves as the preferred energy 
source as was demonstrated in isolated intestinal cells [29]. Many studies with butyrate 
have been performed in cultured cells demonstrating its anti-tumor effect through 
inhibition of cell proliferation and induction of apoptosis [30]. The molecular mechanisms 
underlying these effects of butyrate are widely attributed to its HDAC (histone deacetylase) 
inhibitory characteristics [31]. HDAC inhibition is related to regulation of gene expression 
by influencing chromatin structure and hence butyrate is important for gene regulation. 
Furthermore, SCFA are known to act via GPCR (G-protein coupled receptor) signaling. 
GPR41 (FFAR3) and GPR43 (FFAR2) have been identified as SCFA receptors [32,33]. The 
receptors play a role for regulation of immune response induced by SCFA [34], [35], [36]. 
Protective effects of SCFA on diet-induced obesity, however, seem to be independent of 
this receptor [37]. Hence, other, currently unknown mechanisms likely play a role. 
Angiopoietin-like protein 4 (Angptl4) 
Another proposed mechanism by which microbiota influences host energy metabolism is 
through induction of intestinal Fiaf/Angptl4 (fasting-induced adipose factor /angiopoie-
tin-like 4) [8], [9]. Angptl4 belongs to angiopoietin-like family of proteins and has been 
identified as target of PPAR (peroxisome proliferator-activated receptor) [38]. Angptl4 is a 
circulating factor inhibiting lipoprotein lipase activity thereby affecting fat storage. The 
Angptl4 mRNA levels are suppressed in small intestine in mice after conventionalization [8] 
and mice lacking Angptl4 were not protected from diet-induced obesity [9]. Hence, 
secreted, intestinal Angptl4 was suggested to play a role in protection from diet-induced 
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obesity by targeting distant tissues, which is, however, debated [39]. Fleissner et al. [39] 
showed that there was no difference in circulating Angptl4 in GF mice on high-fat diet or 
western diet, despite higher Angptl4 mRNA level compared to conventionalized mice. 
Detailed mechanisms by which Angptl4 is regulated by microbiota are scarce.
Techniques to study microbiota
While knowledge about microbiota has traditionally been limited to culture-based 
studies, it is now increased with culture-independent methods that allow better charac-
terization of gut microbiota by analysing bacterial genomes. These analyses can be 
achieved with different methods such as sequencing of 16S rRNA gene fragments and 
with a phylogenetic microarray. Originally developed for human species [40], phylogenetic 
microarrays have been developed and used for pig [41] and mouse as well [42]. The latter 
is referred to MITChip (mouse intestinal tract chip) as was used in this thesis. This microarray 
chip consists of oligonucleotide probes targeting two hypervariable regions of the 16S 
rRNA gene targeting 96 phylotypes. While the latter method can answer questions on 
microbiota composition (‘Who is there’), metatranscriptomics using RNA sequencing can 
be used to answer questions on transcriptional activity of the microbiota (‘What are they 
doing’). 
Nutrigenomics – studying host response
Studying interactions of nutrition and genes by using ~omics, high-throughput tools is 
collectively known as nutrigenomics. These tools include transcriptomics, proteomics and 
metabolomics. While transcriptomics measures RNA transcripts in a cell, proteomics 
assesses the protein products and metabolomics the metabolites produced. 
Nutrigenomics is successfully used to unravel underlying mechanisms of regulation and 
control of metabolic homeostasis by diet and host genetics [43]. Important in the control 
of metabolic homeostasis by diet is target gene regulation via transcriptional factors 
which act as nutrient sensors [44]. A well-studied group of nutrient sensors are PPARs. 
PPARs are ligand activated nuclear receptos of which the subtypes PPAR-α, -β , -γ have 
been identified. Next to synthetic ligands such as hypolipidemic drugs, also eicosanoids 
and fatty acids serve as ligands [45]. To study control and regulation of metabolic 
homoestasis by diet, nutrigenomics uses tools such as gene expression profiling and 
knock out mice models. Gene expression profiling can be performed with microarrays. 
Thereby, RNA isolated from tissue or cells is labeled with a dye for hybridization to an array 
that probes the expression of >22,000 genes. To test hypotheses generated from such 
gene expression profiling experiments, knockout mice models are useful. For example, 
using such nutrigenomics tools, the basic role of the isoform Pparα in small intestine [46] 
and in mediating the effect of dietary lipids on expression of genes related to barrier 
function has been demonstrated [47]. 
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Omics data analysis
Omics data are large (high-throughput) amounts of data that are generated in 
nutrigenomics experiments. Guidelines on how to analyse these data, for example from 
microarray experiments, are given in [48]. In first instance, genes differentially regulated 
between treatment and control condition are identified by applying fold change and 
statistical significant cut offs. These differentially regulated genes can further be analysed 
to gain insight into potentially regulated biological processes. Different analysis tools are 
available to study over-represented biological processes in the selected set of genes, such 
as in Ingenuity, Enrichr, DAVID, ClueGO. While thereby sets of genes are chosen for the 
analyses (e.g. by significance and/or fold change cut off), other methods can be applied 
that include all genes in the analyses. The most-used method for such an analysis is 
gene-set enrichment analysis (GSEA) [49]. Thereby, a gene list is generated in which all 
analysed genes are ranked by e.g. fold change or t-test value, taking into account the 
variation within a treatment group. To explore the functional implications of the most 
regulated genes in this list, the enrichment of sets of genes with annotated biological 
functions is calculated. Information about the biological processes or other potential 
functional implications is derived from literature. In addition, to generate new hypotheses 
about potential functional implications and to better understand complex systems, 
multivariate statistical analyses can to be used. Multivariate statistical tests can explore 
relationships between different types of data, i.e. different omics data sets. MixOmics 
(integrOmics) is an R package available to perform such analysis like Partial Least Squares 
regression and correlation analyses and to deliver graphical outputs helping in the 
interpretation of relationships between two omics datasets derived from individual 
samples rather than groups of samples [50].
Outline of thesis
The work presented in this thesis was part of a larger collaborative project from the 
Netherlands Consortium for Systems Biology and the Top Institute for Food and Nutrition 
(NCSB/TIFN) in which partners from the Division of Human Nutrition, the Laboratory of 
Microbiology (Wageningen University) and Groningen University worked together 
addressing questions to SCFA formation by gut microbiota and subsequent metabolism 
in gut and liver in mice. The main part of this thesis focuses on the question to what extent 
and by which mechanisms do dietary fiber and its degradation products, SCFA, in the gut 
affect host transcriptional response. In addition, the results described in this thesis include 
results from the subproject addressing questions on microbial population dynamics in 
relation to exogenous factors (diet) and endogenous factors (host response).
First, the transcriptional response of colonic mucosal cells to different SCFA on the 
background of different diets was determined. Mice were fed either low or high fat diet 
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and treated by rectal infusion with a solution of one of the SCFA (acetate, propionate, 
butyrate) or a control (saline) for 6 consecutive days. The colonic mucosal cell scrapings 
were used for analysing whole-genome gene expression changes by microarray (chapter 2). 
The objective of chapter 3 and 4 was to investigate the effect of different dietary fibers on 
the gut. Therefore, mice were fed diets supplemented with one of the five dietary fibers, 
inulin, fructo-oligosaccharides, resistant starch, guar gum or arabinoxylan for 10 days. 
SCFA were determined by gas chromatography and whole-genome gene expression of 
colon was analysed by microarray. In addition, microbiota composition was measured 
with a phylogenetic microarray (MITChip) (chapter 3) and microbiota activity was 
determined in cecal content by sequencing to determine how different dietary fibers 
impact bacterial gene activity (chapter 4). 
A potential factor mediating effects of diet and microbiota on host energy metabolism is 
ANGPTL4. Therefore, in chapter 5 the mechanism of transcriptional regulation of colonic 
ANGPTL4 by SCFA was investigated. To investigate the mechanism, effects of SCFA on 
regulation of ANGPTL4 were tested in colonic cell lines, and with PPAR transactivation and 
coregulator binding assays. To further explore regulation of PPARγ target genes by SCFA, 
an important regulator of adipogenesis, an adipocyte cell line was used. Furthermore, 
PPARγ target gene regulation was explored by gene expression profiling of colonic cell 
lines treated with either butyrate or a specific, full PPARγ agonist, Rosiglitazone, after 
which microarray was performed. 
Results from chapter 3 and 5 suggested that PPARγ plays an important role in mediating 
the transcriptional response to dietary fiber and SCFA in colon. To test this hypothesis, in-
testine-specific Pparγ knock out (KO) mice were fed with the dietary fiber inulin which was 
found to activate most target genes compared to other dietary fibers. Pparγ-dependent 
gene expression changes were determined by microarray (chapter 6). In addition, to 
study the effect of butyrate on Pparγ-dependent gene regulation, colonic organoids 
derived from Pparγ KO and wild type mice were treated with butyrate and gene expression 
changes were measured by microarray (chapter 6). 
Finally, in chapter 7 the outcomes of chapters 2 to 6 are discussed.       
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Abstract
Acetate, propionate, and butyrate are the main short-chain fatty acids (SCFA) produced in 
the colon as a result of microbial fermentation, and are believed to be important mediators 
of the gut microbiota on host metabolism. The aim of this study was to investigate the 
impact of these three SCFA on the colonic transcriptome in mice, and whether responses 
were modulated by the composition of the diet. Mice were fed a semi-synthetic low fat/
high carbohydrate (LFD), or high fat/low carbohydrate (HFD) diet for two weeks, after 
which they were subjected to repeated rectal infusion of either acetate, propionate, 
butyrate, or saline (control) solutions for 6 consecutive days. Colonic epithelial cell 
scrapings were subjected to gene expression profiling, and analyzed using a range of 
bioinformatics tools. SCFA induced distinct changes on colonic gene expression. 
Macronutrient composition of the diet impacted the colonic gene expression profiles 
more than SCFA treatment. In particular, for propionate opposite gene expression 
responses were observed on the LFD versus the HFD diets, which was not the case for 
acetate and to lesser extend for butyrate. Biological implications of differentially expressed 
genes reflected regulation of several metabolic and cell cycle related processes. In 
conclusion, SCFA induced distinct gene expression responses that are modulated by the 
diet composition.  
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Background
The gut microbiota is highly important for metabolic homeostasis and health, as it was 
found to play a crucial role in the regulation of energy homeostasis and fat storage [1,2]. 
The first evidence supporting this statement was derived from studies in germ-free mice, 
showing that conventionally raised mice had 42% more total body fat compared to 
germ-free mice, and conventionalization of germ-free mice resulted in a 57% increase in 
total body fat [3]. Furthermore, germ-free mice were protected from the development of 
obesity after consuming a high fat diet [4]. A possible factor explaining this effect are the 
microbial metabolites, among which the short-chain fatty acids (SCFAs) are produced at 
the highest levels. The physiological ratio and concentrations of the three main SCFA in 
mice vary dependent on the diet and the microbiota composition [5]. High concentrations 
of SCFA in mice were reported for colon with 100 mmol/L [6]. The three main SCFAs 
produced in the colon are acetate, propionate and butyrate, and each SCFA has distinct 
biological properties and can affect metabolism and health in a specific way. SCFA have 
been reputed to have regulatory role in fatty acid, glucose and cholesterol metabolism [5]. 
Butyrate is almost entirely utilized by colonocytes as their preferred energy substrate and 
therefore only a small proportion reaches the systemic circulation [7,8]. It has been observed 
that colonic administration (enema) of 100mM butyrate enhances the maintenance of 
colonic homeostasis in healthy humans, by regulating fatty acid metabolism, electron 
transport and oxidative stress pathways on gene expression level [9] Acetate and 
propionate are less efficiently used by the colon and can serve as anabolic substrates in 
tissues other than colon [10-12]. The molecular mechanisms underlying the effects of all 
three SCFA on colonic tissue are less well understood and have, to our knowledge, not 
been studied in the same model. Since measuring whole genome gene expression has 
the potential to obtain new insights in molecular mechanism underlying nutritional 
effects on metabolic homeostasis [13] , it is a good tool for studying effects of SCFA on 
colonic tissue. High fat diets have been efficiently used to study effects of diet on 
metabolic disturbances in mice [14], [4]. Furthermore, dietary fibers have been linked to 
the prevention of metabolic disturbances by modulating food intake and body weight in 
both humans and rodent studies [15]. An increasing amount of evidence suggests that the 
health benefits observed with dietary fiber consumption are partly due to the action of 
these SCFAs [16]. The modulating effects of SCFA on high-fat diet induced gene expression, 
however, is less well studies.  
In the current study we examined the effect of high fat diet intervention on changes in 
gene expression profile in colonic epithelial cells after colonic acetate, propionate, and 
butyrate administration. To have a closer look at the effects of each individual SCFA, we 
administered the SCFAs separately in this experiment. The experiment was performed in 
mice that were fed either a low fat or a high fat diet before and during SCFA treatment. 
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Methods
Ethics statement
The institutional and national guidelines for the care and use of animals were followed 
and the experiment was approved by the Local Committee for Care and Use of Laboratory 
Animals at Wageningen University.
Animals and diets
Male C57BL/6J mice were purchased from Charles River Laboratories (Maastricht, the 
Netherlands) at 8 weeks of age. Mice were housed individually in a light- and tempera-
ture-controlled animal facility, with light on from 23:00h to 11:00h. Mice had free access to 
water and food, and 24h food intake was monitored in every cage. Mice received standard 
laboratory chow (RMH-B, Arie Blok, Woerden, the Netherlands) during the first 2 weeks 
after arrival. Subsequently, mice were switched to semi-synthetic diets, either containing 
10 en% of fat (low fat/high carbohydrate diet; LFD; n = 24) or 45 en% of fat (high fat/low 
carbohydrate diet; HFD; n = 24). Diets were based on Research Diets formulas D12450B/
D12451, with adaptations regarding type of fat (palm oil instead of lard) and carbohydrates 
to mimic the fatty acid and carbohydrate composition of the average human diet in 
Western societies. Diets were prepared by Research Diet Services (Wijk bij Duurstede, The 
Netherlands). The complete composition of the diets is shown in Table 1. 
SCFA infusions
After 2 weeks on either the LFD or HFD, the 6-day treatment period started. Mice were 
assigned to one of 4 treatment groups: Control, Acetate, Propionate or Butyrate. On 6 
consecutive days, the mice were mildly sedated with a mixture of isofluorane (1.5%), 
nitrous oxide (70%) and oxygen (30%) 2h before the start of the dark phase, where after 
they received a rectal infusion of the test solutions. At time of infusion, mice were kept 
under sedation. Mice received an 80 µL saline solution (Control; n = 6 per diet group), or an 
80 µL saline solution containing 100 mM sodium acetate (Acetate; n = 6), 100 mM sodium 
propionate (Propionate; n = 6) or 100 mM sodium butyrate (Butyrate; n = 6). All solutions 
had a pH of 6.5 and were isotonic. The solutions were administered by inserting a gel 
loading tip 3 cm into the rectum and slowly pushing the solution out of the tip. 
Sample collection
Four hours after the rectal infusion on day 6, colonic scrapings were collected from 4 mice 
per group (32 in total). To reduce the inter-individual variation in physiological state at time 
of tissue collection, mice were provided a restricted amount of their habitual food 
(approximately 20% of their average daily intake of LFD or HFD) 2h before tissue removal. 
Mice were anaesthetized with isoflurane, where after the colon was excised and the 
length was measured. The adhering fat around the colon was carefully removed, and the 
27
Ef
fe
ct
s 
of
 S
C
FA
 o
n 
co
lo
ni
c 
tr
an
sc
rip
tio
na
l r
eg
ul
at
io
n
2
colon was cut open longitudinally. The intestinal content was removed and the tissue was 
rinsed with phosphate buffered saline. Subsequently, the epithelial lining of the colon was 
scraped. These scrapings were collected in 1.5 mL Eppendorf tubes, which were immediately 
snap frozen in liquid nitrogen and stored at -80°C for subsequent RNA isolation.
Table 1  Composition of the experimental diets
LFD HFD
g% kcal% g% kcal%
Protein 19 20 24 20
Carbohydrate 67 70 41 35
Fat 4 10 24 45
Total 100 100
kcal/g 3.85 4.73
Ingredient g kcal g kcal
Casein, lactic 200 800 200 800
L-Cystine 3 12 3 12
Corn starch 427.2 1,709 72.8 291
Maltodextrin 100 400 100 400
Sucrose 172.8 691 172.8 691
Cellulose, BW200
Soybean oil
50
25
0
225
50
25
0
225
Palm oil 20 180 177.5 1,598
Mineral mix S10026* 10 0 10 0
Dicalcium phosphate
Calcium carbonate
13
5.5
0
0
13
5.5
0
0
Potassium citrate, 1 H2O 16.5 0 16.5 0
Vitamin mix V10001# 10 40 10 40
Choline bitartrate 2 0 2 0
Total 1,055 4,057 858.1 4,057
LFD, low fat diet; HFD, high fat diet. *Mineral mix S10026 contains the following (g/kg mineral mix): 41.9 
magnesium oxide, 257.6 magnesium sulfate•7H2O, 259 sodium chloride, 1.925 chromium KSO4•12H2O, 1.05 cupric 
carbonate, 0.035 potassium iodate, 21 ferric citrate, 12.25 manganous carbonate, 0.035 sodium selenite, 5.6 zinc 
carbonate, 0.20 sodium fluoride, 0.30 ammonium molybdate•4H2O, 399.105 sucrose. 
#Vitamin mix V10001 
contains the following (g/kg vitamin mix): 0.80 retinyl palmitate, 1.0 cholecalciferol, 10 all-rac-a-tocopheryl 
acetate, 0.08 menadione sodiumbisulfite, 2.0 biotin (1.0%), 1.0 cyancocobalamin (0.1%), 0.20 folic acid, 3.0 nicotinic 
acid, 1.6 calcium pantothenate, 0.70 pyridoxine-HCl, 0.60 riboflavin, 0.60 thiamin-HCl, and 978.42 sucrose.
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RNA isolation and quality control
Total RNA was isolated from colon samples using TRIzol reagent (Invitrogen, Breda, the 
Netherlands) according to the manufacturer’s instructions, followed by RNA Cleanup 
using the RNeasy Micro kit (Qiagen, Venlo, the Netherlands). Concentrations and purity of 
RNA samples were determined on a NanoDrop ND-1000 spectrophotometer (Isogen Life 
Science, De Meern, the Netherlands). RNA quality was verified on an Agilent 2100 
Bioanalyzer (Agilent Technologies, Amstelveen, the Netherlands) using 6000 Nano Chips 
according to the manufacturer’s instructions. RNA was judged as suitable for array 
hybridization only if samples exhibited intact bands corresponding to the 18S and 28S 
ribosomal RNA subunits, and displayed no chromosomal peaks or RNA degradation 
products (RNA Integrity Number > 8.0).
Microarray hybridization 
Samples were subjected to genome-wide expression profiling using Affymetrix Mouse 
Gene 1.1 ST arrays (Affymetrix, Santa Clara, CA). Total RNA (100 ng) was used for whole 
transcript cDNA synthesis using the Ambion WT expression kit (Life Technologies, 
Nieuwekerk a/d IJssel, the Netherlands) and subsequently labeled using the Affymetrix 
GeneChip WT Terminal Labeling Kit (Affymetrix, Santa Clara, CA). Samples were hybridized, 
washed, stained, and scanned on an Affymetrix GeneTitan instrument. Detailed protocols 
for array handling can be found in the GeneChip WT Terminal Labeling and Hybridization 
User Manual (Affymetrix; P/N 702808, Rev. 4) and are also available on request. 
Microarray analysis
Packages from the Bioconductor project [17], integrated in an online pipeline [18], were 
used to analyze the array data. Various advanced quality metrics, diagnostic plots, 
pseudoimages, and classification methods were used to determine the quality of the 
arrays prior statistical analysis [19,20]. From the 32 samples, one colon sample, derived 
from a mouse on the LFD in the Acetate group, was excluded from analyses because the 
array was of insufficient quality. The 828,268 probes on the Mouse Gene 1.1 ST array were 
redefined utilizing current genome information from the Entrez Gene database (custom 
CDF v16) [21]. Array data have been submitted to the Gene Expression Omnibus, a 
database repository for gene expression data hosted at the NCBI, under accession number 
GSE48856. Normalized gene expression estimates were obtained from the raw intensity 
values using the Robust Multi-array Average (RMA) preprocessing algorithm available in 
the library ‘AffyPLM’ using default settings [22]. The Mouse Gene 1.1 ST array probes the 
expression of 21,225 unique genes. Differentially expressed genes (probe sets) were 
identified using linear models, applying moderated t-statistics that implemented empirical 
Bayes regularization of standard errors (library ‘limma’). The moderated t-test statistic has 
the same interpretation as an ordinary t-test statistic, except that the standard errors have 
been moderated across genes, i.e. shrunk to a common value, using a Bayesian model [23]. 
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To adjust for both the degree of independence of variances relative to the degree of 
identity and the relationship between variance and signal intensity, the moderated 
t-statistic was extended by a Bayesian hierarchical model to define an intensity-based 
moderated T-statistic (IBMT) [24]. IBMT improves the efficiency of the Empirical Bayes 
moderated t-statistics and thereby achieves greater power while correctly estimating the 
true proportion of false positives. Probe sets that satisfied the criterion of P < 0.01 were 
considered to be significantly regulated. The dataset was filtered to only include probe 
sets that were active (i.e. expressed) in at least 3 samples using the universal expression 
code (UPC) approach (UPC score > 0.50) [25]. This resulted in the inclusion of 8,655 of the 
21,187 probe sets. Partial Least Square Discriminant Analysis (PLS-DA) was used to 
discriminate the different treatments based on gene profiles. Analyses were performed in 
R using the library mixOmics. Similarity of the effects of each SCFA on the LFD and HFD 
was assessed using the Rank-rank Hypergeometric Overlap (RRHO) algorithm [26]. RRHO 
is a threshold-free method which visualizes the overlap between two ranked lists of 
differentially expressed genes. In brief, genes differentially expressed between SCFA 
infusion and the control treatment were ranked according to their IBMT t-statistic. The 
hypergeometric P value of overlap was calculated to determine the significance of 
overlapping genes between two datasets which is visualized in a matrix. On the x-axis of 
the matrix, genes were ranked by their degree of differential regulation (top up to bottom 
down) between SCFA infusion on the LFD compared to the control infusion on the LFD. 
On the y-axis genes were ranked based on their expression change with SCFA treatment 
on the HFD compared to control. 
Analysis of functional implications
Changes in gene expression were related to functional changes using gene set enrichment 
analysis (GSEA) [27]. GSEA has the advantage that it is unbiased, because no gene selection 
step is used, and a score is computed based on all genes in a gene set. Briefly, genes were 
ranked based on the IBMT-statistic and subsequently analyzed for over- or underrepresen-
tation in predefined gene sets. Gene sets were retrieved from the expert-curated KEGG, 
Biocarta, Reactome and WikiPathways pathway databases. Only gene sets consisting of 
more than 15 and fewer than 500 genes were taken into account. Statistical significance of 
GSEA results was determined using 1,000 permutations. The Enrichment Map plugin for 
Cytoscape was used for visualization and interpretation of the GSEA results [28,29]. 
Statistics
Results on food intake and body weight were expressed as means ± SEM, regarding P < 0.05 
as statistically significant.
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Results
Food intake and body weight development
At the start of the 2-week intervention on the LFD and HFD, mice were stratified into 2 
groups based on body weight, that averaged 22.7 g in both groups. Mice fed the HFD 
consumed the same amount of food as mice receiving the LFD (3.11 ± 0.08 versus 3.09 ± 
0.04 g per day, respectively). However, since the HFD contained more energy per gram, 
the caloric intake was significantly higher in mice fed the HFD compared to mice fed the 
LFD (14.8 ± 0.36 versus 11.9 ± 0.14 kcal per day, respectively; P < 0.0001). During the 
treatment period, caloric intake of mice on the HFD remained significantly higher 
compared to mice fed the LFD (Table 2). SCFA treatment did not significantly affect caloric 
intake within both diet groups. After the 2-week intervention, body weight of mice fed the 
HFD was significantly higher compared to mice fed the LFD (26.6 ± 0.31 versus 23.9 ± 0.24 
g respectively; P < 0.0001), which is in line with the observed difference in caloric intake 
between the 2 diet groups. During the SCFA treatment period, body weight change was 
similar with all SCFA treatments (data not shown).
Diet composition is more related to variation in gene expression 
than SCFA infusion   
After the SCFA treatment period, gene expression in colonic scrapings was profiled on 
microarrays. PLS-DA revealed that the mice were clustering on first axis by the 
macronutrient composition of the diet (Figure 1). Mice on the left hand side of the plot 
received HFD whereas mice clustering on the right hand side received LFD. In addition, 
Table 2  Daily food intake during the SCFA treatment period in mice fed the LFD or HFD
Daily food intake (g) Daily food intake (kcal)
LFD Control 3.03 ± 0.076 11.67 ± 0.294
Acetate 2.98 ± 0.118 11.48 ± 0.453
Propionate 3.08 ± 0.114 11.84 ± 0.439
Butyrate 2.89 ± 0.076 11.14 ± 0.293
Average all treatments 3.00 ± 0.049 11.54 ± 0.188
HFD Control 2.71 ± 0.095 12.80 ± 0.450
Acetate 2.70 ± 0.097 12.77 ± 0.457
Propionate 2.57 ± 0.084 12.17 ± 0.400
Butyrate 2.48 ± 0.100 11.73 ± 0.474
Average all treatments 2.61 ± 0.047** 12.37 ± 0.224**
Values are means ± SEM, n = 6 per diet group, ** indicates a significant difference between average daily food 
intake in mice fed the LFD compared to mice fed HFD (P <0.01). LFD, low fat diet; HFD, high fat diet.
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mice receiving propionate on the HFD were deviating from all other mice, whereas on a 
LFD mice receiving propionate were overlapping with butyrate treated mice in their gene 
expression profile. These data indicate the importance of the macronutrient composition 
on the gene expression response to SCFA in colon.  
Figure 1  PLSDA plot colonic gene expression profile
Partial Least Square Discriminant Analysis (PLSDA) was used to discriminate samples of mice 
receiving SCFA or control treatment on the LFD or HFD based on their gene expression profile. The 
first two dimensions, explaining the highest variation, are shown.
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SCFA-induced gene expression response is differentially  
modulated by diet
To characterize and compare the transcriptional responses to SCFA treatment on LFD and 
HFD, a cutoff free method, the RRHO analysis, was applied. As indicated by the RRHO 
p-value heatmaps (Figure 2), the transcriptional response to propionate was strikingly 
different on the two diets. For acetate we noticed in the RRHO heatmap a significant 
(yellow-red) area ranging from the lower left to the upper right corner of the map (Figure 2A). 
This showed that the gene ranking in both lists was rather similar, which indicated that the 
genes regulated by acetate on either the LFD or HFD were similar, even in case of a 
different extent of regulation. For butyrate treatment a comparable RRHO heatmap was 
Figure 2  Effects of dietary fat on colonic gene expression
Heatmaps of Rank-Rank Hypergeometric Overlap (RRHO) analysis of the effect of 6-day acetate (A), 
propionate (B), and butyrate (C) infusion on colonic gene expression, and Venn diagrams showing 
the number of significantly regulated genes (P < 0.01) in the colon of mice after 6 days of rectal 
infusion of acetate (D), propionate (E) or butyrate (F). For RRHO analysis all 8655 filtered genes were 
used to determine the overlap between the transcriptional responses on the LFD and the HFD after 
SCFA infusion. The plots indicate the pattern of overlap between the LFD and the HFD background. 
Differentially regulated genes for each SCFA infusion on HFD versus LFD background were ranked 
based on Limma t value and plotted along the axis, with the X-axis representing the LFD and the 
Y-axis representing the HFD. Color represents the degree of hypergeometric distribution (Benjamini 
and Yekutieli-corrected signed log10 transformed P value of overlap). Each Venn diagram shows the 
number of regulated genes on a LFD background, on a HFD background and the number of genes 
regulated on both dietary backgrounds. Effects of SCFA infusion were compared with effects after 
saline infusion in mice fed the same background diet (LFD or HFD).
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observed, although the significance area was more pronounced in the top-right area 
(Figure 2C), which suggested a higher similarity between genes repressed by butyrate 
between the LFD and the HFD. In contrast, for propionate treatment a completely different 
RRHO heatmap was observed (Figure 2B). A significant (blue-green) area was observed 
mainly in the upper left quarter of the heatmap that further extended across to bottom 
right of the diagonal. Since RRHO conventions state a strong negative signal should be 
interpreted as a strong positive trend in the opposite sense [26], these results showed that 
genes induced by propionate on the LFD were suppressed on the HFD while genes 
induced by propionate on the HFD were suppressed on the LFD. The results indicate that 
diet composition has a major impact on propionate-induced gene regulation.  
To further study effects of diet composition on SCFA-induced gene expression changes, 
we determined the number of genes regulated (P < 0.01) by acetate, propionate or 
butyrate treatment on LFD or HFD as compared to the control infusion (LFD or HFD, 
respectively). We observed an increase in the number of regulated genes for SCFA with 
increasing chain length under LFD conditions, i.e. acetate-LFD (31 genes), propionate-LFD 
(77 genes) and butyrate-LFD (117 genes) compared to control-LFD. This was not observed 
for HFD conditions. Propionate treatment resulted in a much higher number of regulated 
genes than acetate or butyrate on HFD (291 genes vs. 42 for acetate and 60 for butyrate, 
compared to HFD control). To compare genes regulated by each SCFA between the 
different background diets, we used Venn diagrams (Figure 2D-F). The comparison 
revealed that the number of genes commonly regulated by SCFA on the LFD or HFD, 
respectively was relatively low. For propionate we noticed that genes commonly regulated 
on LFD and HFD were regulated in opposite direction. From the 23 commonly regulated 
genes, 11 were induced on LFD and suppressed on HFD, and 11 genes were suppressed 
on the LFD and induced on HFD. Furthermore, we compared the number of genes 
regulated by the three SCFA per diet background (Figure 3) and revealed that SCFA 
induced very distinct gene expression responses with only one gene overlapping on both 
LFD or HFD, respectively. 
In summary, the results showed that SCFA induced distinct responses in colonic gene 
expression and that diet can modulate the SCFA-induced gene expression response. The 
effect was most pronounced for propionate as was seen by the overlapping genes 
regulated in opposite direction under the two different diets. 
Functional implications of gene expression changes
GSEA was performed to determine which biological processes were affected by the SCFA 
treatments. Results on the LFD and HFD were jointly visualized in enrichment maps 
(Supplemental Figure 1A-C). SCFA regulated various processes, and in particular for 
propionate these processes were majorly influenced by feeding LFD or HFD. Gene sets 
that were activated on LFD and suppressed on HFD with propionate infusion included 
DNA repair, cell cycle, metabolic (e.g. amino acid, gluconeogenesis) and vitamin related 
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processes, whereas gene sets suppressed on the LFD and activated on HFD encompassed 
translation and electron transport chain related processes. For acetate, no such 
oppositional regulation was observed. Acetate activated mainly gene sets related to 
translation, and suppressed mainly cell cycle, electron transport chain, mitochondrial 
translation and lipid digestion related processes. Similar to propionate, butyrate also 
regulated gene sets in opposite direction. Among the gene sets activated on HFD and 
suppressed on LFD by butyrate were mainly RNA, DNA and cell cycle related processes. In 
general, most gene sets regulated with butyrate on HFD were activated or not changed, 
while on LFD most gene sets were suppressed. Among these suppressed gene sets on 
LFD were PPAR signaling, lipoprotein metabolism and lipid digestion. On both diets, 
butyrate suppressed mainly electron transport chain and TCA cycle related gene sets. 
Discussion
To our knowledge, this is the first experiment in which the impact of diets differing in 
macronutrient composition, in particular in fat content, on gene expression changes 
induced by colonic SCFAs was investigated. We showed that more variation in gene 
expression profiles was coinciding with macronutrient composition of the diet rather than 
with SCFA treatment. Gene expression responses to propionate were much dependent 
on the diet, whereas that was not observed for acetate and to lesser extend for butyrate. 
Functionally, expression changes reflected differential modulation of several metabolic 
processes. 
Figure 3  Venn diagrams of significantly regulated genes in colon
Each Venn diagram shows the number of significantly regulated genes (P < 0.01) in the colon of mice 
fed the LFD (A) or the HFD (B) after 6 days of rectal infusion of acetate, propionate, and butyrate. 
Effects of SCFA infusion were compared with effects after saline infusion in mice fed the same 
background diet (LFD or HFD).
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Although a HFD combined with colonic SCFA treatment has not been studied before, 
experiments have been conducted to determine the effect of diets both high in fibers 
and fat. A mouse study reported that fermentable fiber decreased energy intake, body 
weight gain, and fat mass when added to a high fat diet [30]. A similar effect was observed 
in pigs fed diets differing in fat level (5% or 17.5%) and fiber type (fermentable or non-fer-
mentable fiber) [31]. The fermentable fiber inulin resulted in an attenuation of the body 
weight development and fat mass accumulation induced by high fat feeding, suggesting 
a strong interplay between dietary fat and fiber type. We speculate this interaction might 
be, at least partially, attributed to an increased SCFA production resulting from fermentation 
of fibers by bacteria in the colon, as we showed that SCFA have modulatory effects on 
diet- induced gene expression. 
It was previously shown that the colonic microbiota composition is affected by dietary fat 
content [32]. Although our experiment did not allow the measurement of microbiota 
composition, we assume the 2-week run-in period on either a low or high fat diet might 
have resulted in a stable change in microbiota composition, as has been reported [33-35]. 
Therefore, it is very likely that part of the colonic gene expression changes observed on 
the HFD background are the result of changed microbial composition. Interestingly, a 
number of studies showed that animals fed a HFD have lower intestinal concentrations of 
acetate, propionate, and butyrate than animals on a LFD [31,36]. It appears that HFD 
feeding reduces the fermentation capacity of the microbiota compared with a LFD, which 
might be related to the lower amount of carbohydrates in the HFD compared to LFD. In 
our study, the amount of colonic SCFAs that was infused was kept constant both in mice 
fed the LFD and in mice fed the HFD. 
Effects of acetate and butyrate were comparable, whereas propionate induced very 
distinct changes in gene expression profile. For example, both acetate and butyrate 
suppressed gene sets related to lipid digestion, while this was not seen for propionate. 
Propionate specifically regulated gene sets related to amino acid metabolism. It is known 
that both acetate and butyrate enter the TCA cycle as acetyl-CoA, whereas propionate 
enters as succinyl-CoA [37]. It can be speculated that this pattern of SCFA utilization is 
related to the similar effects of acetate and butyrate on gene expression level. Furthermore, 
it is known that butyrate and acetate are interconverted by the intestinal microbiota [38]. 
This inter-conversion might have resulted in the production of additional acetate or 
butyrate in both infusion groups which might, in part, explain similar and overlapping 
effects on colonic gene expression. In general, the metabolic implications of lipoprotein 
and lipid metabolic processes are not well described for colonic tissue. However, the 
changes on gene expression level suggest a role for colonic tissue in lipid metabolism.
Conclusion
We showed that diet composition has a major impact on gene expression response to 
SCFAs in colon, an important metabolic organ, and conclude that effects of SCFA on gene 
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expression are modulated by diet-driven changes in colon. Next to butyrate, which has 
well known importance for colon, we found that also other SCFA have an impact on 
colonic gene regulation. While acetate and butyrate induced a similar gene expression 
profile, the effects of propionate on gene regulation are more specific. 
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Figure S1  Enrichment maps indicating positively and negatively enriched gene sets 
Enrichment maps were created to visualize gene expression changes in colon after acetate (A), 
propionate (B), and butyrate (C) treatment. Nodes represent functional gene sets, and edges 
between nodes represent their similarity. The inner part of each node indicates the effect on a LFD 
background; the outer part of each node indicates the effect on a HFD background. Red indicates 
induction and blue indicates suppression of gene sets with SCFA infusion compared with saline 
infusion. A white color indicates that the gene set was not enriched. Node size represents the gene 
set size, and edge thickness represents the degree of overlap between two connected gene sets. 
The significance thresholds used were P < 0.05, False Discovery Rate < 0.01, and Jaccard + Overlap 
Combined 0.375
40
Figure S1  Continued
41
Ef
fe
ct
s 
of
 S
C
FA
 o
n 
co
lo
ni
c 
tr
an
sc
rip
tio
na
l r
eg
ul
at
io
n
2
Figure S1  Continued

Chapter 3
Comparison of the effects  
of five dietary fibers on mucosal 
transcriptional profiles and luminal 
microbiota composition and SCFA 
concentrations in murine colon
Katja Lange*, Floor Hugenholtz*, Melliana C Jonathan, 
Henk A Schols, Michiel Kleerebezem, Hauke Smidt, Michael Müller, 
Guido J.E.J. Hooiveld
*These authors contributed equally to this work
Submitted.
44
Abstract
Consumption of diets rich in fibers has been associated with beneficial effects on gastro-
intestinal health. However, detailed, comparative studies on molecular effects of dietary 
fibers in colon are limited. The aim of our study was to investigate and compare the effects 
of five fibers on the mucosal transcriptome, together with alterations in the luminal 
microbiota composition and SCFA concentrations in colon. Mice were fed fibers that 
differed in carbohydrate composition or a control diet for 10 days. Colonic gene expression 
profiles and luminal microbiota composition were determined by microarray techniques, 
and integrated using multivariate statistics. Our data showed a distinct reaction of the 
host and microbiota to resistant starch, a fiber that was not completely fermented in the 
colon, whereas the other fibers induced similar responses on gene expression and 
microbiota. Consistent associations were revealed between fiber-induced enrichment of 
Clostridium cluster XIVa representatives and Parabacteroides distasonis, and changes in 
mucosal expression of genes related to energy metabolism. The nuclear receptor Pparγ 
was predicted to be an important regulator of the mucosal responses. Taken together, our 
results suggest that despite different source and composition, fermentable fibers induce 
a highly similar mucosal response that may at least be partially governed by Pparγ. 
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Introduction
From a scientific and regulatory perspective multiple definitions of dietary fiber have been 
proposed, but in 2009 the first internationally agreed definition was adopted by the CODEX 
Alimentarius Commission [1,2]. Essentially, dietary fibers encompass predominantly complex 
carbohydrate polymers with ten or more monomeric units that escape digestion and 
absorption in the small intestine. However, when derived from a plant origin, dietary fiber may 
include fractions of lignin and/or other compounds associated with polysaccharides in 
the plant cell walls, and the decision on whether to include carbohydrates of 3 to 9 
monomeric units is ultimately left up to national authorities [1,2]. Importantly, consumption 
of fiber-rich diets has been associated with a variety of beneficial health effects, including 
the improvement of gastrointestinal homeostasis [3-6]. 
Upon entering the large intestine, dietary fibers are completely or partially fermented by 
the gut microbiota, resulting mostly in the generation of short chain fatty acids (SCFA) 
[7,8]. The main SCFA that are produced are acetate, propionate, and butyrate, but the SCFA 
production and ratio depend on the type of fiber, which potentially affect the existing 
microbiota composition. [9-11].
Much research has been conducted to investigate effects of dietary fibers on gut health 
and microbiota composition, however, most in vitro, animal or human studies investigated 
a single fiber at a time. Regarding the microbiota, both of the two main phyla Bacteroidetes 
and Firmicutes contain a large range of carbohydrate utilizing enzymes [12], indicating a 
role in complex dietary fiber degradation for both phyla. For example, it has been reported 
that Bacteroides spp. have a range of glycoside hydrolases and are capable of switching 
between different substrates [12,13], producing several metabolites including succinate, 
acetate and propionate [9]. On the other hand, some groups of bacteria, such as some 
members of the Bifidobacterium genus, are specialized to ferment certain oligosaccha-
rides [14,15], with lactate and acetate as the main fermentation products [9]. As a result 
dietary fibers modulate the microbiota composition by triggering bacteria that directly 
feed on them, but also the cross-feeding bacteria that depend on these primary degraders. 
Data on the genome-wide transcriptional effects of dietary fibers in colonic mucosa are 
scarce. This is remarkable since there is a major interest in characterizing the genes and 
networks that are regulated by food components, because this contributes to our 
understanding of a healthy diet [16,17]. It has only been reported that differential gene 
expression due to consumption of resistant starch (RS) suggested improvement of 
structure and function of the gastrointestinal tract in rats [18], and induced catabolic but 
suppressed immune and cell division pathways in the proximal colon of pigs [19]. In 
addition, it was shown that oligofructose (FOS) induced expression of genes involved in 
the tricarboxylic acid (TCA) cycle, oxidative phosphorylation and proteasome-mediated 
degradation of intracellular proteins in the rat colon [20].
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The aim of the current study was to comprehensively investigate and compare the effects 
of five different fibers on the mucosal transcriptome, together with alterations in the 
luminal microbiota composition in the murine colon. To this end, mice were fed diets 
enriched with fibers that differed in carbohydrate composition or a control diet for 10 
days. Colonic gene expression profiles and luminal microbiota composition were 
determined by microarray techniques, and integrated using multivariate statistics.
Methods
Ethics statement
The institutional and national guidelines for the care and use of animals were followed 
and the experiment was approved by the Local Committee for Care and Use of Laboratory 
Animals at Wageningen University (DRS code: 2010167).
Animals, diets, design and sampling
Male C57BL/6J mice were purchased from Charles River Laboratories (Maastricht, the 
Netherlands) at 6 weeks of age. Mice were housed in pairs in a light- and temperature- 
controlled animal facility of Wageningen University (12 hour light-dark cycle; light on from 
11h PM to 11h AM, 21 °C). Mice had free access to water and food throughout the entire 
experimental period. Upon arrival, mice were fed standard lab chow (RMH-B, Arie Blok, 
Woerden, the Netherlands) for 3 wks. Subsequently, all mice were adjusted to the control 
diet, a standard semi-synthetic low fat diet containing corn starch, for 2 wks. To achieve 
similar weight distribution among the diet groups, mice were stratified according to their 
body weight to one of the six diet groups (n=10 per diet group), i.e. control (CON), inulin 
(IN), oligofructose (FOS), arabinoxylan (AX), guar gum (GG) or resistant starch (RS). The 
diets enriched in fiber were identical to the control diet, except that 10% (w/w) of corn 
starch was replaced by each fiber (20% for RS, see below). Inulin (brand name Frutafit IQ), 
a fructan isolated from roots of chicory (DP2-60, average chain length monomers: 11) and 
oligofructose (brand name Frutalose OFP), another fructan (DP2-7) obtained from inulin 
by partial enzymatic hydrolysis, were a gift of Dr Diederick Meyer (Sensus, Roosendaal, the 
Netherlands). Arabinoxylan (brand name NAXUS), mechanically extracted from wheat 
endosperm, was a gift of Dr Hans van der Saag (BioActor, Maastricht, the Netherlands). 
Guar gum (brand name Viscogum), a galactomannan, and resistant starch (brand name C* 
ActiStar 11700), a retrograded starch obtained from tapioca by an enzymatic treatment, 
were obtained from Cargill R&D Centre Europe (Vilvoorde, Belgium). On the basis of 
physical and chemical characteristics, the RS used in this study can be classified as RS type 
3 (RS3). According to the supplier, the RS was only 50% resistant to digestion in the small 
intestine, and was therefore included in the diet at a 20% (w/w) level, i.e. double the amount of 
the other fibers. Diets were prepared by Research Diet Services (Wijk bij Duurstede, The 
Netherlands). Detailed composition of the diets is presented in Supplemental Table 1. 
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Mice were fed the fiber or control diets for 10 days. This period was based on the observation 
in mice that a switch from a standard low-fat, plant polysaccharide-rich diet to a high-fat, 
high-sugar Western diet resulted in a shift in microbiota composition that stabilized by 7 
days [21]. On the day of sections, mice were fasted for 4hrs (starting at 5 AM). Mice then 
received a calibrated meal of 1g of their habitual diet to reduce the inter-individual 
variation in physiological state at time of tissue collection. Four hours later mice were 
anaesthetized with isoflurane, and the colon was excised. The adhering fat around the 
colon was carefully removed, and the colon was cut open longitudinally. The luminal 
content was sampled and the tissue was rinsed with ice-cold phosphate buffered saline. 
Subsequently, the epithelial lining of the colon was scraped off. Luminal content and 
scrapings were collected in tubes, which were immediately snap frozen in liquid nitrogen 
and stored at -80°C. 
RNA isolation, Affymetrix microarray processing and analysis 
Colonic scrapings (n=6 per diet group) were subjected to genome-wide expression 
profiling. In brief, total RNA was isolated from epithelial scrapings and were hybridized on 
Mouse Gene 1.1 ST arrays (Affymetrix). Packages from the Bioconductor project [22], 
integrated in an online pipeline [23], were used for quality control and statistical analysis 
of the array data. Due to insufficient quality, 1 array from the control group had to be 
excluded from further analysis. The dataset was filtered to only include probe sets that 
were active (i.e. expressed) in at least 5 samples using the universal expression code (UPC) 
approach (UPC score > 0.50) [24]. This resulted in the inclusion of 8,831 (42%) of the 21,187 
probe sets. Differentially expressed probe sets were identified by using linear models and 
an intensity-based moderated t-statistic [25,26]. Probe sets that satisfied the criterion of P 
< 0.01 were considered to be significantly regulated. Array data have been submitted to 
the Gene Expression Omnibus under accession number GSE59494. Detailed information 
on microarray processing and data analysis can be found under Supplemental Methods. 
Biological interpretation of array data
Changes in gene expression were related to biologically meaningful changes using gene 
set enrichment analysis (GSEA) [27]. It is well accepted that GSEA has multiple advantages 
over analyses performed on the level of individual genes [27-29]. GSEA evaluates gene 
expression on the level of gene sets that are based on prior biological knowledge, e.g. 
published information about biochemical pathways or signal transduction routes, 
allowing more reproducible and more interpretable analysis of gene expression data; 
GSEA is unbiased, because no gene selection step (fold change and/or p-value cutoff) is 
used; a GSEA score is computed based on all genes in gene set, which boosts the signal-
to-noise ratio and allows to detect affected biological processes that are due to only 
subtle changes in expression of individual genes. Gene sets were retrieved from the 
expert-curated KEGG, Biocarta, Reactome and WikiPathways pathway databases. Only 
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gene sets consisting of more than 15 and fewer than 500 genes were taken into account. 
For each comparison, genes were ranked on their t-value that was calculated by the 
empirical Bayes method. Statistical significance of GSEA results was determined using 
1,000 permutations. The Enrichment Map plugin for Cytoscape was used for visualization 
and interpretation of the GSEA results [30]. Upstream Regulator Analysis in IPA (content 
version 18030641 released 2013; Ingenuity Systems) was used to identify the cascade of 
potential upstream transcriptional regulators that may explain the observed gene 
expression changes in the data set, and whether they are likely activated or inhibited. 
Biological interpretation of selected genes, e.g. identified by multivariate correlation 
analysis, was performed in Enrichr [31].
DNA isolation, microbiota MITchip processing and analysis 
Total bacterial DNA was extracted from colonic luminal content samples (n=4-5 per diet 
group) using the repeated bead beating plus column method [32]. Quantification of the 
overall bacterial community density was performed by qPCR targeting the 16 rRNA gene, 
whereas the microbial community composition was analyzed using the Mouse Intestinal 
Tract Chip (MITChip) [33] (for further details also see Supplemental Methods). The relative 
abundance of 96 genus-level bacterial groups detected on the MITchip was determined by 
the Robust Probabilistic Averaging algorithm [34]. To assess the correlation of the microbial 
groups with all diets groups, multivariate redundancy analysis (RDA) was performed as 
implemented in Canoco for Windows 4.5 [35]. The Monte Carlo Permutation test was used 
to assess the significance of the variation in the dataset in relation to the diet. 
Short-chain fatty acid analysis of colonic luminal content 
Luminal samples (n=3-5 per diet group) were analyzed for SCFA concentration by gas 
chromatography as described before [36]. 
Saccharide analysis of colonic luminal content
Luminal samples (n=1 per group) were used for analysis of mono-, di- and oligosaccharides by 
high-performance anion-exchange chromatography coupled with pulsed amperometric 
detection (HPAEC-PAD), essentially as described before [37]. Full experimental details can 
be found under Supplemental Methods. 
Multivariate integration and correlation analysis 
To get insight into the interactions between changes in gene expression and microbiota 
composition, the datasets were combined using the linear multivariate method partial 
least squares (PLS) [38]. This analysis ignores diet group membership. For 15 mice both 
gene expression and microbiota composition data was available, but to increase power 
the dataset was expanded with 7 measurements performed in mice housed in the same 
cage. Since we did not want to make any ‘a priori’ assumption on the relationship between 
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the two sets of variables that were analyzed, the canonical correlation framework of PLS 
was used [39]. Both datasets were log2 transformed before analysis, and the correlation 
matrices were visualized in clustered image maps [40]. Analyses were performed in R 
using the library mixOmics [41].
Results
Modulation of gene expression in colonic epithelial cells  
by dietary fibers
Expression profiling by microarray was performed to assess the genome-wide differences 
in gene expression in colonic epithelial cells of animals fed different dietary fibers. First 
individual mice were compared on basis of their gene expression profile and diet using 
sparse PLS-Discriminant Analysis (DA). Results of this analysis showed that the gene 
expression profiles were clearly distinguishable between samples of the control, RS and 
the other 4 fiber groups (FOS, IN, GG, AX) (Figure 1). Within the cluster of IN, FOS, AX, and 
GG samples, separation was much less distinct due to individual animal variation, but the 
AX samples tended to separate from the majority of IN, FOS and GG samples. Thus, based 
on their effect on global gene expression patterns, diet groups could be grouped in three 
main clusters. Next, the number of significantly (P < 0.01) regulated genes per fiber 
compared to control were determined. The expression of in total 1,733 genes was altered 
by at least 1 fiber. The largest number of changed genes was observed for FOS (925), and 
smallest for RS (287). The percentage of uniquely regulated genes varied between 21% (IN) 
and 40% (RS). Only 28 genes were commonly regulated by all fibers (Supplemental 
Figure 1). Taken together, RS appeared to be most similar to the control diet and induced 
only few, but specific gene expression changes, whereas the other fibers induced a larger, 
but more similar responses.
Biological interpretation of differential gene expression  
in epithelial cells
It is well recognized that analyses of expression data on the level of gene sets is more 
sensitive, reproducible and interpretable than the analysis at the level of individual genes 
(see Methods section). Gene set enrichment analysis (GSEA) was therefore performed to 
gain better insight into the biological functions represented by the regulated genes. 
Significantly induced or suppressed gene sets (p < 0.001, FDR <0.01) were identified for 
each fiber (Supplemental Figure 2), and biological processes summarized in Table 1. For 
RS the smallest number of changed gene sets were found, and these sets were mostly 
distinct from the sets found for the other fibers, being in line with the expression data at 
the level of individual genes. Gene sets induced by IN, GG, FOS and AX were largely 
comparable. Among the induced gene sets were energy-generating processes such as 
TCA cycle, electron transport chain, and oxidative phosphorylation. In addition, glycolysis, 
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phase I/II metabolism and target genes of the transcription factors peroxisome proliferator- 
activated receptor (PPAR) and nuclear factor (erythroid-derived 2)-like 2 (NRF2), were 
commonly activated for the fiber diets, except RS. Suppression of gene sets describing 
RNA processing and translation was found for RS as well as IN, GG and AX. Fiber-specific 
responses included activation of fatty acid oxidation and adipocytokine signaling that 
was specifically found for IN, cholesterol/steroid synthesis and arachidonic and linoleic 
fatty acid metabolism, specific for GG, tryptophan metabolism (AX only), and branched- 
chain amino acid catabolism, degradation/proteasome system and mitochondrial translation 
(FOS only). 
Figure 1  Effects of dietary fiber on gene expression profiles in colonic epithelial cells
PLS-DA score plot of gene expression profiles in colonic epithelial cells of mice fed 5 different fibers 
or the control diet. In the plot the samples (individual mice) were plotted based on the two main 
variates. Ellipses indicate 90% confidence intervals of the scores.
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Identification of Pparγ as important upstream regulator
The underlying mechanisms by which the fibers modulated gene expression changes are 
not well understood. We therefore aimed to identify potential upstream transcriptional 
regulators that could explain the observed shifts in gene expression profiles (Table 2). In 
line with results obtained by GSEA, PPAR, particularly the isoform Pparγ, was predicted to 
Table 1  Biological processes regulated by dietary fibers
Gene sets significantly regulated (P<0.001, FDR<0.01) by dietary fiber compared to control were 
determined by gene set enrichment analysis. Subsequently, clusters were manually grouped and 
labeled to highlight the prevalent biologic functions among related gene sets. See Supplemental 
Figure 2 for a high-resolution version of the maps that includes the names of the gene sets.
RS FOS AX IN GG
Transcription ↓
Translation ↓ ↓ ↓ ↓
RNA processing ↓ ↓ ↓ ↓
Chromatin  
modification
↓ ↓
DNA repair ↓ ↓
Glucose metabolism ­↑ ↑­ ­↑ ­↑
Phase I/II metabolism ↓ ­↑ ­↑ ­↑ ↑­
PPAR & Nrf2 targets ­↑ ­↑ ↑­ ↑­
TCA cycle & Oxidative 
phosphorylation
­↑ ­↑ ↑­ ↑­
Lipid metabolism ­↑ ↑­ ­↑
Amino acid  
metabolism
↑­ ↑­ ­↑
Degradation/
proteasome 
system
Tryptophan 
metabolism
Fatty acid 
oxidation
Cholesterol/
Steroid 
 metabolism
Branched 
chain 
amino acid 
 catabolism/
Arginine, 
Proline 
 metabolism
Adipocytokine 
signaling
Arachidonic &
Linoleic acid 
metabolism
Mitochondrial 
translation
UPR (unfolded 
protein 
 response)
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be activated by FOS, AX, GG, but most for IN. This was supported by the observation that 
many Pparγ targets genes were indeed found to be regulated by one or more of these 
fibers (Supplemental Figure 3). In addition to Pparγ, several other regulators were 
predicted to play a role in the transcriptional responses caused by one or more of the 
fibers (Table 2). Notably, the histone demethylase KDM5B was exclusively predicted to 
control the RS-modulated gene expression profiles, which may at least in part explain the 
specific gene expression profile induced by RS. Taken together, our analyses identified the 
nuclear receptor Pparγ as potential key upstream regulator mediating the gene expression 
response to fibers in colonic epithelia.
Table 2   Common and specific potential upstream regulator in colon of mice  
after feeding different fiber diets as determined by Ingenuity Systems  
Pathway Analysis Software 
(Transcriptional regulator and ligand-dependent nuclear receptor which showed an activation 
z-score ≥ 2 or ≤ -2 and a p-value < 0.05 are displayed)
Activation score per dietary fiber
RS FOS AX IN GG
PPARγ 2.83 2.01 4.23 3.07
HNF4A 2.58 3.50
TP53 2.36 2.82
ATF4 2.61 2.43
PPARGC1A 2.39 2.08
XBP1 2.93
NR5A2 2.61
SREBF1 2.58
FOXC2 2.43
SREBF2 2.22
PTTG1 2.21
NR1I2 2.09
CEBPB 2.02
KDM5B 2.00
NCOA2 2.00
TP63 -2.15
STAT5B -2.16
MBD2 -2.23
STAT5A -2.36
MYC -2.63
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Modulation of luminal microbiota composition by dietary fibers
Intestinal content of the colon from four mice per dietary treatment was subjected to 
microbiota quantification and composition analysis. Although all fibers seemed to 
increase colonic microbiota density compared to the control diet, no statistical significance 
was reached (Supplemental Figure 4). MITChip analysis revealed that all five fibers 
changed the colonic microbiota composition, except for a single mouse from the RS 
group that clustered with the mice from the CON group (Supplemental Figure 5). The 
microbial diversity, as determined by the Shannon index, was not significantly different 
between any of the diets (data not shown). To relate changes in microbiota composition 
to the different diets, the hybridization signals of the 96 genus-level phylogenetic groups 
were subjected to redundancy analysis (RDA). Overall, 73.7% of the total variation in 
microbiota composition was captured within the first two canonical differentiation axes, 
with diet explaining 34.8% (Figure 2). Samples from the RS and control diet clustered 
separately from IN, AX, FOS and GG. The genus-like groups in the plot that correlated with 
RS and control diets belong to the Bacteroidetes phylum, and also encompassed specific 
classes of the Firmicutes phylum (Bacilli, Clostridium clusters I, II and IV), and single genus 
groups of the Actinobacteria, Proteobacteria and Deferribacter phyla. In the opposite 
direction groups within Clostridium cluster XIVa and a specific genus group of the 
Bacteroidetes phylum correlated with IN, GG and FOS. The AX diet-group was positioned 
centrally in the plot, illustrating that this diet did not clearly correlate with changes in any 
specific bacterial groups.
Modulation of luminal SCFA concentrations by dietary fibers
Despite differences in fiber type, IN, FOS, GG and AX induced highly similar epithelial cell 
gene expression responses. Therefore, it was assumed that this might be explained by 
similar production of fermentation products of these fibers by the microbiota. As the main 
fermentation metabolites of dietary fibers, SCFA were analyzed in the luminal content. 
Total SCFA concentrations significantly increased in colonic luminal samples obtained 
from mice that were fed IN, AX, and GG (P<0.05), while a similar trend was observed for 
FOS (P=0.07). The highest cumulative SCFA concentrations were observed for mice fed 
GG, followed by IN. In contrast, the SCFA concentrations in samples obtained from mice 
fed RS were comparable to those obtained from the control fed animals (Figure  3A). In all 
diet groups, the acetate concentration was highest. Analysis of variance revealed that 
mean concentrations of both acetate and propionate were significantly different between 
any of the fibers (P<0.05) (Figure 3B). Specifically, acetate concentrations in samples obtained 
from mice fed AX, IN and GG were significantly higher compared to samples obtained 
from mice fed CON and RS diet, while propionate concentrations were significantly higher 
in samples from mice fed FOS, AX, IN and GG compared to CON. Butyrate concentrations 
were not significantly different between the diet groups but showed a trend (P=0.061). No 
significant difference was observed for iso-butyrate, valerate or iso-valerate.
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Integrative analysis of changes in colonic epithelial cell gene 
expression and luminal microbiota composition
To get further insight in the interaction between changes in gene expression and 
microbiota composition, which may allow the generation of new hypotheses about 
potential mechanisms that explain host transcriptional responses to fiber fermentation by 
Figure 2  Differential modulation of colonic microbiota composition by dietary fibers
Correlation triplot based on a redundancy analysis (RDA) depicting the relationship between colonic 
luminal microbiota composition and the differences induced by dietary fibers. Dietary fiber, used as 
explanatory variable, explained 34.8% of the total variation in the microbiota composition, and 
73.7% of that variation was explained by the first two canonical axes shown here. Samples are 
labelled per diet group, and bacterial groups are indicated by arrows. The arrows point in the 
direction of maximal variation in the species abundances, and their lengths are proportional to their 
maximal rate of change. Long arrows correspond to species contributing more to the data set 
variation. Right-angle projection of a sample dot on a species arrow gives approximate species 
abundance in the sample.
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Figure 4  Integration of epithelial cell gene expression with luminal microbiota composition
Sparse PLS canonical correlation analysis was performed to integrate gene expression values with 
relative abundance data of bacteria for individual mice. The heatmap represents the correlation 
structure of both dataset; red: positively correlated, blue: negatively correlated. The more intense 
the color is, the higher the correlation value. Correlation values were subjected to unsupervised 
hierarchal clustering based on Euclidean distance for both genes and microbial groups. Five main 
gene clusters (numbers), and three main bacterial clusters (capital letters) were identified.
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the microbiota, changes in microbiota composition correlated with changes in colonic 
epithelial cell gene expression. The correlation pattern between microbiota and gene 
expression across 22 samples was visualized in a clustered image map. The correlation 
analysis revealed five clusters of genes and three main clusters of bacterial groups (Figure 4). 
The strongest correlations were found for bacteria in cluster C, which positively correlated 
with genes in cluster 1, but negatively correlated with genes in cluster 5. This cluster C 
contained known butyrate-producing bacteria belonging to Clostridium cluster XIVa. 
These bacteria co-clustered with saccharolytic bacteria such as Parabacteroides distasonis 
[42]. Genes in cluster 1 were involved in metabolic, energy-generating and oxidative 
processes, whereas genes in cluster 5 were involved in adhesion dynamics and signalling. 
While these processes correlated positively with bacteria from Clostridium cluster XIVa, 
Turicibacter et. rel and Clostridium perfringens showed negative correlation with these sets 
of genes. Correlation of the three main SCFA, acetate, propionate and butyrate with host 
gene expression showed strongest correlation for acetate and propionate (data not 
shown). Thus, multivariate analyses revealed strong correlations between gene expression 
changes and relative abundance of bacteria, among which members of Clostridium cluster 
XIVa stood out because of strong association with mucosal gene expression patterns. 
Saccharide profiles of the colonic luminal content
Except for RS, the fibers used in this study are known as water-soluble fibres. Hence, to 
obtain an indication on the extent of degradation of the fibers, the water-soluble fraction 
of the colonic luminal content was subjected to analysis using HPAEC-PAD. The results 
revealed that most oligosaccharides from IN, AX, FOS and GG were absent in the colon. 
The estimated amounts of mono/disaccharides and oligosaccharides are presented in 
Figure 5. No maltodextrins were detected in the samples from IN, AX, FOS and GG, 
indicating that the corn starch in the diet was completely digested before it reached the 
colon. As an example, the oligosaccharide profiles of the colonic luminal content of 
FOS-fed mice compared with FOS and maltodextrins are presented in Supplemental 
Figure 6. Results from the other three fibres were similar to that of FOS. Additionally, size 
exclusion chromatography indicated that also no water-soluble polysaccharides were 
present in the case of IN, AX and GG (data not shown), suggesting that like FOS, these 
fibers were also extensively fermented. In contrast to IN, AX, FOS and GG, maltodextrin 
was present in the samples from CON and RS (Figure 5). The presence of maltodextrins in 
CON indicated that not all of the corn starch in CON diet was digested and absorbed 
before reaching the colon. For RS, large amounts of glucose and maltodextrins were 
present in the colon, showing that RS was degraded by the microbiota to maltodextrins, 
but also that it was not completely fermented in the colon. In this experiment, however, it 
was not possible to estimate the rate of dietary fiber degradation in the colon.
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Discussion
In the present study five different dietary fibers were fed to mice to comprehensively 
study their effects on epithelial cell gene expression, luminal microbiota composition and 
SCFA concentrations. Despite differences in source and composition, we found that 4 of 
the 5 fibers (IN, FOS, AX, and GG) induced a highly similar gene expression and microbiota 
composition profile in colon, which coincided with increased SCFA concentrations. 
Another fiber, RS, induced a distinct response and in some cases showed more similar 
responses to CON, which coincided with the presence of maltodextrin in the luminal 
content of mice fed with both diets. In addition, the nuclear receptor Pparγ was identified 
as a potential key upstream regulator. 
Biological implication of gene regulation in epithelial cells
Dietary fibers have diverse effects on the microbiota and host metabolism. To the best of 
our knowledge, however, it has not yet been determined how in the same experiment, i.e. 
in mice from the same breeding colony housed in the same facility and fed the same 
background diet, different dietary fibers modulate colonic gene expression. At the start of 
this study, we anticipated that fibers that varied in source and composition would all 
induce a distinct responses in terms of colonic epithelial gene expression. However, our 
results showed that the diet groups could be grouped in 3 main clusters (CON, RS and the 
Figure 5  Saccharide content in colonic luminal samples of mice fed different fibers
Saccharide content was analyzed in luminal content of mice (n=1; per group) using HPAEC-PAD. 
Mono/disaccharides fraction represent glucose, fructose and sucrose, whereas the oligosaccharides 
fraction represent maltodextrin. Concentrations are expressed as percentage w/w. Quantification of 
mono-/di-saccharides were based on glucose, whereas quantification of oligosaccharides were 
based on oligofructose (FOS), with the assumption that FOS is completely soluble and analyzed by 
HPAEC. The concentration of FOS was corrected for the glucose, fructose and sucrose present.
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other 4 fibers [IN, FOS, AX, and GG]), and that many of the transcriptional responses for 
these latter 4 fibers were conserved on the level of biological processes, as determined by 
gene set enrichment analysis. However, specific genes were more variable. 
It is assumed that the effects of fibers are mainly mediated by the type and level of SCFA 
that are produced during their fermentation by the microbiota. These SCFA have been 
shown to elicit diverse effects on colonic gene expression patterns [43-45]. Our results 
support this view, since the separation of the epithelial gene expression profiles in 3 
clusters coincided with the cumulative SCFA levels measured in the colonic lumen. As a 
consequence, the biological implications of gene regulation induced by the fibers that 
yielded increased SCFA concentrations are very much the same. These fibers all induced 
genes involved in the glycolysis, TCA cycle, electron transport chain and oxidative phos-
phorylation, all pathways responsible for generating energy by substrate oxidation. This is 
to be expected because SCFAs, and especially butyrate, are known to serve as preferred 
energy source for colonocytes as a precursor to the TCA cycle and electron transport 
chain [46,47]. Moreover, facilitation by the microbiota of oxidative metabolism of glucose 
in colonocytes has been reported [48]. Because the generation of ATP results in the 
formation of reactive oxygen species [49], this may explain the activation of NRF2-con-
trolled antioxidant response pathways [50], that comprise induction of GST levels, as also 
has been observed by others [51]. Large clusters of gene sets suppressed by fibers 
represented processes describing gene transcription and translation, which is indicative 
for reduced epithelial cell proliferation, which is in agreement with findings that fibers 
inhibit growth and proliferation (reviewed in [52]). Since this also was observed for RS, that 
did not increase SCFA concentrations, our results suggest that at least part of this effect is 
independent of SCFA, as has been suggested [52]. We hypothesize that the observed 
fiber-specific effects are also mediated by specific degradation products and not SCFA [8]. 
Preliminary analyses of mono-, di- and oligosaccharides in the intestinal lumen samples 
revealed that contrary to mice fed the other diets, CON and RS fed mice contained 
maltodextrin in their colonic lumen, which might explain the distinct response (Fig. 5).
Pparγ is identified as central regulator of transcriptional responses 
to fermented fibers 
Our analysis consistently identified Pparγ as likely regulator that mediate the effects of the 
fermented fibers on gene expression. In line with this observation, target genes of the 
nuclear receptor Ppar were found to be consistently induced, albeit to a different extent, 
for all of these 4 fibers. In addition, it has been reported that in proximal colon Pparγ 
mainly regulates genes involved in energy metabolism, in particular lipid catabolism, but 
also affects signaling, motility and cell adhesion [53]. In our study, especially the IN fed 
mice displayed an increased expression level of genes involved in lipid metabolic 
processes. Since Pparγ has recently been shown to be activated by SCFAs, in particular 
butyrate [54], this provides strong evidence for a molecular mechanism by which 
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fermentable fibers may modulate colonic gene expression. Nevertheless, the variability of 
gene response magnitude as well as specific gene expression patterns that may be related 
to Pparγ activation and the role of SCFA production patterns warrant further research. 
Activation of PPARγ is also of interest because this transcription factor has been 
demonstrated to coordinate the expression of anti-inflammatory properties in 
inflammatory bowel disease [55] and appears to play a pivotal role in the interplay 
between metabolism and immune function regulation [56]. 
Abundance of Clostridium cluster XIVa correlates with epithelial cell 
metabolic pathways
We showed that the fibers yielding increased SCFA concentrations in the colonic lumen all 
increased the transcription of genes involved in metabolic processes associated with 
energy metabolism. Our correlation analysis demonstrated multiple relationships 
between the microbiota composition and these changing host gene expression patterns. 
In particular bacterial groups within Clostridium cluster XIVa positively correlated with 
genes involved in energy metabolism. Next to primary degrading bacterial species, this 
bacterial group is known to encompass many secondary fermenters, of which several 
have been shown to produce butyrate as their metabolic end product [57]. Unfortunately, 
and analogous to many other studies, the data presented here are based on single 
time-point measurements, and thereby fail to represent actual production or absorption 
rates of SCFA. Such flux data could give a considerable refinement to our understanding 
of the rate of production of butyrate by these bacteria and the actual levels of butyrate 
flux experienced by the colonic epithelia, respectively [58].
Conclusion
Our results provide a comprehensive overview on the effects of five fibers in the murine 
colon, which suggest that despite different source and composition, fermentable fibers 
are inducing a highly similar mucosal response that may at least be partially governed by 
Pparγ.   
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Supplemental Information 
 
Supplemental Figure 1   Overlap of genes significantly regulated by each dietary fiber 
(P<0.01)
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Supplemental Figure 2
Enrichment Map of gene sets that were changed by fiber compared to control. GSEA was performed 
to identify functional gene sets, i.e. metabolic pathways or signaling transduction routes, that were 
changed by each fiber compared to control (p<0.001, FDR<0.01). Nodes represent functional gene 
sets, and edges between nodes represent their similarity. A red node indicates induction of a gene 
set, a blue node indicates suppression of a gene set , and a white node indicate no significant 
regulation of a gene set by a fiber compared to control. Node size represents the gene set size, and 
edge thickness represents the degree of overlap between 2 connected gene sets. Clusters were 
grouped and manually labeled to highlight the prevalent biologic functions among related gene 
sets.
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Supplemental Figure 3   Upstream regulator analysis
Pparγ target genes were determined by Ingenuity Pathway Analysis. A heatmap represents the 
relative gene expression values for each fiber diet compared to control. Red indicates increased 
expression, while green indicates decreased expression. The relative gene expression values were 
log2 transformed, i.e. a fold change of 0.6 means 1.5 fold increase, while -0.6 means -1.5 decrease in 
expression by the fiber compared to control.
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Supplemental Figure 4   Quantitative PCR on total bacteria
16S rRNA gene-targeted qPCR was used to assess total bacterial numbers. The copy number per 16S 
rRNA gene was calculated back to total copy number per organ weight.
Supplemental Figure 5   Clustering of MITChip profiles at the probe-level
Pearson distance-based clustering of the samples on log10 transformed probe level data of the 
MITChip.
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Supplemental Figure 6   Representative monomer and oligomer profiles analyzed using 
HPAEC-PAD
Oligosaccharide profiles of (A) oligofructose (FOS), (B) colonic luminal content of a FOS-fed mouse, 
as analysed by high performance anion exchange chromatography coupled to pulsed amperometric 
detection (HPAEC-PAD). The profile of (C) maltodextrin is presented as a comparison.
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Supplemental Table 1  Diet composition
1. Low fat - palm oil  
- CON
2. Low fat - palm oil  
- IN
3. Low fat - palm oil 
- FOS
4. Low fat - palm oil  
- AX
5. Low fat - palm oil  
- GG
6. Low fat - palm oil  
- RS
Based on formula # D12450B 10% INULIN 10% FOS 10% NAXUS 10% GUAR GUM 20% Resistant Starch
Ingredient gm % (w/w) gm % (w/w) gm % (w/w) gm % (w/w) gm % (w/w) gm % (w/w)
Casein, lactic 200.00 18.96 200.00 18.96 200.00 18.96 200.00 18.96 200.00 18.96 200.00 18.96
L-Cystine 3.00 0.28 3.00 0.28 3.00 0.28 3.00 0.28 3.00 0.28 3.00 0.28
Corn Starch (control fiber) 427.20 40.49 321.70 30.49 321.70 30.49 321.70 30.49 321.70 30.49 216.20 20.49
Maltodextrin 100.00 9.48 100.00 9.48 100.00 9.48 100.00 9.48 100.00 9.48 100.00 9.48
Sucrose 172.80 16.38 172.80 16.38 172.80 16.38 172.80 16.38 172.80 16.38 172.80 16.38
Experimental fiber n.a.  105.50 10.00 105.50 10.00 105.50 10.00 105.50 10.00 211.00 20.00
Cellulose, BW200 50.00 4.74 50.00 4.74 50.00 4.74 50.00 4.74 50.00 4.74 50.00 4.74
Soybean Oil 25.00 2.37 25.00 2.37 25.00 2.37 25.00 2.37 25.00 2.37 25.00 2.37
Palm oil 20.00 1.90 20.00 1.90 20.00 1.90 20.00 1.90 20.00 1.90 20.00 1.90
Mineral Mix S10026* 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95
DiCalcium Phosphate 13.00 1.23 13.00 1.23 13.00 1.23 13.00 1.23 13.00 1.23 13.00 1.23
Calcium Carbonate 5.50 0.52 5.50 0.52 5.50 0.52 5.50 0.52 5.50 0.52 5.50 0.52
Potassium Citrate, 1 H2O 16.50 1.56 16.50 1.56 16.50 1.56 16.50 1.56 16.50 1.56 16.50 1.56
Vitamin Mix V10001** 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95
Choline Bitartrate 2.00 0.19 2.00 0.19 2.00 0.19 2.00 0.19 2.00 0.19 2.00 0.19
FD&C Yellow Dye #5 0.05 0.00 0.05 0.00 0.05 0.00 0.05 0.00 0.05 0.00 0.05 0.00
FD&C Red Dye #40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
FD&C Blue Dye #1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 1055.05 100.00 1055.05 100.00 1055.05 100.00 1055.05 100.00 1055.05 100.00 1055.05  
*Mineral mix S10026 contains the following (g/kg mineral mix): 41.9 magnesium oxide, 257.6 magnesium 
sulfate•7H2O, 259 sodium chloride, 1.925 chromium KSO4•12H2O, 1.05 cupric carbonate, 0.035 potassium iodate, 
21 ferric citrate, 12.25 manganous carbonate, 0.035 sodium selenite, 5.6 zinc carbonate, 0.20 sodium fluoride, 0.30 
ammonium molybdate•4H2O, 399.105 sucrose. 
**Vitamin mix V10001 contains the following (g/kg vitamin mix): 0.80 retinyl palmitate, 1.0 cholecalciferol, 10 
all-rac-a-tocopheryl acetate, 0.08 menadione sodiumbisulfite, 2.0 biotin (1.0%), 1.0 cyancocobalamin (0.1%), 0.20 
folic acid, 3.0 nicotinic acid, 1.6 calcium pantothenate, 0.70 pyridoxine-HCl, 0.60 riboflavin, 0.60 thiamin-HCl, and 
978.42 sucrose.
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Supplemental Table 1  Diet composition
1. Low fat - palm oil  
- CON
2. Low fat - palm oil  
- IN
3. Low fat - palm oil 
- FOS
4. Low fat - palm oil  
- AX
5. Low fat - palm oil  
- GG
6. Low fat - palm oil  
- RS
Based on formula # D12450B 10% INULIN 10% FOS 10% NAXUS 10% GUAR GUM 20% Resistant Starch
Ingredient gm % (w/w) gm % (w/w) gm % (w/w) gm % (w/w) gm % (w/w) gm % (w/w)
Casein, lactic 200.00 18.96 200.00 18.96 200.00 18.96 200.00 18.96 200.00 18.96 200.00 18.96
L-Cystine 3.00 0.28 3.00 0.28 3.00 0.28 3.00 0.28 3.00 0.28 3.00 0.28
Corn Starch (control fiber) 427.20 40.49 321.70 30.49 321.70 30.49 321.70 30.49 321.70 30.49 216.20 20.49
Maltodextrin 100.00 9.48 100.00 9.48 100.00 9.48 100.00 9.48 100.00 9.48 100.00 9.48
Sucrose 172.80 16.38 172.80 16.38 172.80 16.38 172.80 16.38 172.80 16.38 172.80 16.38
Experimental fiber n.a.  105.50 10.00 105.50 10.00 105.50 10.00 105.50 10.00 211.00 20.00
Cellulose, BW200 50.00 4.74 50.00 4.74 50.00 4.74 50.00 4.74 50.00 4.74 50.00 4.74
Soybean Oil 25.00 2.37 25.00 2.37 25.00 2.37 25.00 2.37 25.00 2.37 25.00 2.37
Palm oil 20.00 1.90 20.00 1.90 20.00 1.90 20.00 1.90 20.00 1.90 20.00 1.90
Mineral Mix S10026* 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95
DiCalcium Phosphate 13.00 1.23 13.00 1.23 13.00 1.23 13.00 1.23 13.00 1.23 13.00 1.23
Calcium Carbonate 5.50 0.52 5.50 0.52 5.50 0.52 5.50 0.52 5.50 0.52 5.50 0.52
Potassium Citrate, 1 H2O 16.50 1.56 16.50 1.56 16.50 1.56 16.50 1.56 16.50 1.56 16.50 1.56
Vitamin Mix V10001** 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95 10.00 0.95
Choline Bitartrate 2.00 0.19 2.00 0.19 2.00 0.19 2.00 0.19 2.00 0.19 2.00 0.19
FD&C Yellow Dye #5 0.05 0.00 0.05 0.00 0.05 0.00 0.05 0.00 0.05 0.00 0.05 0.00
FD&C Red Dye #40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
FD&C Blue Dye #1 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total 1055.05 100.00 1055.05 100.00 1055.05 100.00 1055.05 100.00 1055.05 100.00 1055.05  
*Mineral mix S10026 contains the following (g/kg mineral mix): 41.9 magnesium oxide, 257.6 magnesium 
sulfate•7H2O, 259 sodium chloride, 1.925 chromium KSO4•12H2O, 1.05 cupric carbonate, 0.035 potassium iodate, 
21 ferric citrate, 12.25 manganous carbonate, 0.035 sodium selenite, 5.6 zinc carbonate, 0.20 sodium fluoride, 0.30 
ammonium molybdate•4H2O, 399.105 sucrose. 
**Vitamin mix V10001 contains the following (g/kg vitamin mix): 0.80 retinyl palmitate, 1.0 cholecalciferol, 10 
all-rac-a-tocopheryl acetate, 0.08 menadione sodiumbisulfite, 2.0 biotin (1.0%), 1.0 cyancocobalamin (0.1%), 0.20 
folic acid, 3.0 nicotinic acid, 1.6 calcium pantothenate, 0.70 pyridoxine-HCl, 0.60 riboflavin, 0.60 thiamin-HCl, and 
978.42 sucrose.
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Microarray processing and data analysis
Total RNA (100 ng) was used for whole transcript cDNA synthesis by using the Ambion WT 
expression kit (Life Technologies, Bleiswijk, the Netherlands) and subsequently labelled 
using the Affymetrix GeneChip WT Terminal Labeling Kit. Samples were hybridized on 
Mouse Gene 1.1 ST arrays (Affymetrix, Santa Clara, US), washed, stained, and scanned on 
an Affymetrix GeneTitan instrument. Detailed protocols for array handling can be found in 
the GeneChip WT Terminal Labeling and Hybridization User Manual (P/N 702808, Rev. 7; 
Affymetrix). Packages from the Bioconductor project [22], integrated in an online pipeline 
[23], were used to analyze the array data. Various advanced-quality metrics, diagnostic 
plots, pseudoimages, and classification methods were used to determine the quality of 
the arrays before statistical analysis [59]. The probes on the Mouse Gene 1.1 ST array were 
redefined using current genome information [60]. In this study, probes were reorganized 
on the basis of the gene definitions available in the NCBI Mus musculus Entrez Gene 
database based on the mouse genome build 38 patch release 1 (GRCm38.p1) (custom 
CDF v17). Normalized gene expression estimates were obtained from the raw intensity 
values using the robust multiarray analysis (RMA) preprocessing algorithm available in the 
library ‘AffyPLM’ using default settings [61]. Differentially expressed probe sets (genes) 
were identified by using linear models, applying moderated t-statistics that implemented 
empirical Bayes regularization of standard errors [25]. To adjust for both the degree of 
independence of variances relative to the degree of identity and the relation between 
variance and signal intensity, the moderated t-statistic was extended by a Bayesian 
hierarchical model to define an intensity-based moderated t-statistic [26].
Microbiota analysis
MITChip
This phylogenetic microarray was designed using criteria of the Human Intestinal Tract 
Chip (HITChip) [62]. The MITChip consists of 3,580 different oligonucleotides specific for 
the mouse intestinal microbiota [33,62,63]. The array targets the V1 and V6 regions of 
bacterial 16S rRNA genes. The 16S rRNA genes were amplified from twenty nanogram of 
intestinal extracted DNA with the primers T7prom-Bact-27-F and Uni-1492-R (see Table). 
PCR products were then transcribed, and RNA was labelled with Cy3 and Cy5 dyes and 
fragmented as described previously [33,62,63]. Finally the samples were hybridized on the 
arrays at 62.5oC for 16 hours in a rotation oven (Agilent Technologies, Amstelveen, the 
Netherlands). After washing and scanning of the slides, data was extracted with the 
Agilent Feature Extraction software, version 9.1. The data was normalized and analysed 
using a set of R-based scripts in combination with a custom-designed relational database 
[64], which operates under the MySQL database management system.
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Quantification of bacterial community
Quantification of the bacterial 16S rRNA gene was performed by a qPCR assay using the 
primers developed by Suzuki et al. [65]. The qPCRs were performed in 384-well plates 
(BioRad, Veenendaal, the Netherlands) sealed with a film (Microseal B film, Bio-Rad) using 
a MyIQ cycler with MyIQ software (version 1.0.410, Bio-Rad). The reactions were carried out 
in a total volume of 12.5 µl consisting of 1x IQ SYBR green Supermix (Bio-Rad), 200 nM of 
the forward and reverse primer and 2 µl of template DNA, and the cycling program and 
melting curve analysis as previously described [66]. The standard curve consisting of a 
8-fold dilution series was a 16S rRNA gene PCR product of Escherichia coli top10. 
Table  List of primers used for microbiome analyses [62,65]
Primer name Sequence Application
T7prom-Bact-27-F 5’-TGA ATT GTA ATA CGA CTC ACT ATA GGG GTT TGA 
TCC TGG CTC AG–3’
MITChip
Uni-1492-R 5’-CGG CTA CCT TGT TAC GAC-3’ MITChip
PROK1492R 5’ -GGW TAC CTT GTT ACG ACT T-3’ qPCR
BACT1369F 5’-CGG TGA ATA CGT TCY CGG-3’ qPCR
Oligosaccharide analysis of colonic luminal content by high performance 
anion exchange chromatography
Frozen samples of colonic content of mice (n=1 per group) fed different fiber diets were 
used for analysis of mono-, di- and oligosaccharides. The conditions used for oligosaccha-
ride profiling with high performance anion exchange chromatography coupled to pulsed 
amperometric detection (HPAEC-PAD) have been described in detail before [37]. In brief, 
samples were weighed and suspended in water (20 mg/mL), followed by mixing and 
heating in a boiling water bath for 5 min. After cooling to room temperature, the samples 
were centrifuged (10,000 × g, 5 min), and the supernatant (25 µL) was injected into an ICS 
3000 HPAEC system (Dionex Corporation, Sunnyvale, CA, US) with pulsed amperometric 
detection. One gradient was used for all samples, where monomers were separated from 
the oligomers. Quantification of mono-/di-saccharides were based on glucose, whereas 
quantification of oligosaccharides were based on oligofructose (FOS), with the assumption 
that FOS are completely soluble and analysed by HPAEC. The concentration of FOS was 
corrected for glucose, fructose and sucrose present.

Chapter 4
Linking the fate of dietary fibers  
in the murine caecum to microbial 
transcriptome patterns
Floor Hugenholtz*, Katja Lange*, Mark Davids, Peter Schaap, Michael Müller, 
Guido J.E.J. Hooiveld, Michiel Kleerebezem, Hauke Smidt
*These authors contributed equally to this work
In preparation.
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Abstract
The microbiota of the gastrointestinal tract plays a key role in the degradation of food 
components that escape digestion by host enzymes. Complex metabolic networks of 
interacting microbes in the gastrointestinal tract of humans and other mammals yield a 
wide range of metabolites of which the short chain fatty acids (SCFA), in particular 
butyrate, acetate, and propionate, are the most abundant products of carbohydrate 
fermentation. Here we studied the quantitative interactions between diet, microbiota and 
host and modelled the multivariate data using Systems Biology approaches. 
The experiments targeted the caecum of conventionally raised mice that were fed 
different fiber-containing diets. Microbiota composition was assessed using phylogenetic 
microarray technology, and was complemented with metatranscriptome, metabolome 
and host mucosal tissue transcriptome data. Relative abundance of butyrate producing 
bacteria correlated with host genes involved in energy metabolism and affecting the 
immune system. Moreover the metatranscriptome revealed distinct activities of bacterial 
families in the fermentation of fibers into SCFA. The Bacteroidaceae, Porphyromonadaceae, 
Verrucomicrobioaceae, Bifidobacteriaceae, Lachnospiraceae, Clostridiaceae, Eubacteriaceae, 
several Bacilli families, Ruminococcaceae and Erysipelotrichaceae all took part in fiber 
utilization, expressing genes encoding glycosidases and/or sugar transport systems. All 
families expressed in different ratios genes that code for enzymes involved in the 
production of SCFA. Overall different dietary fibers induce distinct changes in the caecal 
microbiota, their functional activities and SCFA production with profound effects on host 
metabolic and immune function in the caecum.
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Introduction
A diet rich in fiber has a beneficial health effect by promoting gastrointestinal homeostasis, 
and decreasing risk for obesity, cancer and metabolic disorders. The enzyme repertoire of 
humans and mammals is commonly not able to catabolize non-starch polysaccharides, 
like those derived from plant cell walls, resistant starches, and oligosaccharides, whereas a 
broad range of intestinal bacteria can ferment these dietary fibers. The intestinal 
microbiota is diverse, dense, metabolically active, and largely saccharolytic [1], [2], [3]. Most 
members of the large intestinal microbiota are not depending on the availability of simple 
sugars, but are rather able to derive carbon and energy from the breakdown of a range of 
complex carbohydrates, sometimes involving single members of the ecosystem, but 
often requiring a concerted community effort.
The bulk of the fiber fermentation takes place in the large intestine, where the fibers are 
the main energy source for the microbiota. Dietary fiber is fermented into a range of 
metabolites, of which the short chain fatty acids (SCFA) acetate, propionate and butyrate 
are the most abundant [4], [5], [6], [7]. The SCFA production pattern is dependent on diet 
composition, transit time in the small and large intestine, intestinal pH, and the microbial 
species and their relative abundance within the microbiota [8], [9], [10]. SCFA are taken up 
by the mucosa, and have been reported to affect numerous processes related to the 
immune system [11] and energy metabolism [12]. Additionally, the intestinal microbiota 
exerts a major influence on host physiology, including the tuning of the host’s immune 
and metabolic state [13]. SCFA are readily absorbed by the colonic epithelium where 
butyrate serves as the main energy source, although in smaller amounts acetate and 
propionate can also be metabolised [14]. After absorption and metabolic conversion, the 
remainder of the SCFA enter the portal blood and are processed by the liver, the central 
metabolic organ in the body [15]. Intestine-derived acetate is incorporated in fatty acid 
synthesis in the liver and in part transferred to the peripheral tissue, whereas propionate 
induces lipogenesis and gluconeogenesis in liver [16]. 
The amount and ratio of SCFA can be affected by specific types of fiber [5], [17]; [Chapter 3]. 
The relative abundance of specific groups of bacteria is known to increase when certain 
types of fibers are consumed. For example, when resistant starch is consumed, the relative 
abundance of species of Clostridium cluster IV that includes butyrate producers is 
increased, while consumption of FOS and IN tend  to expand bifidobacterial populations 
[18], [19]. The explanation for these type of community responses are rather complex. For 
example a dietary intervention with resistant starch usually results in increased butyrate 
concentrations in the intestine, indicative of complex food webs consisting of primary 
degraders such as those belonging to the Actinobacteria (including the Bifidobacteriaceae) 
and Bacteroidetes that ferment starch and produce lactate, succinate, acetate and 
propionate, which are subsequently taken up by secondary fermenters to produce mainly 
acetate, propionate and butyrate, explaining the emergence of elevated butyrate levels 
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upon resistant starch feeding via a cross-feeding (syntrophic) interaction within the 
microbial consortium [20],[5]. 
In our previous study mice were fed five different fibers or a control diet containing corn 
starch that is readily degraded and largely absorbed within the small intestine [Chapter 3]. 
Colonic samples obtained from the non-starch fiber-fed mice showed an overall increase 
in luminal SCFA concentrations, which coincided with an increased relative abundance of 
the Bacteroides distasonis group and Clostridium cluster XIVa species in the colonic 
microbiota. These bacteria most likely act as primary or secondary fiber degraders, 
although data from cultured representatives of the detected species are not available. To 
further specify the microbial involvement in the degradation of these fibers, and to study 
the effects on the host mucosal tissue, this study focuses on the main fiber fermentation 
location in the mouse intestine, i.e. the caecum [Chapter 3]. The large caecal volume is 
compatible with multiple analyses in individual mice, including the determination of SCFA 
concentrations, microbiota composition and its activity using metatranscriptome analysis. 
Furthermore, these multivariate microbial and metabolic datasets were correlated to host 
mucosal responses in the caecum, determined by tissue transcriptome analyses, aiming 
to construct models of diet-microbe-host interactions. 
Material and methods
Animals, diets, design and sampling
Male C57BL/6J mice were purchased from Charles River Laboratories (Maastricht, the 
Netherlands) at 6 weeks of age. Mice were housed in pairs in a light- and temperature- 
controlled animal facility of Wageningen University (12 hour light-dark cycle; light on from 
11h PM to 11h AM, 21 °C). Mice had free access to water and food throughout the entire 
experimental period. Upon arrival, mice were fed standard lab chow (RMH-B, Arie Blok, 
Woerden, the Netherlands) for 3 wks. Subsequently, all mice were adjusted to the control 
diet, a standard semi-synthetic low fat diet containing corn starch, for 2 wks. To achieve 
similar weight distribution among the diet groups, mice were stratified according to their 
body weight to one of the six diet groups (n=10 per diet group), i.e. control (CON), inulin 
(IN), oligofructose (FOS), arabinoxylan (AX), guar gum (GG) or resistant starch (RS). Mice 
were fed the fiber or control diets for 10 days. Detailed information on diet composition, 
procedure on the day of section and tissue sampling is described in chapter 3.  
Short-chain fatty acid analysis in caecal luminal content 
Short chain fatty acids were measured in mouse intestinal samples at section. Luminal 
content of the caecum (n=10 per group) was collected in H3PO4 and isocaproic acid (as an 
internal standard) containing buffer solution. Samples were stored at -20ºC until further 
processing. The day of analysis, samples were thawed, centrifuged at 14.000 rpm (5 min), 
and supernatant was collected and stored at 5ºC. The samples were then subjected to gas 
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chromatography (Fisons HRGC Mega 2, CE Instruments, Milan, Italy) at 190°C using a glass 
column fitted with Chromosorb 101 with a carrier gas (N2 saturated with methanoic acid).
Microbial Composition
Total DNA was extracted from 0.01-0.1 grams of caecal content samples using the repeated 
bead beating plus column (RBB+C) method of [21]. The composition of microbial 
communities in the intestinal samples was analysed with the Mouse Intestinal Tract Chip 
(MITChip). This phylogenetic microarray was designed using criteria of the Human 
Intestinal Tract Chip (HITChip) [22]. The MITChip consists of 3,580 different oligonucle-
otides specific for the mouse intestinal microbiota [22], [23], [24]. The oligonucleotides on 
the array target the V1 and V6 regions of bacterial 16S rRNA genes. The 16S rRNA genes 
were amplified from twenty nanogram of DNA extracted from intestinal samples, with the 
primers T7prom-Bact-27-F and Uni-1492-R (Table 1). PCR products were then transcribed, 
and RNA was labelled with Cy3 and Cy5 dyes and fragmented as described previously [22], 
[23], [24]. Finally the samples were hybridized on the arrays at 62.5oC for 16h in a rotation 
oven (Agilent Technologies, Amstelveen, The Netherlands). After washing and scanning of 
the slides, data was extracted with the Agilent Feature Extraction software, version 9.1. 
The data was normalized and analysed using a set of R-based scripts in combination with 
a custom-designed relational database, which operates under the MySQL database 
management system. To determine correlation of the Robust Probabilistic Averaging 
(RPA) signal intensities of 2667 specific probes for the 96 genus-level bacterial groups 
detected on the MITChip with a specific diet or SCFA, redundancy analysis (RDA) in Canoco 
5.0 was used, and visualized in a triplot [25], [26]. The Monte Carlo Permutation test was 
used to assess the significance of the variation in the dataset in relation to the diet and 
SCFA. 
The Unpaired Wilcoxon signed-rank test was used to determine bacterial groups significantly 
different between the control (CON) and inulin (IN), oligofructose (FOS), arabinoxylan (AX), 
guar gum (GG) and resistant starch (RS) diet. The RPA signal intensities of the 96 genus-level 
groups were tested. 
Table 1  List of primers (Suzuki et al. 2000, Rajilic-Stojanovic et al. 2009).
Primer name Sequence Application
T7prom-Bact-27-F 5’-TGA ATT GTA ATA CGA CTC ACT ATA GGG GTT 
TGA TCC TGG CTC AG–3’
MITChip
Uni-1492-R 5’-CGG CTA CCT TGT TAC GAC-3’ MITChip
PROK1492R 5’ -GGW TAC CTT GTT ACG ACT T-3’ QPCR
BACT1369F 5’-CGG TGA ATA CGT TCY CGG-3’ QPCR
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Quantification of bacterial community
Quantification of the bacterial 16S rRNA gene was done by a qPCR assay using the primers 
developed by [27]. The qPCRs were performed in 384-well plates (BioRad) sealed with a 
film (Microseal B film, Bio-Rad) using a MyIQ cycler with MyIQ software (version 1.0.410, 
Bio-Rad). The reactions were carried out in a total volume of 12.5 µl consisting of 1x IQ 
SYBR green Supermix (Bio-Rad), 200 nM of the forward and reverse primer and 2 µl of 
template DNA, and the cycling program and melting curve analysis as previously described 
[28]. The standard curve consisting of an 8-fold dilution series was a 16S rRNA gene PCR 
product of Escherichia coli top10. The copy number was calculated per caecum weight.
RNA extraction, mRNA enrichment, cDNA synthesis and  
Illumina sequencing
Four intestinal caecum content samples from each dietary treatment were used to analyse 
the metatranscriptome activity profiles. The RNA was extracted from 0.1-0.2 grams of 
caecal content. The content was re-suspended in 500 µL ice-cold TE buffer (Tris-HCL pH 
7.6, EDTA pH 8.0). Total RNA was obtained via the Macaloid-based RNA isolation protocol 
[29],[30] with in addition the use of Phase Lock Gel heavy tubes (5 Prime GmbH, Germany) 
during the phase separation. The RNA purification was done with the RNAeasy mini kit 
(Qiagen, USA), including an on-column DNAseI (Roche, Germany) treatment [29]. The total 
RNA was eluted in 30 µL ice-cold TE buffer and the RNA quantity and quality were assessed 
using a NanoDrop ND-1000 spectrophotometer (Nanodrop Technologies, Wilmington, 
USA) and Experion RNA Stdsens analysis kit (Biorad Laboratories Inc., USA), respectively. 
mRNA enrichment was performed by using the mRNA enrichment kit (MICROBExpress, 
Ambion, Applied Biosystem, the Netherlands) using the manufacturer’s protocol. As with 
the total RNA the quantity and quality were assessed, the latter was done to check on the 
efficiency of the mRNA enrichment. One µg of the enriched mRNA sample was used to 
transcribe the RNA in cDNA. Double stranded cDNA was synthesized with the SuperScript 
Double-Stranded cDNA Synthesis kit (Invitrogen, the Netherlands), with addition of 
SuperScript III Reverse Transcriptase (Invitrogen, the Netherlands) and random priming 
using random hexamers (Invitrogen, the Netherlands) [31],[32],[30]. To remove the RNA, a 
RNAse A (Roche, Germany) treatment was preformed, followed by phenol-chloroform 
extraction of the cDNA and ethanol precipitation. The product was checked on gel and 3 
to 8 µg of cDNA was send to the sequencing provider for sequencing (GATC Biotech, 
Germany). Single read Illumina Libraries were prepared from the double-stranded cDNA 
according to the ChiP-seq protocol [33] with insert sizes between 200-300bp, suing 
barcoded tags for library constructions to enable parallel sequencing (GATC Biotech, 
Germany). Sequencing was performed using Illumina Hiseq2000 and using 5pM 
concentration of the library and the single-end protocol [30]. 
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Sequence data processing
In total, sequencing yielded between 11 and 34 million reads per sample. The data is 
available in the NCBI small reads archive (sra) repository, under . The reads were processed 
via a previously described protocol (PhD thesis Floor Hugenholtz, Chapter 5). Briefly the 
data was filtered for ribosomal RNA sequences, adapter sequences and poor quality reads 
using SortMeRNA (version 1.2) [34], cutadapt [35], PRINSEQ (lite-version) [36], respectively. 
Reads smaller than 50 nucleotides were discarded. The resulting mRNA fractions were 
merged and de novo assembled into larger contigs, creating one reference set for all 
samples. A total of 70710 contigs were assembled with a total length of 59 Mb (n50=1074). 
Encoded in these contigs a total of 104110 potential open reading frames were predicted. 
To determine the taxonomic origin of the contigs, the predicted protein sequences were 
aligned with NCBI’s non-redundant database, and the taxonomical family classification of 
the best hit was retrieved. Functional annotation was done by assigning KEGG orthology 
identifiers using the KEGG’s KAAS server. Expression levels of the predicted proteins were 
determined by aligning the mRNA reads with assembled contigs and counting the total 
amount of nucleotides aligned with the corresponding ORFs.
Transcriptome analysis and Functional implications 
All steps for Microarray hybridization and analysis, including RNA isolation and purification, 
were performed as described before [Chapter 3]. Functional implications were analysed 
using Enrichr [37]. 
Multivariate statistical analysis
We used Partial Least Square analysis (PLS) from mixOmics library in R to first, analyse 
effects of dietary fibers on gene expression (PLS Discriminant analysis) and second, to 
integrate microbiota composition and metatranscriptome with mucosal gene expression 
(PLS canonical correlation). For latter analysis, twenty-three animals were chosen for 
analysis of microbiota composition and host gene expression of which for 15 mice both 
datasets were available and 8 mice were added that were cage partner to increase the 
power. For transcriptome-transcriptome analysis 11 mice were included in the analysis of 
which for 7 mice both datasets were available and 4 mice were added that were cage 
partner (analysis was performed as described in chapter 3). 
Results
The effects of different dietary fibers - resistant starch (RS), arabinoxylan (AX), fructooligo-
saccharides (FOS), inulin (IN) and guar gum (GG) - were studied to evaluate whether the 
responses of the microbiota and the host to different dietary fibers are congruent or 
diverse. The effects of these dietary interventions were measured in caecal samples by 
determination of the steady state levels of luminal SCFA, the microbiota composition by 
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16S rRNA gene profiling, and the microbiota activity by metatranscriptomics, respectively. 
In addition, the cognate host responses in the caecal mucosa were determined using 
murine microarrays and this was correlated to the 16S microbial composition dataset and 
to the microbial metatranscriptome data (see flow chart, Figure 1).
Dietary fibers differentially modulate luminal SCFA levels
In all mice the main metabolic products of dietary fiber fermentation in the caecal lumen 
were analysed by gas chromatographic quantification of acetate, propionate, butyrate, 
valerate, and the branched-chain SCFA iso-butyrate and iso-valerate. Total SCFA 
concentrations significantly increased in caecal lumen of mice in the IN and GG diet 
groups as compared to the CON diet (p<0.05), and the highest SCFA concentrations were 
observed for mice fed the IN diet (Figure 2). In contrast, the RS, AX and FOS diets no 
changes the overall SCFA concentrations were observed. 
Figure 1  Flow-chart of data analysis
1. Luminal microbiota composition 
MITChip 
Epithelial gene expression 
Microarray 
2. Luminal microbiota gene expression 
RNA seq 
Integration 
PLS canonical correlation 
Epithelial gene expression 
Microarray 
21,225  genes 
UPC filtering 
 (Piccolo et al., 2003): 
8,427 genes 
96 genus-level bacterial groups  
11 - 34 million reads 
4.5x10^5 - 3.0x10^6 mRNA 
KEGG orthology identifiers  
8,427 genes 
Integration 
PLS canonical correlation 
Dietary fibre: 
IN, GG,FOS,AX,RS 
SCFA
concentrations  
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Dietary fibers modulate the microbiota composition
The caecal content of five mice per dietary treatment was used to analyse the microbiota 
after 10 days of dietary treatment. The density of the caecal microbiota was analysed by 
16S rRNA gene-targeted quantitative PCR (qPCR), whereas the MITChip platform was 
employed for compositional profiling. Although all fiber diets, and especially the IN-diet, 
tended to increase the microbiota density in the caecum as compared to the CON diet, 
none of these effects were significant (Figure S 1). Microbial diversity was also not affected 
by the diets used in the present study (data not shown). Analogous to what has previously 
been reported for the colon in these mice, caecal microbiota composition of mice fed the 
GG, AX, IN, or FOS diet, but not those receiving an RS-diet, could be discriminated from 
that of mice receiving the control diet (Figure S 2). In order to correlate changes in 
microbiota composition and metabolism to the different diets, the SCFA concentrations 
and the hybridization signals of in total 96 genus-level phylogenetic groups targeted by 
the MITChip were subjected to redundancy analysis (RDA). The RDA included the 
concentrations of acetate, propionate and butyrate and the diets as explanatory variables, 
which were concluded to explain 58.6% of the total variation in microbial composition, of 
which 73.5% was captured within the first two canonical axes of the RDA analysis (Figure 3). 
The RS and CON diet groups clustered separately from the IN, AX, FOS and GG groups 
Figure 2   Ceacal luminal SCFA concentrations in µmol/g content measured with  
gas chromatography
Abbreviations are for control (CON), Resistant Starch (RS), Arabinoxylan (AX), Fructooligosaccharides 
(FOS), Inulin (IN) and Guar Gum (GG). * indicates significance (Student T.test P<0.05) between the 
dietary group and control (CON)
*
*
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along the first canonical axis, whereas the FOS and IN diet-groups appeared to be largely 
overlapping. Genus-like groups that correlated in their relative abundance with the RS and 
the control diet included Collinsella, Propionibacterium, Olsenella et rel., Alistipes et rel., 
Bacteroides splanchnicus et rel., Porphyromonas asaccharolytica et rel., Fibrobacter succinogenes 
et rel., Lactobacillus salivarius et rel., Staphylococcus aureus et rel., Turicibacter et rel., 
Clostridium perfringens et rel., Faecalibacterium prausnitzii et rel., Ruminobacter amylophilus 
et rel., Clostridium difficile et rel., Ruminococcus obeum et rel., Fusobacterium, Bilophila et rel., 
Desulfovibrio et rel., Sphingomonas et rel., Labrys methylaminiphilus et rel. and Unclassified 
TM7. In the opposite direction relative abundance of the groups Clostridium herbivorans et 
rel., Clostridium sphenoides et rel., an unclassified Clostridium cluster XIVa group and 
Bacteroidetes distasonis et rel. was correlated with IN, FOS, GG and AX diets. Moreover, 
luminal acetate and propionate concentration also correlated with the IN, FOS, GG and AX 
Figure 3
Redundancy analysis, RDA, where the explanatory variables are acetate, propionate, butyrate and 
the diets: control (CON), Resistant Starch (RS), Arabinoxylan (AX), Fructooligosaccharides (FOS), Inulin 
(IN) and Guar Gum (GG). These variables explain 58.6% of total variation. In this plot 73.5% of the 
explained variation is shown.
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85
M
ol
ec
ul
ar
 e
ff
ec
ts
 o
f d
ie
ta
ry
 fi
b
er
 in
 t
he
 c
ae
cu
m
4
diets and the four microbial groups that associated positively with these diets. An 
increased luminal butyrate concentration was observed with the GG and AX diets, but did 
not strongly correlate with a specific microbial group. 
Effect of dietary fiber on caecum mucosal gene expression
We used Partial Least Square Discriminant Analysis (PLS DA) to analyse gene expression 
changes in caecal mucosa in mice fed different diets. The expression of 8427 filtered 
protein encoding genes was used as input for a sparse PLS DA. The analysis revealed that 
samples could mainly be distinguished between mice fed on CON and RS diets and mice 
fed IN, FOS and GG diets (Figure 4). AX fed mice were clustering between these two main 
clusters, indicating intermediate effects on gene expression as compared to all other diet 
groups. The data revealed that the different fiber diets modulate gene expression 
Figure 4
Partial Least Square Discriminant Analysis (PLS-DA) score plot on gene expression profiles in caecal 
epithelial cells of mice fed different diets: control (CON), resistant starch (RS), arabinoxylan (AX), 
 fructooligosaccharides (FOS), inulin (IN) and guar gum (GG). In the plot the samples (individual mice) 
were plotted based on the two main variates.
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differentially. This observation is similar to effects of dietary fiber on gene expression in 
colonic mucosa (Chapter 3), although contrary to the colon transcriptomes, the caecal 
tissue transcriptomes were clearly discriminated by diet, except for IN and FOS. This 
observation implies that fiber diets can elicit more specific effects on caecal mucosa as 
compared to colonic mucosa, which appears to be congruent with the notion that the 
caecum is the main fermentative organ in the mouse intestinal tract. 
Correlation between microbiota composition and caecal mucosa 
gene expression profiles
To reveal associations between microbiota composition and mucosal gene expression 
profiles in the different diet groups, we integrated these two microarray datasets using a 
PLS-based canonical correlation approach. The results for the first three components 
were represented in a Clustered Image Map (CIM) with correlation coefficients depicted 
by different colours (Figure 5). In total 599 mucosal genes and 29 bacterial groups 
(abundance > 1%) were retained for the first three components, and clustering of the 
correlation coefficients revealed six main clusters of host genes that correlated to six main 
clusters of bacteria (Gene lists per cluster are available upon request). The largest 
microbiota cluster in this correlation analysis (Figure 5, cluster C) contained a range of 
bacterial groups, of which some were previously shown to be associated with the control 
and RS diets, like Alistipes et rel., Bacteroides splanchnicus et rel., Porphyromonas asaccharo-
lytica et rel., Clostridium difficile et rel., Ruminococcus obeum et rel., Desulfovibrio et rel., 
Sphingomonas et rel., and Unclassified TM7. This microbiota cluster correlated with the 
repression of epithelial gene sets associated with phosphorylation, other signalling 
processes and protein modification (cluster 1), although this effect appeared not 
completely specific for this microbial cluster. Likewise, this microbial cluster also correlated 
with enhance expression levels of genes associated with protein catabolism and RNA 
related processes and apoptosis (cluster 4), although this host response was again not 
exclusively correlated to this group of bacteria. Stronger correlations were identified 
between the second largest bacterial cluster (cluster D) that contained microbial groups 
including Parabacteroides distasonis et rel., Acitenobacter et rel. and seven genus groups 
within the Clostridium cluster XIVa group. Remarkably, this microbiota cluster encompassed 
all the microbial groups that were previously found to be associated with the FOS, IN, AX, 
and GG diets, e.g. Clostridium herbivorans et rel., Unclassified Clostridiales XIVa (close to 
Anaerostipes caccae), Clostridium sphenoides et rel., and Bacteroides distasonis et rel.. Cultured 
representatives of these bacterial groups are known for their capacity to degrade diet and 
host derived oligo- and poly-saccharides. Higher relative abundances of these bacterial 
groups was correlated with an elevated expression of genes associated with NF-κB related 
processes, as well as proteolysis and energy-generating processes, including oxidative 
phosphorylation and glycolysis. Inversely, the relative abundance of these microbial 
groups correlated negatively with the expression of mucosal functions related to immune- 
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Figure 5
Correlation of epithelial cell gene expression with luminal microbiota composition. Sparse PLS 
canonical correlation analysis was performed to integrate gene expression values with relative 
abundance data of bacteria for individual mice. The heatmap represents the correlation structure of 
both dataset; red: positively correlated, blue: negatively correlated. More intense colours indicate 
stronger correlation. Correlation values were subjected to unsupervised hierarchal clustering based 
on Euclidean distance for both genes and microbial groups. Six main gene clusters (1-6) and six main 
bacterial clusters (A–F) were identified.
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responses (T cell activation), DNA/RNA and glycosaminoglycan biosynthesis, and cell-cell 
communication. A single microbial group (Clostridium perfringens et rel.) appeared to 
correlate with exactly opposing mucosal transcriptome responses. The remaining 
microbial cluster A, E and F, encompassed functionally as well as phylogenetically broad 
microbial groups that correlated with relatively mild changes in caecal mucosa gene 
expression patterns. 
These analyses illustrate that bacterial groups that were associated with the fiber 
containing diets (except the RS diet) and the elevated caecal SCFA concentrations, also 
were associated with alterations in gene expression profiles in the caecal mucosa of the 
mice in variable ways, affecting processes that include energy metabolism and immune 
response, which are the essential pillars of host-microbe homeostasis in the intestinal 
tract.
Effect of IN and GG on gene-functions expressed by the microbiota
The IN and GG diet groups showed the highest SCFA concentrations and most distinct 
microbial profiles compared to the CON diet. Therefore, the caecal content of 4 mice of 
the IN, GG and CON groups were used for metatranscriptome analysis, using a procedure 
encompassing extraction of total microbial RNA, rRNA depletion, double-strand cDNA 
synthesis and single-end shotgun Illumina sequencing. A total of 11 to 34 million meta-
transcriptome reads were generated per sample. These reads were filtered for non mRNA 
and low quality reads, leading to the extraction of 4.5 x 105 to 3.0 x 106 mRNA reads that 
were assembled and functionally and phylogenetically assigned to unravel the overall as 
well as group-specific microbiota activity profiles. Using this approach approximately 
46-69% of the overall mRNA reads could be assigned to specific transcripts (Table 2), of 
which 70-85% was functionally annotated. 
Using the sample specific functional assignments of the detected transcripts, without 
taking their phylogenetic origin into account, RDA analysis revealed that these func-
tion-patterns clustered according to diet, clearly separating CON, and GG and IN diets 
(Figure 6). To further unravel the functional impacts of the different fiber diets (GG and IN 
versus control), the functions (i.e., KEGGs) associated with the first axis of the RDA 
(explaining ~ 27.6 % of the overall variation within this analysis) were evaluated. Most of 
the differentially expressed KEGGs were within the KEGG category of “Metabolism” (>70%), 
predominated by carbohydrate, amino-acid, and central energy metabolism associated 
functions, as well as a scattering of other metabolic functions (Table S 1). In addition, 
genes belonging to the KEGG category “Environmental Information Processing” appeared 
to be substantially represented in the microbial activity patterns that discriminated the IN 
and GG diets from the CON diet. This category includes functions involved in response 
and adaptation of bacteria to their environment and encompasses both signal 
transduction pathways like two-component systems, as well as “membrane transport” 
associated functions like ABC-transporters and Phosphotransferase systems (PTS), that are 
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important for the utilization of alternative carbon sources (e.g., fibers from the diet), and 
are required to drive the adaptations of the overall microbiota metabolism that was 
detected. Intriguingly, the CON diet microbiota appeared to express genes with KEGG 
identifiers of the “cell motility” category at a higher level as compared to the microbiota of 
mice fed GG or IN diets. The induction of bacterial motility within the microbiota, 
specifically in the caeca of the CON-diet animals, may imply that the microbiota 
experiences nutrient starvation under these conditions, which appears in agreement with 
the lower abundance of dietary nutrients (e.g. fibers) in the caecal lumen of these animals, 
and is known to induce motility in vitro [38],[39].
Correlation between microbiota expressed functions and  
caecal mucosa gene expression patterns
To pinpoint microbial and host functions that are associated, the metatranscriptome 
KEGG functions were correlated with the caecal mucosa gene expression patterns using 
sPLS canonical correlations, leading to the detection of two strongly correlating co-clusters 
of bacterial and host transcripts. The strongest correlations (Figure 7, marked areas of the 
correlation analysis), encompassed host-functions associated with glutathione, glutamate 
metabolism and glycerolipid metabolic processes, and PPAR signalling, (negatively 
correlated; gene enrichment lists per cluster are available upon request), as well as 
immune-related processes such as B cell and T cell receptor and toll- like receptor signalling 
(positively correlated, gene enrichment lists per cluster are available upon request). The 
Table 2  Reads of the Iilumina sequences and the result of data processing per sample.
Total reads after
quality filtering
mRNA Assembled 
mRNA reads
Bacterial protein 
coding in assembled 
contigs
GG_1 1.3E+07 8.2E+05 61.3% 80.6%
CON_1 1.4E+07 9.4E+05 55.1% 83.6%
IN_1 1.7E+07 1.2E+06 54.6% 71.6%
GG_2 2.0E+07 1.8E+06 55.3% 84.9%
IN_2 1.6E+07 2.0E+06 58.6% 83.6%
GG_3 2.5E+07 1.7E+06 68.7% 75.8%
IN_3 1.4E+07 7.0E+05 58.4% 70.4%
CON_2 2.5E+07 1.5E+06 57.0% 79.4%
GG_4 2.0E+07 1.3E+06 45.7% 70.6%
CON_3 1.1E+07 4.5E+05 58.4% 79.8%
CON_4 2.8E+07 1.0E+06 54.0% 75.1%
IN_4 3.4E+07 3.0E+06 56.4% 83.0%
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microbial functions correlated with these host processes, were scattered across a variety 
of different microbial pathways and processes, and only displayed a minor enrichment of 
the KEGG category “Amino-acid metabolism”. Intriguingly, the microbiota-associated 
functions that displayed an opposite correlation with these host functions (Figure 7; 
the pink (B), purple (F) and dark blue (G) clusters), predominantly belonged to the KEGG 
categories “Environmental Information Processing”, “Cellular Processes”, “Genetic Information 
Processing” and “Nucleotide metabolism”. 
Effect of IN and GG on active microbial community
The microbiota functional profiles determined in the different diet groups could be due 
to a shift in the relative contribution to the overall activity patterns by specific microbial 
groups rather than a function adaptation of the overall microbial community per se. The 
differentially expressed KEGG annotated functions could be assigned to five bacterial 
families, i.e., Verrucomicrobiaceae, Bacteroidaceae, Lactobacillaceae, and Erysipelotrichaceae 
were detected at a significantly higher level in the GG diet compared to the control diet 
(Figure S 3). Conversely, the Lachnospiraceae assigned functions were in lower abundance 
Figure 6
Redundancy analysis (RDA) of metatranscriptome data, where the explanatory variables are the 
diets control (CON), Inulin (IN) and Guar Gum (GG). These variables explain 37.4% of total variation. In 
this plot all the explained variation is shown.
-1.5 2.0
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in the GG diet compared to control. The same bacterial families displayed a similar trend 
in the IN samples compared to control samples, albeit not reaching significance. 
To identify which bacterial families are active in the degradation of the fibers, all meta-
transcriptome datasets were analysed in detail for the taxonomic origin of expressed 
Figure 7
Correlation between microbiota expressed functions and caecal gene mucosa expression patterns. 
Sparse PLS canonical correlation analysis was performed to integrate epithelial cell gene expression 
with microbial metatranscriptome KEGG functions for individual mice. The heatmap represents the 
correlation structure of both datasets; red: positively correlated, blue: negatively correlated. More 
intense colours indicate stronger correlation. Correlation values were subjected to unsupervised 
hierarchal clustering based on Euclidean distance for both genes and microbial groups. Five main 
gene clusters (1-5), and seven main bacterial clusters (A-G) were identified.
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genes involved in glycoside hydrolysis (Figure 8A) and saccharide transport (Figure 8BC, 
Table S 2). Bifidobacteriaceae, Lachnospiraceae, Clostridiaceae and the Erysipelotrichaceae 
particularly expressed genes associated with glycoside hydrolysis and saccharide transport, 
possibly indicating active degradation of fibers and sugar transport into the cells. The 
Bifido bacteriaceae appeared to have increased expression of both glycosidases and sugar 
transporters in the IN and GG compared to the control. This family is known for its increase 
in abundance during interventions with oligofructosaccharides, like IN and FOS [40], [4], 
[18], [41]. The increased activity of Bifidobacteriaceae during GG intervention has not been 
reported to date, but according to the metatranscriptome data generated in this study 
appeared to be even somewhat more elevated in GG diet as compared to the IN diet. This 
finding implies that the Bifidobacteriaceae are strongly involved in GG fiber catabolism. 
The other bacterial families detected displayed quite distinct responses to the different 
diets. The Lachnospiraceae increased the glycosidase expression in IN and GG diets 
Figure 8   Relative abundance of gene expression of a) Glycosidases, b) ABC-tranporters 
and c) Phosphotransferase systems (PTS) at family level.
A
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compared to the control diet, while their expression of sugar transport functions was 
decreased. Conversely, the Erysipelotrichaceae elevated expression of sugar transport 
functions in the IN and GG diets, while their glycosidase expression appeared not to 
respond to the diet changes. Finally, the Clostridiaceae decreased the glycosidase 
expression levels in the fiber diets while the carbohydrate transport remained expressed 
at the same level in all diets.
Notably, although 25 % of all the detected glycosidase transcripts was assigned to the 
Bacteroidetes, this phylum hardly expressed saccharide transporter functions. The 
Bacteroidetes expressed a relatively large fraction of the overall (and diverse) hydrolase 
encoding genes, but appeared less active in importing the monomeric sugars produced 
by enzymatic polysaccharide hydrolysis. However, isolates within the Bacteroides and 
Prevotella genera encode operons that cluster genes encoding fiber binding, several 
carbohydrate degrading enzymes and transport functions [42], [43], and the encoded 
polysaccharide degradation machinery of Bacteroides thetaiotaomicron was proposed to 
be closely associated with the transport machinery anchored in the outer membrane. This 
assembly could ensure direct transfer from the hydrolytic enzymes to the transport 
Figure 8  Continued.
B
C
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system to minimize loss of monosaccharides to other bacteria [42], which may not require 
elevated expression levels of other transport functions.
The Bacilli displayed a relatively lower expression of genes encoding glycosidases and 
higher expression of sugar transporter-encoding genes in the IN and GG groups. In 
particular the Phospotransferase systems (PTS) expression by the Bacilli was strongly 
elevated in the IN and GG groups, suggesting that these populations depend on other 
microorganisms to generate the mono- and disaccharides through the initial hydrolysis of 
dietary polysaccharides. Analogously, also the Ruminococcaceae actively expressed sugar 
transport functions, but did not contribute to the expression of glycosidase encoding 
genes. This is somewhat unexpected, since members of the Ruminococcaceae are known 
as fiber degraders that possess glycosidases, like Ruminococcus bromii, Faecalibacterium 
prausnitzii and Ruminococcus flavevacies [44], [45]. Notably, the Ruminococcaceae shifted 
the expression of sugar transport systems from PTS systems to ABC transporters in the GG 
diet (and to a lesser extent in the IN diet) as compared to the CON diet. The substrate 
predictions of the PTS that are strongly expressed in the control diet group were related 
to saccharides that are derived from mucus degradation, which may be suppressed by the 
supply of dietary carbohydrates in the GG and IN diets (Figure S 4). PTS transport enables 
efficient import of mono- and/or disaccharides, which is coupled to substrate phosphor-
ylation [44] and is commonly the preferred mode of transport in bacteria when they 
reside in carbohydrate limited environments. This is likely the situation for the Ruminococ-
caceae in the CON group caeca, where mucus-derived mono- and di-saccharides as well 
as other carbon sources were most likely depleted and/or not accessible for the members 
of this family. ABC transport allows import of mono- up to oligosaccharides, which could 
be energetically favourable for the Ruminococcaceae in the enriched environment 
associated with the fiber diets. This transport-flexibility is absent from many other bacterial 
families, like the Lachnospiraceae, of which the overall expression of carbon metabolism 
associated functions was suppressed in the GG and IN diet compared to the CON diet, 
implying that this bacterial family is unable to compete with other species for the dietary 
fibers. 
With the intention to reconstruct the activity profiles involved in SCFA production, KEGGs 
assigned to key enzymes in SCFA production pathways were selected (Figure S 5). The 
expression of genes encoding these enzymes and their predicted taxonomic assignment 
differed between the CON, IN and GG groups in all of the pathways evaluated (Figure 9). 
In the GG diet the Erysipelotrichaceae seemed to more abundantly express various SCFA 
pathways compared to the control diet. The Erysipelotrichaceae were highly active in the 
conversion of pyruvate to lactate and/or vice-versa. In addition the Erysipelotrichaceae did 
express the acetyl-coA to butyryl-coA via crotonyl-coA pathway, where the conversion of 
crotonyl-coA to butyryl-coA allows anaerobes to conserve energy (Figure S 6; [46] and 
should lead to butyrate production. However the butyrate kinase and the butyryl-CoA:-
acetate CoA-transferase enzymes of Erysipelotrichaceae were not identified in our dataset, 
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Figure 9  Activity of SCFA metabolism pathways 
A) Control animals. Arrow thickness indicates activity of this pathway relative to the total activity. B) 
and C) are the Inulin and Guargum dietary treatment, respectively. The colour and thickness of the 
arrows indicate a fold change compared to the same path in the control diet.
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Figure 9  Continued
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which may be due to the erroneous annotation of acetate and butyrate kinases and SCFA 
transferases since these enzymes display a high-level of similarity [47], [48,49]. Moreover, 
some of the phosphate butyryl-transferase and butyrate kinase were predicted to be 
expressed by members of the Bacillaceae, Bacteroidaceae and Porphyromonadaceae 
families, implying that these families are involved in the production of butyrate, which is 
in clear contrast with previous studies that indicated that Bacillaceae and Bacteroidaceae 
family members are not producing butyrate [45]. Again this may indicate that the 
inaccurate annotations of gene sequences related to kinases and transferases involved in 
SCFA pathways confuse these metabolic interpretations of the metatranscriptome data. 
In the IN group there was a high activity in ethanol consumption by members of the 
 Desulfovibrionaceae, in line with previous reports that isolates within this family use ethanol 
as a carbon source [50]. Transcripts associated with the production of propionate were 
predominantly assigned to members of the Clostridiaceae, Bacteroidaceae and Porphyro-
monadaceae, where the latter two groups probably produce propionate from oxaloacetate 
via succinate. Although increased luminal concentrations of acetate, propionate and 
butyrate were detected in the GG and IN diets, only increased relative expression levels of 
genes associated with propionate were detected in the IN and GG metatranscriptomes 
compared to those of the CON diet, whereas transcripts associated with acetate and 
butyrate production appeared to be present at a relatively lower level in GG and IN 
compared to control diet. 
Discussion
Dietary fibers have been associated with health benefits. After their degradation by the 
intestinal tract microbiota, SCFA are generated and taken up into the epithelium of the 
host. Here we show that the dietary fibers IN and GG yield increased total SCFA 
concentrations in the caecum and in parallel increase the expression of metabolic 
processes involved in central energy metabolism in the caecal mucosa of the mice. 
Moreover microbial analysis revealed shifts in composition and activity patterns when the 
mice were given the different carbohydrate sources. 
Mice fed the FOS, AX or RS diets did not have increased total SCFA concentrations in their 
caeca, although FOS and AX could still stimulate enhanced expression of the central 
energy metabolism pathways in the mucosa of these mice. Similar observations were 
reported previously for the colonic mucosa of these mice, although in the colon lumen 
both the FOS and AX diets increased SCFA levels [chapter 3]. The experimental design of 
this study allowed sampling of luminal content at a single time point and thus generated 
a snapshot view of the intestinal system, which excludes interpretations of the rate of 
SCFA production and or consumption, which may be drastically affected by the different 
diets. Enhanced SCFA flux into the host mucosa could explain the similarity in the 
local mucosal responses measured in the IN, GG, FOS and AX diets. Such a snapshot 
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determination of SCFA concentrations in the lumen is clearly a measurement of limited 
value for the determination of the microbiota fibers-fermentation output [51]. Microbiota 
composition and activity shifts may provide a better proxy for the estimation of in situ 
 fiber-fermentation rates in the intestinal lumen, and these parameters were found strongly 
affected by the addition of fibers to the diet.
The fiber digestion by the microbiota could be further specified by analysis of the 
expression of glycosidase and sugar transport functions. Here we could distinguish three 
categories of bacteria, (i) bacteria that express glycosidases, but hardly sugar transporters; 
(ii) bacteria that express both glycosidases and sugar transporters; (iii) bacteria that hardly 
express glycosidases, but do express sugar transporters (Figure 10). The first group is 
mainly represented by the Bacteroidaceae, the Porphyromonadaceae and the Verrucomi-
crobioaceae, of which the latter displayed elevated expression in the IN and GG diet. The 
Verrucomicrobioceae member detected predominantly belonged to Akkermansia 
muciniphila (data not shown). The increase of activity in the IN and GG groups of this 
typical mucin digesting microbe [52] may indicate that these diets lead to increased 
mucus production, although this was not apparent from the mucosal transcriptome 
analyses, but may not be primarily regulated at the level of gene transcription [53]. The 
second group corresponds to members of the Bifidobacteriaceae, Lachnospiraceae, 
 Erysipe lotrichaceae and Clostridiaceae. 
These four families all expressed sugar transporter encoding genes parallel to the 
glycosidases, which is in clear contrast to the first group and may be due to a lack of 
mechanistic coupling of polysaccharide hydrolysis and saccharide transport as has been 
proposed for some members of the first group of bacteria (e.g. Bacteroides thetaiotami-
cron; [42]). Notably, the Erysipelotrichaceae have only recently been recognized as a 
separate bacterial family, and many members still need to be characterized and re-assigned 
to this family [45], NCBI taxonomy, September 2014). Our results show that this family plays 
an important role in the murine microbiota and contributes strongly to its overall 
metabolite conversions (Figure 10). The third group are bacteria that profit from 
glycosidase activity of other bacteria and import the released sugars. These are the 
Eubacteriaceae, several Bacilli families and the Ruminococcaceae. All bacterial families in 
three different catagories ferment the carbohydrates they ingest to produce SCFA in 
different composition and ratio, although their individual contribution to the overall SCFA 
production by the microbiota may differ as a function of the dietary treatment. However, 
deciphering of the specific activity in particular SCFA pathways of individual bacterial 
families was hampered by the apparent inaccuracy of SCFA pathway mapping of genes, 
where many functions appear to be wrongly assigned, due to the high degree of similarity 
of the enzymes involved. To overcome this, advanced annotation and domain recognition 
tools need to be developed to accurately dissect these different enzyme families, which is 
a prerequisite to enable SCFA pathway reconstruction for environmental samples on basis 
of metatransciptome or similar metagenomic information. 
99
M
ol
ec
ul
ar
 e
ff
ec
ts
 o
f d
ie
ta
ry
 fi
b
er
 in
 t
he
 c
ae
cu
m
4
Figure 10  Overview of identified processes during fermentation
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In summary the SCFA can be used as an energy source for the epithelial cells of the host. 
The correlation of MITChip and host gene-expression revealed fiber degrading and 
possibly butyrate producing bacteria activating energy metabolism in the host and 
repress transcriptional regulation and immune system processes. Moreover, based on the 
KEGG functions derived from the metatranscriptome data we observed a correlation with 
similar host genes to KEGG functions related to bacterial growth. This could indicate that 
active and fiber utilizing bacteria influence the host mucosa directly by enhancing its 
energy metabolism and affecting the immune system. Next to the known fiber responding 
families - Bacteroidaceae, Porphyromonadaceae, Verrucomicrobioaceae, Bifidobacteriaceae, 
Lachnospiraceae, Clostridiaceae, Eubacteriaceae, several Bacilli families and the Ruminococ-
caceae – we identified a new family, the Erysipelotrichaceae, as a prominent and active 
member of the murine gut microbiota. 
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Supplemental information
Figure S 1   Microbial abundance as measured by 16S rRNA gene-targeted quantitative 
PCR (qPCR)
Figure S 2   Pearson distance clustering of the samples on log10 transformed probe 
level data of the MITChip
Abbreviations are for control (CON), Resistant Starch (RS), Arabinoxylan (AX), Fructooligosaccharides 
(FOS), Inulin (IN) and Guar Gum (GG).
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Figure S 3   Relative abundance of metatranscriptome (activity) at family level 
Family names depicted in purple are significantly different in activity between control and Guargum 
groups.
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Figure S 4   Expressed Phosphotransferase systems (PTS) in the metatransciptome 
Uncoloured units were not found in the data. Grey, equally expressed in all groups; orange, higher 
expression in IN and GG; blue, lower expression in IN and GG; yellow, higher expression in GG 
compared to CON; red, higher expression in IN compared to CON.
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Figure S 5   KEGG numbers of the SCFA metabolism pathways used to create Figure 9
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Figure S 6   iPATH visualization of the expression levels in the metabolic processes 
assigned to Erysipelotrichaceae
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Table S 1   KEGG orthology distribution of 250 KEGGs explaining the differentiation of the 
diets in Figure 6.6 best 
More expressed in IN and GG are the KEGGs in the direction of the IN and GG groups, less expressed 
are the KEGGs that correlated to the CON group.
Nr of Keggs Total Kegg
More expressed  
in IN and GG
Less expressed  
in IN and GG
Metabolism 95 87 70.5%
Carbohydrate metabolism 33.1% 38.6% 20.9%
Glycolysis / Gluconeogenesis 5 4
Citrate cycle (TCA cycle) 4 -
Pentose phosphate pathway 1 3
Pentose and glucuronate interconversions 3 2
Fructose and mannose metabolism 2 6
Galactose metabolism 7 4
Ascorbate and aldarate metabolism 1 1
Starch and sucrose metabolism 2 -
Amino sugar and nucleotide sugar metabolism 6 9
Pyruvate metabolism 2 1
Glyoxylate and dicarboxylate metabolism 2 1
Propanoate metabolism 1 1
Butanoate metabolism 4 2
C5-Branched dibasic acid metabolism 1
Energy metabolism 8.9% 6.7% 10.3%
Oxidative phosphorylation 3 -
Carbon fixation in photosynthetic organisms 2 1
Carbon fixation pathways in prokaryotes - 1
Methane metabolism - 3
Nitrogen metabolism 2 -
Sulfur metabolism 4 3
Lipid metabolism 6.5% 4.2% 3.8%
Fatty acid biosynthesis - 1
Fatty acid degradation - 1
Synthesis and degradation of ketone bodies - 1
Sphingolipid metabolism 2 1
Linoleic acid metabolism 1 -
Biosynthesis of unsaturated fatty acids - 1
110
Table S 1   Continued
Nr of Keggs Total Kegg
More expressed  
in IN and GG
Less expressed  
in IN and GG
Primary bile acid biosynthesis 1 -
Glycerolipid metabolism 3 -
Glycerophospholipid metabolism 1 -
Nucleotide metabolism 6.5% 5.0% 7.4%
Purine metabolism 7 3
Pyrimidine metabolism 1 3
Amino acid metabolism 10.5% 7.6% 11.9%
Alanine, aspartate and glutamate metabolism 2 -
Glycine, serine and threonine metabolism 1 1
Cysteine and methionine metabolism 2 2
Valine, leucine and isoleucine biosynthesis 1 -
Valine, leucine and isoleucine degradation - 1
Lysine biosynthesis 1 -
Lysine degradation - 1
Arginine and proline metabolism 4 1
Phenylalanine, tyrosine and tryptophan 
biosynthesis
2 -
Phenylalanine metabolism - 2
Tryptophan metabolism - 1
Metabolism of other amino acids 1.6% 1.7% 2.1%
Selenocompound metabolism 1 1
D-Alanine metabolism 1 -
beta-Alanine metabolism - 1
Glycan biosynthesis and metabolism 2.4% 5.0% 3.2%
N-Glycan biosynthesis - 1
Various types of N-glycan biosynthesis - 2
Glycosaminoglycan degradation - 1
Glycosphingolipid biosynthesis - globo series 1 -
Peptidoglycan biosynthesis 1 -
Other glycan degradation 1 2
Metabolism of cofactors and vitamins 3.2% 5.9% 6.2%
Nicotinate and nicotinamide metabolism 1 -
Porphyrin and chlorophyll metabolism 3 1
Pantothenate and CoA biosynthesis - 4
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Table S 1   Continued
Nr of Keggs Total Kegg
More expressed  
in IN and GG
Less expressed  
in IN and GG
Biotin metabolism - 1
Ubiquinone and other terpenoid-quinone 
biosynthesis
- 1
Metabolism of terpenoids and polyketides 1.6% 0.8% 1.9%
Terpenoid backbone biosynthesis 1 1
Carotenoid biosynthesis 1 -
Biosynthesis of other secondary 
metabolites
0.8% 0.8% 1.2%
Streptomycin biosynthesis 1 -
Caffeine metabolism - 1
Xenobiotics biodegradation and 
metabolism
1.6% 6.7% 1.6%
Chloroalkane and chloroalkene degradation 1 -
Bisphenol degradation 1 -
Benzoate degradation - 3
Xylene degradation - 1
Atrazine degradation - 1
Dioxin degradation - 1
Drug metabolism - other enzymes - 2
Genetic Information Processing 4 5 13.2%
Transcription 0% 0.8% 0.3%
RNA polymerase - 1
Translation 0.8% 2.5% 6.0%
Aminoacyl-tRNA biosynthesis 1 1
Ribosome - 2
Folding, sorting and degradation 0.8% 0.8% 2.4%
RNA degradation 1 -
Protein processing in endoplasmic reticulum - 1
Replication and repair 1.6% 0% 4.5%
Nucleotide excision repair 1 -
Homologous recombination 1 -
Environmental Information Processing 23 21 11.8%
Membrane transport 11.3% 11.8% 7.5%
ABC transporters 8 10
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Table S 1   Continued
Nr of Keggs Total Kegg
More expressed  
in IN and GG
Less expressed  
in IN and GG
Phosphotransferase system (PTS) 6 4
Signal transduction 7.3% 5.9% 4.2%
Two-component system 6 6
HIF-1 signaling pathway 1 -
FoxO signaling pathway 1 -
Phosphatidylinositol signaling system 1 -
Calcium signaling pathway - 1
Cellular Processes 2 6 4.5%
Transport and catabolism 1.6% 0.8% 0.9%
Peroxisome 2 1
Cell motility 0% 4.2% 2.9%
Bacterial chemotaxis - 2
Flagellar assembly - 3
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Abstract
Angiopoietin-like protein 4 (ANGPTL4/FIAF) has been proposed as circulating mediator 
between the gut microbiota and fat storage. Here we show that transcription and 
secretion of ANGPTL4 in human T84 and HT-29 colon adenocarcinoma cells is highly 
induced by physiological concentrations of short chain fatty acids (SCFA). SCFA induce 
ANGPTL4 by activating the nuclear receptor PPARγ, as demonstrated using PPARγ 
antagonist, PPARγ knock-down, and transactivation assays, which show activation of 
PPARγ but not PPARα and PPARδ by SCFA. At concentrations required for PPARγ activation 
and ANGPTL4 induction in colon adenocarcinoma cells, SCFA do not stimulate PPARγ in 
mouse 3T3-L1 and human SGBS adipocytes, suggesting that SCFA act as selective PPARγ 
modulators (SPPARM), which is supported by coactivator peptide recruitment assay and 
structural modelling. Consistent with the notion that fermentation leads to PPAR activation 
in vivo, feeding mice a diet rich in inulin induced PPAR target genes and pathways in the 
colon. We conclude that 1) SCFA potently stimulate ANGPTL4 synthesis in human colon 
adenocarcinoma cells; 2) SCFA transactivate and bind to PPARγ. Our data point to activation 
of PPARs as a novel mechanism of gene regulation by SCFA in the colon, in addition to 
other mechanisms of action of SCFA.
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Introduction
In the last decade, interest in the role of the intestinal microbiota has grown exponentially. 
The functional role of the gut microbiota has mainly been studied in relation to intestinal 
health and immune function. However, there are growing speculations that the gut 
microbiota may also influence other diseases, including type 1 diabetes, autism, and 
obesity, and potentially impact more distant organs [1]. Those notions have spurred the 
search for circulating factors that communicate between the intestinal microbiota and 
other parts of the body. One factor that was found to be strongly downregulated in 
intestine upon colonization of the gut of germ free mice with microbiota and that appears 
to be important for microbiota-induced deposition of triglycerides in adipocytes is Angio-
poietin-like 4 (ANGPTL4), also referred to as FIAF (Fasting Induced Adipose Factor)[2,3]. 
ANGPTL4 is secreted by a variety of tissues including adipose tissue, liver, skeletal muscle, 
and intestine [4]. It is released as a 50kD pro-hormone that is subsequently cleaved into 
N- and C-terminal fragments. The N-terminal fragment of ANGPTL4 blocks activity of the 
enzyme lipoprotein lipase (LPL), which catalyzes uptake of circulating lipids into tissues [5]. 
Accordingly, ANGPTL4 overexpression raises circulating triglyceride levels [6-10]. In 
cardiomyocytes and macrophages, induction of ANGPTL4 by fatty acids and subsequent 
inhibition of LPL is part of a feedback mechanism aimed at preventing cellular lipid 
overload and thus reducing lipotoxicity and inflammation [11,12]. 
Expression of ANGPTL4 is under transcriptional control of Peroxisome Proliferator Activated 
Receptors (PPARs). Indeed, ANGPTL4 was originally cloned as a target gene of PPARα and 
PPARγ [13,14]. Depending on the specific tissue, ANGPTL4 mRNA levels are governed 
primarily by PPARα (liver, small intestine)[13,15], PPARδ (skeletal muscle, heart, macrophages)
[11,12,16], or PPARγ (adipocytes)[13,14]. In addition to the tissues mentioned above, ANGPTL4 
is also expressed in human colon [17](http://biogps.org/), but little is known about the 
factors regulating ANGPTL4 mRNA expression and protein secretion in this tissue. PPARδ is 
highly expressed in human colonocytes, followed by PPARγ, and to a lesser extent PPARα, 
suggesting that PPARs may be important regulators of ANGPTL4 expression [18].  A similar 
expression profile is found in mouse colonocytes [19]. Considering the status of ANGPTL4 
as putative mediator between the gut microbiota and adipose tissue, we were interested 
to identify the microbiota-related factors that influence ANGPTL4 production in the colon. 
Potential factors that are formed by intestinal microbial activity are short chain fatty acids, 
which are the most abundant ones in colon. Accordingly, we studied the regulation of 
ANGPTL4 by SCFA.
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Materials and Methods
Animal experiments
Male C57BL/6J mice were purchased from Charles River Laboratories and housed in pairs 
on a 12-hour light/dark cycle at 21 °C with free access to feed and water throughout the 
entire experimental period. For 2 weeks before the start of the interventions, mice were 
fed a standard semi-synthetic low fat diet based on D12450B (Research Diets Inc., New 
Brunswick, NJ) with modified content of sucrose and corn starch (16.4% and 40.5% w/w, 
respectively). In the first experiment, 12-week-old mice were mildly sedated with isoflurane 
at 9:00 am. Mice were kept under sedation and received either a 80 µL rectal infusion of 
saline (n=4) or saline containing 100 mM sodium propionate (n=4). Both solutions had a 
pH of 6.5. The solutions were administered by inserting a gel loading tip 3 cm into the 
rectum and slowly pushing the solution out of the tip. The infusion were administered on 
6 consecutive days. Four hours after the rectal infusion on day 6, mice were anaesthetized 
with isoflurane and subsequently sacrificed by cervical dislocation. The colon was excised 
and adhering fat was carefully removed. The epithelial lining of the colon was scraped and 
immediately frozen in liquid nitrogen to be stored at -80°C for subsequent RNA isolation. 
In the second experiment, mice were stratified according to their body weight and 
allocated to the control diet group (n=5, low fat diet as described above) or Inulin diet 
group (n=6, low fat diet with 10% w/w corn starch replaced by Inulin). After 10 days of 
dietary intervention, mice were fasted overnight and provided with 1 g of experimental 
diet. After 4 hours, mice were anesthetized using isoflurane and sacrificed by cervical 
dislocation. Colon was removed, luminal content and mucosal scrapings were collected, 
snap-frozen in liquid nitrogen and stored at −80°C (scrapings) or -20°C (content). Luminal 
content was used for SCFA measurement by gas chromatography. Mucosal scrapings 
were used for RNA isolation. The experiments were authorized by the Local Committee 
for Care and Use of Laboratory Animals at Wageningen University.
SCFA measurement 
SCFA concentrations were measured in the luminal content of different parts of the gas-
trointestinal tract of C57BL/6 mice fed a low fat diet. After sacrifice, luminal content was 
collected in tubes containing phosphoric (H3PO4) and isocaproic acid, after which the 
tubes were thoroughly mixed and stored at -20ºC. For analysis, samples were thawed, 
mixed on a vortex and centrifuged at 14.000 rpm for 5 min. The supernatant was collected 
and SCFA concentrations were determined by gas chromatography (Fisons HRGC Mega 2, 
CE Instruments, Milan, Italy) at 190°C using a glass column fitted with Chromosorb 101. The 
carrier gas was N2 saturated with methanoic acid, and isocaproic acid was used as an 
internal standard.
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Cell Culture
T84 and HT-29 human colonic carcinoma epithelial cells were cultured in DMEM F-12 or 
DMEM medium (Lonza, the Netherlands) containing 5% or 10% fetal calf serum (FCS), 
respectively, and 1% penicillin/streptomycin at 37oC in a humidified incubator of 95% 
air/5% CO2. Cells were grown till 80-90% confluence and treated for the indicated time 
periods with sodium acetate, sodium propionate and sodium butyrate from a stock in PBS 
to a final concentration of 1 mM or 8 mM. Alternatively, cells were treated with synthetic 
agonists for PPARα (Wy14643, 5 μM), PPARδ (GW501516, 1 μM) and PPARγ (rosiglitazone, 1 
μM) or synthetic PPARγ antagonist GW9662 (5 μM) or Trichostatin A (100 nM) from a stock 
in DMSO. In one experiment, cells were pre-incubated with α-amanitin (10 μg/mL) from a 
stock in water for 1 hour followed by 24 hours co-incubation with butyrate at 1 mM. After 
the indicated time points medium was collected and used for analysis of ANGPTL4 by 
ELISA, and/or cells were harvested for subsequent RNA isolation.
siRNA transfection
Silencing of the PPARγ gene in T84 cells was done using ON-TARGETplus SMARTpool for 
Human PPARγ (Thermo Scientific Dharmacon, Etten-Leur, The Netherlands), representing 
a mixture of four siRNAs:CAAAUCACCAUUCGUUAUC,GACAUGAAUUCCUUAAUGA, GAUAU-
CAAGCCCUUCACUA, GACAGCGACUUGGCAAUAU. As control we used ON-TARGETplus 
Non-targeting Pool (Thermo Scientific Dharmacon). Transfection was done according to 
the manufacturers protocol using DharmaFECT 1 transfection reagent. The cells were 
transfected with 100 nM siRNA and incubated for 48 hours, followed by treatment with 
butyrate (1 mM) for a period of 24 hours. Thereafter, medium was collected for ANGPTL4 
protein analysis by ELISA and the cells were used for RNA isolation and subsequent qPCR.
PPARγ chromatin immuno-precipitation (ChIP)
T84 cells were grown in 10 cm plates to a density of approximately 5 million cells/dish and 
treated with butyrate (8 mM) or rosiglitazone (1 μM). After 1 hour medium was removed 
and cells were fixed in 1% formaldehyde in PBS . After 10 minutes, crosslinking was stopped 
by the addition of glycine to a final concentration of 0.125 M. The cells were washed three 
times with ice cold PBS and re-suspended in 0.3 mL of lysis buffer (0.1% SDS,1% Tritonx-100, 
0.15 M NaCl, 1mM EDTA, 20mM Tris pH 8.0). The lysate was frozen at -80°C until further 
analysis. ChIP was carried out as described in Siersbæk et al. [21], with the exceptions that 
disuccinimidyl glutarate was not used for cross-linking, and sonication was performed in 
2x10 on/off cycles of 30 sec. The PPARγ antibody used was PPARγ H100 (sc-7196, Santa 
Cruz Biotechnologies, USA).
PPARγ stable reporter assay
PPARγ CALUX cell line was obtained from BioDetection Systems B.V. (Amsterdam, the 
Netherlands).  PPARγ CALUX cells are based on human osteoblastic (U2-OS) cells (American 
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Collection Cell Culture (ATCC)), Manassas , VA, USA),  stably transfected with a human PPARγ 
expression plasmid and a luciferase reporter construct [22]. The cells were cultured as 
described previously in a 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s 
F12 medium (Invitrogen, Breda, the Netherlands) supplemented with 7.5% fetal bovine 
serum (FBS) (Invitrogen), 1% nonessential amino acids (Invitrogen) and penicillin/
streptomycin (Invitrogen) to final concentrations 10U/mL and 10μg/mL, respectively 
[22,23]. Once per month 200 μg/mL G418-disulfate was added to the culture medium.
The PPARγ CALUX assay was performed as described previously [22,24]. In short, for the 
exposure experiments PPARγ-CALUX cells were plated in the 96-well plates with 
phenol-free DF supplemented with 5% dextran coated charcoal-stripped FBS (Invitrogen) 
at a volume of 200 μL per well. The next day medium was refreshed and cells were 
incubated in triplicates with test compounds added to the culture medium.  After 24 
hours, the cells were checked visually for cytotoxicity, the medium was removed, and the 
cells were lysed in Luciferase Cell Culture Lysis Reagent (Promega, Leiden, the Netherlands). 
Luciferase activity was measured in cellular extracts using a Synergy HT Multi-Detection 
Microplate Reader (Luminometer of BioTek Instruments Inc., USA).  For each test compound 
at last two independent experiments were performed.     
GAL4-PPAR stable reporter assay
The assay was carried out in Hela cells stably expressing a chimeric protein containing the 
ligand binding domain (LBD) of human PPARα, PPARδ or PPARγ fused to the yeast 
transactivator GAL4 DNA binding domain (DBD) and  a luciferase (Luc) reporter gene 
driven by a pentamer of the GAL4 recognition sequence in front of a β-globin promoter. 
The cells were seeded in 96-well plates and incubated the following day with tested 
compounds for 24h. At the end of the incubation, the luciferase activity was measured 
using a BMG LUMIstar Galaxy luminometer. Results expressed as relative light units (RLU) 
were obtained from experiments performed in triplicate. Rosiglitazone , GW7647 and 
L165041 (all at 1 µM) were used as positive controls for activation of PPARα, PPARδ and 
PPARγ, respectively. The measurements were performed as a commercial service by 
Tebu-bio laboratories (http://www.tebu-bio.com/upload/cms/-PPAR_Screening_Poster.
pdf), Le Perray-en-Yvelines, France.
ANGPTL4 ELISA
ANGPTL4 levels in the medium were measured by ELISA as detailed previously [17]. Briefly, 
96-well plates were coated with anti-human ANGPTL4 polyclonal goat IgG antibody 
(AF3485, R&D Systems) and incubated overnight at 4°C. Plates were washed extensively 
between each step. After blocking, 100 μL of medium of cells was applied, followed by 2 
hour incubation at room temperature. A standard curve was prepared using recombinant 
human ANGPTL4 (3485-AN, R&D Systems) at 0.3 to 2.1 ng/well. Next, 100 μL of diluted 
biotinylated anti-human ANGPTL4 polyclonal goat IgG antibody (BAF3485, R&D Systems) 
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was added for 2 hour, followed by addition of streptavidin-conjugated horseradish 
peroxidase for 20 min, and tetramethyl benzidine substrate reagent for 6 min. The reaction 
was stopped by addition of 50 μL of 10% H2SO4, and the absorbance was measured at 
450 nm.
Cofactor recruitment assay
Nuclear receptor PamChip arrays (PamGene, s’Hertogenbosch, The Netherlands) were 
used as described previously [25]. Upon binding a ligand, PPARs undergo a conformational 
change that promotes the formation of a cofactor binding pocket, subsequently allowing 
interaction with the so-called LxxLL motif within some coregulators. The PamChip arrays 
consist of 53 peptides encompassing the LxxLL motifs of 21 different coregulator proteins. 
The sequences are provided as supplementary data in Koppen et al. [25]. Briefly, the arrays 
were incubated with glutathione S-transferase-tagged PPARγ ligand binding domain 
(LBD) (Invitrogen, Breda, The Netherlands) in the presence and absence of the ligands i.e. 
sodium acetate, sodium propionate, sodium butyrate (each at 40 mM), and rosiglitazone 
(1 μM). Quantification of the interaction between PPARγ and coregulators was made using 
Alexa 488-conjugated anti-glutathione S-transferase rabbit polyclonal antibody 
(Invitrogen).
Affymetrix GeneChip microarray analysis
Microarray analysis was performed on T84 cells treated with 0.1 μM rosiglitazone or 1 mM 
butyrate for 24h. Total RNA was prepared using TRIzol reagent (Invitrogen), and purified on 
columns using the RNeasy Mini Kit (Qiagen, Venlo, The Netherlands). RNA quality and 
integrity were verified with the RNA 6000 Nano assay on the Agilent 2100 Bioanalyzer 
(Agilent Technologies, Amsterdam, the Netherlands). Hybridization, washing, and 
scanning of the Affymetrix Human Gene 1.1 ST Array Plate was performed on Affymetrix 
GeneTitan. Scans of the Affymetrix arrays were processed using packages from the 
Bioconductor project [26]. Raw signal intensities obtained by robust multiarray (RMA) 
normalization [27]. Probe-sets were defined according to Dai et al. using remapped chip 
definition file (CDF) version 15 based on the Entrez gene database [28]. The microarray 
data were submitted to Gene Expression Omnibus (Accession GSE40706).
Microarray analysis of colon of mice fed inulin was carried out as described above using 
the Affymetrix Mouse Gene 1.1 ST Array Plate (Accession GSE43065).
3T3-L1 adipogenesis
3T3-L1 fibroblasts were amplified in DMEM/10% calf serum and subsequently seeded into 
six-well plates. Two days after the cells reached confluence, the medium was changed to 
DMEM/10% fetal calf serum containing 0.5 mM 3-isobutyl-1-methylxanthine, 2 μg/ml 
insulin (Actrapid), 0.5 μM dexamethasone,  and either the short chain fatty acids or 
rosiglitazone (1 μM). After two days, the medium was changed to DMEM/10% fetal calf 
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serum containing 2 μg/ml insulin and the short chain fatty acids or rosiglitazone. Cells 
were harvested after two more days for RNA isolation (day 4). This mild adipogenesis 
protocol permits assessment of PPARγ agonist activity of added compounds [29]. Oil Red 
O staining was performed at day 10 using a standard protocol. 
In a second protocol, two days after the cells confluence (=day 0), the medium was 
changed to DMEM/10% fetal calf serum containing 0.5 mM 3-isobutyl-1-methylxanthine, 
5 μg/ml insulin, and 1 μM dexamethasone. After three days, the medium was changed to 
DMEM/10% fetal calf serum containing 5 μg/ml insulin. The medium was subsequently 
changed every 3 days, and no further insulin was added after 6 days. At day 10, 3T3-L1 
adipocytes were treated with rosiglitazone (1 μM) and the short chain fatty acids (8 mM) 
for 24 hours.
Adipogenesis in SGBS
Human Simpson–Golabi–Behmel syndrome (SGBS) adipocytes were cultured and grown 
to confluency in 0F medium (DMEM/F12/Biotin-panthotenate/PSA) plus 10% FCS. One 
day post-confluency, the medium was changed to Quick-diff medium which is 3FC 
medium (0F medium plus 0.01 mg/mL human apo-transferrin, 2x10-8 M insulin, 10-7 M 
cortisol, 0.2 nM T3) with 50 nM dexamethasone, 500 µM 3-isobutyl-1-methylxanthine and 
2 µM Rosi or 8 mM SCFA. On day 4, medium was changed to 3FC medium and changed 
every 4 days until day 15.  Expression of differentiation markers and PPARγ targets was 
determined by qPCR at day 15. DMSO was used as control.
RNA isolation and qPCR
RNA was isolated from T84 cells using RNeasy columns or Trizol. 1 µg of total RNA was 
reverse- transcribed with iScript (Bio-Rad, Veenendaal, the Netherlands) or Fermentas cDNA 
synthesis kit according to the instructions from the manufacturer. cDNA was amplified on 
a Bio-Rad CFX384 Real Time System using Sensimix (Bioline, GC Biotech, Alphen aan de 
Rijn, The Netherlands). Cyclophilin or 36B4 was used as housekeeping gene. PCR primer 
sequences were taken from the PrimerBank and ordered from Eurogentec (Seraing, 
Belgium). Primer sequences are presented in table 1.
Modeling of Butyrate Binding to PPARγ
For modeling the structure of the complex between PPARγ and butyrate, HADDOCK 
version 2.1 was used [30]. HADDOCK is a highly successful modeling approach that makes 
use of structural knowledge when available to drive the docking procedure.  In this case, 
the x-ray crystal structure of PPARγ with decanoic acid bound (3U9Q) was used to identify 
the likely binding site for short chain fatty acids such as butyrate [31]. The docking was 
performed using the web server version of HADDOCK  [32], with the following modifications. 
The high temperature rigid body torsion angle dynamics and the first rigid body cooling 
stage were not performed (number of steps set to 0) and the second cooling phase of 
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torsion angle dynamics with flexible side-chains at the interface was started with a 
reduced initial temperature of 500K instead of the default 1000K.  
All calculations were performed with CNS1.2 [33]. Non-bonded interactions were 
calculated with the OPLS force field using a cutoff of 8.5 Å [34]. The electrostatic potential 
(Eelec) was calculated by using a shift function, while a switching function (between 6.5 
and 8.5Å) was used to define the Van der Waals potential (EvdW). The HADDOCK score was 
used to rank the generated poses. It is a weighted sum of intermolecular electrostatic 
(Eelec), van der Waals (EvdW), desolvation (Edesolv) and ambiguous interaction restraint 
(AIR) energies with weight factors of 0.2, 1.0, 1.0 and 0.1, respectively.
The ambiguous interaction restraints used to drive the docking of butyrate to PPARγ were 
derived from the X-ray crystal structure of PPARγ with decanoic acid (DA) bound (3U9Q), 
where protein residues near the decanoic acid were identified as the butyrate binding 
site. All protein residues within 3.9Å of the decanoic acid (residues 278, 281, 282, 285, 289, 
323, 356, 360, 363, 449, 469, and 473) were defined as active restraints for the rigid body 
docking phase, and as passive restraints for the subsequent semi-flexible refinement 
stage. The ligand was considered active for both docking phases. This strategy effectively 
pulls the butyrate ligand into the binding site during rigid-body docking while allowing a 
thorough exploration of the binding pocket during the refinement stage. With the protein 
Table 1  list of primers used
Gene Forward primer Reverse primer
m36B4 ATGGGTACAAGCGCGTCCTG GCCTTGACCTTTTCAGTAAG
Fabp4 AAGAAGTGGGAGTGGGCTTT AATCCCCATTTACGCTGATG
Gyk ATCCGCTGGCTAAGAGACAACC TGCACTGGGCTCCCAATAAGG
Slc2a4 GGAAGGAAAAGGGCTATGCTG TGAGGAACCGTCCAAGAATGA
Adipoq GCAGAGATGGCACTCCTGGA CCCTTCAGCTCCTGTCATTCC
Angptl4 GTTTGCAGACTCAGCTCAAGG CCAAGAGGTCTATCTGGCTCTG
ANGPTL4 CACAGCCTGCAGACACAACTC GGAGGCCAAACTGGCTTTGC
PPARG GAGCCCAAGTTTGAGTTTGC CAGGGCTTGTAGCAGGTTGT
PPARA CAGAACAAGGAGGCGGAGGTC TTCAGGTCCAAGTTTGCGAAGC
PPARD TGGCTTTGTCACCCGTGAGT ACAGAATGATGGCCGCAATGAA
PLIN2 ATGGCATCCGTTGCAGTTGAT GATGGTCTTCACACCGTTCTC
UCP2 TGCCCTCCTGAAAGCCAAC CTTGACCACGTCTACAGGGGA
AQP8 GCGAGTGTCCTGGTACGAAC CAGGCACCCGATGAAGATGAA
LGALS1 TCGCCAGCAACCTGAATCTC GCACGAAGCTCTTAGCGTCA
h36B4 CGGGAAGGCTGTGGTGCTG GTGAACACAAAGCCCACATTCC
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active site residues defined as passive during the semi-flexible refinement stage, the 
ligand is not restrained to any particular orientation or location within the defined binding 
site. For comparison, a second docking trial was performed with active residues for the 
entire PPARγ binding site, defined as amino acids within 3.9Å of either the partial agonist 
decanoic acid (from 3U9Q, residues 278, 281, 282, 285, 289, 323, 356, 360, 363, 449, 469, and 
473) or the full agonist nitrosylated fatty acid (from 3CWD, residues 285, 286, 288, 289, 326, 
327, 330, 340, 341, 364, 449, and 473). Docking with this wider binding pocket definition did 
not give additional solutions.
At the end of the docking protocol, clustering based on ligand pairwise root mean square 
deviation criteria was performed and the best scoring structure of the best scoring cluster 
was taken as the best solution. The clustering distance cutoff was reduced from the 
default 7.5Å cutoff for protein-protein complexes to 1.75Å, which is more suitable for 
protein-ligand complexes. 
The interactions between decanoic acid and PPARγ were analyzed by submitting the 
X-ray crystal structure 3U9Q to the HADDOCK refinement server [32] which only performs 
a gentle refinement in explicit solvent and returns similar statistics as a full docking run.
Results
ANGPTL4 production is stimulated by short chain fatty acids
One set of molecules that may mediate the effect of microbiota on ANGPTL4 expression in 
the colon are the short chain fatty acids (SCFA) acetate, propionate and butyrate. To 
estimate the concentration of fatty acids to be used for in vitro experiments, we determined 
the total SCFA concentration in the lumen of different parts of the gastrointestinal (GI) 
tract of mice fed a low fat diet (Figure 1A). Total SCFA concentration varied from <10 mM 
in the proximal small intestine to >40 mM in the caecum. In the colon the highest 
concentrations were found for acetate, followed by propionate and butyrate (Figure 1B). In 
the literature, even higher concentrations have been reported that exceed 100 mM [35]. 
Based on these data, we used low to medium millimolar SCFA concentrations. 
To study regulation of ANGPTL4 production in colonocytes, we used the human colonic 
adenocarcinoma cell lines T84 and HT29. Remarkably, all SCFA significantly increased 
ANGPTL4 secretion by T84 and HT-29 cells (Figure 1C). Strongest effects were observed for 
butyrate, followed by propionate and acetate. Increased ANGPTL4 secretion was mirrored 
by a pronounced increase in ANGPTL4 mRNA (Figure 1D), suggesting SCFA stimulate 
ANGPTL4 transcription, which was further supported by the rapid time-course of induction 
of ANGPTL4 mRNA by butyrate (Figure 1E). Furthermore, induction of ANGPTL4 secretion 
by butyrate was almost completely abolished by α-amanitin, an inhibitor of RNA 
polymerase II (Figure 1F). In support of in vivo regulation of Angptl4 gene expression by 
SCFA, rectal infusion of propionate significantly increased Angptl4 mRNA expression in 
mouse colon (Figure 1G).
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Butyrate and to a lesser extent propionate are able to inhibit histone deacetylase (HDAC) 
activity, while acetate is ineffective [36,37]. To study the impact of HDAC inhibition on 
ANGPTL4 secretion, we treated T84 and HT-29 cells with the specific HDAC inhibitor 
trichostatin A, which similar to butyrate inhibits class I and class II HDACs. Unlike butyrate, 
trichostatin A had no effect on ANGPTL4 secretion (Figure 1H), indicating that the 
stimulatory effect of butyrate on ANGPTL4 is likely independent of HDAC inhibition. The 
effectiveness of trichostatin A was demonstrated by the marked induction of the LGALS1 
gene (Figure 1I).
PPARγ mediates induction of ANGPTL4 by SCFA 
Because the medium chain fatty acid decanoic acid was recently shown to be a direct 
ligand of PPARγ and ANGPTL4 is a sensitive target of PPARγ in colonocytes [31,38], we 
hypothesized that butyrate may upregulate ANGPTL4 expression in colonocytes by 
activating PPARγ. To test the responsiveness of ANGPTL4 to PPAR activation in T84 and 
HT-29 cells, the cells were treated with synthetic agonists for PPARα, PPARδ and PPARγ. The 
PPARγ agonist rosiglitazone was the most potent inducer of ANGPTL4 protein secretion 
(Figure 2A) and mRNA (Figure 2B) in both cell types, followed by PPARδ agonist GW501516 
and PPARα agonist Wy14643. These results are consistent with the high expression of 
PPARG mRNA in T84 cells (Figure 2C, top panel) and to a lesser extent in HT-29 cells (lower 
panel), and the corresponding protein levels of the three PPARs in the two cell lines [39-43]. 
Upon incubation with rosiglitazone, a time- and dose-dependent increase in ANGPTL4 
protein was observed in T84 cells (Figure 2D,E), indicating that ANGPTL4 production is 
highly sensitive to PPARγ activation. Accordingly, we considered PPARγ as a possible 
candidate mediating induction of ANGPTL4 mRNA by butyrate. 
To investigate whether the stimulatory effect of butyrate on ANGPTL4 secretion occurs via 
PPARγ, we used the PPARγ antagonist GW9662. Induction of ANGPTL4 secretion by 
butyrate in T84 cells was strongly diminished by GW9662 (Figure 3A), suggesting that 
butyrate increases ANGPTL4 secretion mainly by activating PPARγ. Similarly, siRNA 
mediated knock-down of PPARγ mRNA by about 60% led to a very significant 40% 
decrease in butyrate-induced ANGPTL4 mRNA level (Figure 3B) and butyrate-induced 
ANGPTL4 protein secretion (Figure 3C), again suggesting that the effect of butyrate on 
ANGPTL4 is largely mediated by PPARγ. Stimulation of PPARγ mRNA by butyrate (Figure 
3B) likely reflects PPARγ autoregulation. To further pursue the role of PPARγ in ANGPTL4 
regulation by butyrate, we performed chromatin immunoprecipitation to study binding 
of PPARγ to the ANGPTL4 gene. The results indicate that PPARγ occupies the PPAR binding 
site within intron 3 of the ANGPTL4 gene (Figure 3D), which is known to mediate PPAR 
responsiveness [44,45]. Occupancy was modestly induced by both butyrate and 
rosiglitazone. Taken together, these data strongly suggest that induction of ANGPTL4 by 
butyrate in T84 cells is mediated by PPARγ.
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Figure 1   Physiological concentrations of SCFA stimulate ANGPTL4 mRNA and protein 
secretion in colon adenocarcinoma cells
A) Total SCFA concentration in different sections of the intestine of mice fed low fat diet. Errors bars 
represent SEM. B) Concentration of individual SCFA in colon of mice fed low fat diet. Errors bars 
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To investigate whether butyrate acts as general inducer of PPARγ-dependent gene 
regulation, we performed microarray on T84 cells treated either with butyrate (1 mM and 8 
mM) or rosiglitazone. Remarkably, effects of butyrate on global gene expression were much 
more pronounced compared to rosiglitazone, likely linked to its property as potent HDAC 
inhibitor (Figure 4A, Suppl. Figure 1). Interestingly, more overlap was observed between 1 
mM butyrate and rosiglitazone than between 8 mM butyrate and rosiglitazone (Suppl. 
Figure 1). Cluster analysis identified clusters of genes induced by rosiglitazone and butyrate 
(Figure 4A). Genes in one cluster, which besides ANGPTL4 included PPAR targets HMOX1, 
PDK4 and UCP2 [46-48], were induced by 1 mM and 8 mM butyrate. Genes in another cluster, 
which included other PPAR targets including AQP8 and PLIN2 [49,50], were induced by 1 mM 
butyrate and surprisingly not induced or even suppressed by 8 mM butyrate. The role of 
PPARγ in mediating the stimulatory effect of 1 mM butyrate on expression of PLIN2 and 
UCP2, representing two distinct clusters, was verified by siRNA (Figure 4B). 
The biphasic regulation of AQP8 and PLIN2 by butyrate but not by propionate and acetate 
was confirmed by qPCR (Figure 4C). Such a biphasic regulation is only possible if a gene is 
regulated by at least two distinct mechanisms: a stimulatory effect presumably via PPARγ 
already active at lower butyrate concentrations and a suppressive effect impacting a 
subset of PPAR targets at higher butyrate concentrations. Overall, these data indicate that 
SCFA act as a general inducer of PPARγ-dependent gene regulation in T84 cells. However, 
especially at higher concentrations, the main effects of SCFA in T84 cells are independent 
of PPARγ.
SCFA function as PPARγ agonists
To further study activation of PPARγ by SCFA, we employed a stable PPARγ reporter assay. 
Hela cells stably transfected with a fusion construct between the DNA-binding domain of 
Gal4 and the ligand-binding domain of PPARγ, PPARα, or PPARδ were incubated with 
increasing concentrations of SCFA. Remarkably, PPARγ was strongly activated by butyrate 
and to a lesser extent by propionate (Figure 5A). In contrast, PPARα and PPARδ were not 
activated by any of the SCFA, even at higher concentrations. 
represent SEM. C) ANGPTL4 concentration in medium of T84 and HT-29 cells treated with SCFA for 
24 hours at the indicated concentrations. D) ANGPTL4 mRNA in T84 and HT-29 cells treated with 
SCFA for 24 hours at the indicated concentrations. E) Time-course of induction of ANGPTL4 mRNA in 
T84 cells by butyrate (1 mM). F) Inhibitory effect of α-Amanitin (10 µg/mL) on induction of ANGPTL4 
secretion by 1 mM butyrate in T84 cells. G) Effect of rectal infusion of propionate on Angptl4 mRNA 
in epithelial scrapings of mouse colon. Errors bars represent SEM. H) Time-course of regulation of 
ANGPTL4 protein in medium of T84 and HT-29 cells by trichostatin A (100 nM) and butyrate (8 mM). 
I) Stimulatory effect of trichostatin A (100 nM) on LGALS1 mRNA in T84 cells.  Errors bars represent SD 
except when indicated otherwise. Asterisk indicates significantly different from control according to 
Student’s t-test (p<0.05).
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To corroborate activation of PPARγ by SCFA we performed an alternative reporter assay in 
U2OS cells stably transfected with a human PPARγ expression and a PPRE-luciferase 
reporter construct. Similar to the results described above, propionate but especially 
butyrate markedly activated PPARγ reporter activity, while acetate had minimal effect 
(Figure 5B). The threshold for stimulating reporter activity was 0.5 mM for butyrate 
compared to 10 nM for rosiglitazone, indicating that butyrate has relatively weak PPARγ 
agonist activity.
To explore the possibility that SCFA serve as direct PPARγ agonists, we used Nuclear Receptor 
PamChip® Arrays. In this system the interaction between soluble nuclear receptors and 53 
immobilized peptides corresponding to specific coregulator-nuclear receptor binding 
Figure 2   PPARγ potently stimulates ANGPTL4 in colon adenocarcinoma cells
Synthetic agonists for PPARα (Wy14643, 5 μM), PPARδ (GW501516, 1 μM) and PPARγ (rosiglitazone, 1 
μM) stimulate ANGPTL4 secretion (A) and mRNA expression (B) in T84 and HT-29 cells. C) Amplification 
curve of PPARα, PPARδ, and PPARγ mRNA as determined by qPCR in T84 and HT-29 cells. Size of 
amplicons varied less than 10%. D) Time course of induction of ANGPTL4 protein in medium by 
rosiglitazone (1 μM). E) Dose-dependent induction of ANGPTL4 protein in medium by rosiglitazone. 
Unless indicated otherwise, cells were treated for 24h. Errors bars represent SD. Asterisk indicates 
significantly different from control according to Student’s t-test (p<0.05).
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regions is studied. Using this system for PPARγ, we previously generated ligand-specific 
coregulator interaction profiles [25]. Both rosiglitazone and butyrate promoted the 
interaction between PPARγ and numerous coactivator peptides (e.g. CBP; Figure 5C). 
However, in contrast to rosiglitazone, butyrate did not relieve the interaction between 
PPARγ and NCoR1 and NCoR2 corepressor peptides. Consistent with the PPARγ reporter 
data, acetate had little effect. Quantitative analysis of the PamChip® Arrays is presented in 
Figure 5D. These data suggest that butyrate functions as selective PPARγ modulator 
(SPPARM) [51].
Modeling of butyrate bound to PPARγ
To find support for SCFA behaving as selective PPARγ modulators we performed structural 
modeling of the binding of butyrate to PPARγ using HADDOCK [30,32] (Figure 6A). Docking 
of butyrate into PPARγ resulted in three different clusters of solutions, each showing 
butyrate bound in the ligand-binding pocket of the protein. The best cluster in terms of 
HADDOCK score was also the largest one (179/200 calculated structures) (Table 2) and 
Figure 3   Induction of ANGPTL4 by butyrate is mediated by PPARγ
A) Inhibitory effect of PPARγ antagonist GW9662 (5 μM) on induction of ANGPTL4 secretion in 
medium by rosiglitazone (10 nM) and butyrate (1 mM) in T84 cells. Effect of siRNA mediated PPARγ 
knock-down (B, left panel) in T84 cells on butyrate-induced upregulation of ANGPTL4 mRNA (B, right 
panel) and ANGPTL4 protein in medium (C). D) PPARγ ChIP-qPCR on selected loci in T84 cells treated 
with butyrate (8 mM) or rosiglitazone (1 μM) for 24 hours. Bars represent the mean recovery plus 
range of two independent experiments. Errors bars represent SD except when indicated otherwise. 
Asterisk indicates significantly different from control according to Student’s t-test (p<0.05).
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Figure 4   Global effects of butyrate in T84 cells
T84 cells were treated with rosilitazone (1 μM) or butyrate (1 mM and 8 mM) for 24 hours and 
subjected to Affymetrix microarray analysis. A) hierarchical clustering based on Pearson’s correlation 
with average linkage. B) Effect of siRNA mediated PPARγ knock-down in T84 cells on induction of 
PLIN2 and UCP2 mRNA by butyrate. AQP8 mRNA (C) and PLIN2 mRNA (D) levels were determined in 
T84 cells treated with SCFA for 24 hours at the indicated concentrations. Errors bars represent SD. 
Asterisk indicates significantly different from control according to Student’s t-test (p<0.05).
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Figure 5   SCFA are agonists of PPARγ
A) Stable GAL4-PPAR chimera reporter assay showing activation of PPARγ but not PPARα and PPARδ 
by SCFA at concentrations ≥1mM. The dotted lines represent the levels of luciferase activity reached 
upon incubation with synthetic PPAR agonists. Cells were treated for 24 hours. Errors bars represent 
SD. B) Stable PPARγ reporter assay showing activation of PPARγ by SCFA at concentrations ≥500 μM. 
Cells were treated for 24 hours. Note the different x-axis for rosiglitazone and the SCFA. Errors bars 
represent SD. C) A nuclear receptor PamChip assay was used to measure the interaction between 
PPARγ and immobilized peptides corresponding to specific coregulator-nuclear receptor binding 
regions in the presence and absence of rosiglitazone (1 μM), butyrate (40 mM), or acetate (40 mM). 
Representative images are shown. D) Quantitation of the PamChip assay results for rosiglitazone and 
butyrate compared to control. Arrows point to the same peptides as in C.
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Figure 6   Modeling of butyrate into the PPARγ binding pocket
A) The model reveals the complex between butyrate and PPARγ with the best HADDOCK score 
(butyrate shown as cyan sticks), overlaid with the crystal structure of the decanoic acid complex 
with PPARγ (3U9Q, decanoic acid shown as green sticks) by aligning the protein backbone atoms of 
the two structures (ribbon displayed for the HADDOCK model).  The displayed protein side-chains 
are shown as thin cyan or green sticks, and the sidechains making contacts with the docked butyrate 
or decanoic acid, respectively.  Hydrogen bond contacts between the butyrate and the protein are 
shown as yellow dashed lines. B) Comparison of the binding location for coactivator peptide PGC-1α 
(blue ribbon) bound to PPARγ (HADDOCK model of the PPARγ-butyrate complex, left) with the 
binding site for the SMRT corepressor peptide (purple ribbon) binding to PPARα (1KKQ, right) [69].  In 
both structures the C-terminal portion of the PPAR molecule that forms helix AF-2 is colored pink for 
comparison.  The structures were aligned using the backbone atoms of the receptors.
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contained the best scoring models. It reveals a binding mode very similar to decanoic acid 
within the crystal structure of PPARγ (3U9Q) [31]. Specifically, the average RMSD between 
the butyrate and decanoic acid common atoms upon aligning the backbone atoms of 
the PPARγ (ligand-RMSD) was 1.55±0.29Å for the best four cluster members. The remaining 
clusters have less favorable interaction energy.  
Interactions between butyrate and PPARγ are dominated by electrostatic interactions and 
hydrogen bonds between the carboxylate group and several hydrogen bond donating 
protein side-chains, which are very similar to those found in the structure with decanoic 
acid (Figure 6A).  In the latter, hydrogen bonds are found to four different side-chains near 
the carboxylate group, namely His323 HE2, Ser289 OG, His449 HE2, and Tyr473 OH.  The 
top four structures of the best cluster reveal specific hydrogen bonds from the butyrate 
oxygens to His323, Tyr473, and His449.  The hydrogen bond to Ser289 is never observed, 
while in two of the structures a fourth hydrogen bond is made to Tyr327 OH. The average 
buried surface area for the best four docking solutions is 286 ± 14 Å2, and the average 
HADDOCK score for the best four structures is -7 ± 3.  In comparison, the buried surface 
area and HADDOCK score calculated for the decanoic acid-PPARγ structure are 478Å2, and 
–22.1, respectively.
We next explored the possible influence of butyrate on coactivator and corepressor 
binding (Figure 6B). Fortunately, the structure of PPARγ with decanoic acid also contained 
a bound PGC1α coactivator peptide, allowing us to model butyrate docked within the 
crystal structure of PPARγ complexed with the PGC-1α peptide. However, no structures 
were available for co-repressor (peptides) binding to PPARγ, which limited us to the crystal 
structure of PPARα complexed with an antagonist and the SMRT corepressor peptide 
(1KKQ). As shown in Figure 6B, the binding sites for the coactivator (left, shown in blue) 
and corepressor (right, shown in purple) peptides occupy structurally analogous positions 
Table 2   Comparison of PPARγ complexes with fatty acidsa: 3U9Q is the HADDOCK- 
refined crystal structures of the PPARγ-decanoic acid complex, while the other 
three clusters were obtained by HADDOCK modeling of the butyrate –  
PPARγ complex
Complex BSA (Å2) HADDOCK scoreb  
[a.u.]
Ligand-RMSDc  
(Å)
Size of cluster
3U9Q 478 ± 6 -22.1 ± 2.9 0.0 n/a
Cluster 1-butyrate 286 ± 14 -7 ± 3 1.55 ± 0.29 179
Cluster 2-butyrate 280 ± 6 0.1 ± 4 4.70 ± 0.77 13
Cluster 3-butyrate 275 ± 6 4.6 ± 4 0.99  0.13 6
a) Averages and standard deviations calculated over the best four members of a set of structures are reported.
b) HADDOCK score as defined in Materials and Methods.
c) Positional RMSD of the ligand atoms calculated after superimposition of the protein backbone atoms.
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on PPARγ and PPARα, and are likely to be mutually exclusive binding events.  The C-terminal 
AF2 helix of PPARγ (shown in pink) forms part of the binding site for the coactivator 
peptide PGC-1α, and stabilization of this helix is known to promote binding of coactivator 
peptides [31]. As can be seen from the structural comparison, the AF2 helix of PPARγ also 
occludes part of the structurally analogous binding site for the corepressor peptide 
binding to PPARα. The butyrate molecule in the HADDOCK model makes several contacts 
to the AF2 helix (such as the hydrogen bond to Tyr473 OH) that are very similar to the 
contacts that were observed between decanoic acid and the AF2 helix in the X-ray crystal 
structure of the decanoic acid-PPARγ complex (3U9Q), which is consistent with our finding 
using coactivator peptide binding assay that butyrate can promote at least partial agonism 
of the PPARγ receptor, but does not promote dissociation of corepressor peptides.
SCFA do not induce PPARγ-mediated adipogenesis
Given that SCFA can activate PPARγ-mediated transcription in reporter assays but exhibit 
only a partial overlap with a full PPARγ agonist in their coregulator binding profile, SCFA 
may not display the same capacity as full agonists in cell-based assays. Since PPARγ is a 
critical regulator of adipogenesis and mediates stimulation of adipogenesis by rosiglitazone, 
we subsequently used stimulation of 3T3-L1 adipogenesis as in vitro readout for PPARγ 
activation by SCFA. It has been shown that NCoR1 represses 3T3-L1 adipogenesis and that 
dismissal of NCoR1 is essential for induction of adipogenesis by PPARγ agonists [52,53]. 
Since SCFA/butyrate did not release the association between NCoR1 and PPARγ as observed 
using the PamChip array, it may be expected that SCFA are unable to mimic the adipogenic 
effects of PPARγ agonists [29]. Consistent with this notion and in contrast to rosiglitazone, 
SCFA did not induce 3T3-L1 adipogenesis, as revealed by oil red O staining (Figure 7A) and 
gene expression analysis of adipogenesis markers, which also represent PPARγ targets 
(Figure 7B). In fact, at higher concentrations butyrate and propionate suppressed 
adipogenesis (Figure 7C). Furthermore, in contrast to rosiglitazone, butyrate did not 
upregulate PPARγ targets in differentiated 3T3-L1 adipocytes (Figure 7D). Similarly, in 
contrast to rosiglitazone, SCFA were unable to induce adipogenesis in the human 
Simpson–Golabi–Behmel syndrome (SGBS) adipocyte model, as revealed by lack of 
induction of adipogenesis markers (Figure 7E). Together with the data from colon cell lines 
and PamChip® Arrays, these data support the classification of SCFA as selective PPARγ 
modulators. 
Consumption of inulin leads to PPAR activation in mouse colon
To find support for activation of PPARγ by SCFA in vivo, we studied the effect of dietary 
fiber on PPAR activation in mouse colon. To that end, C57Bl/6 mice were fed either a 
control diet containing no soluble fiber or the same diet containing 10% inulin for 10 days. 
Inulin feeding markedly increased concentrations of acetate and propionate in the colon, 
which reached significance for propionate (Figure 8A). To study the effect of inulin on 
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Figure 7   Butyrate and propionate inhibit 3T3-L1 adipogenesis
A) Oil red O staining of 3T3-L1 adipocytes at day 10 treated with SCFA (8 mM) from day 0. Mix 
contained 2.67 mM of each SCFA. B) Expression of differentiation markers and PPARγ targets was 
determined by qPCR at day 4. C) Concentration dependent effect of butyrate on 3T3-L1 differentia-
tion when added at day 0 as determined by expression of differentiation markers at day 4. D) Effect 
of SCFA (8 mM) and rosiglitazone (1 μM) on expression of PPARγ targets in fully differentiated 3T3-L1 
adipocytes. Cells were treated for 24 hours. E)  Effect of SCFA (8 mM) and rosiglitazone (1 μM) added 
on day 1 on human SGBS adipocyte differentiation and expression of adipogenesis marker genes at 
day 15. Errors bars represent SD. Asterisk indicates significantly different from control according to 
Student’s t-test (p<0.05).
144
PPAR target gene expression, colons were subjected to microarray analysis followed by 
gene set enrichment analysis. Remarkably, the most significantly induced gene set was 
“PPAR targets” (FDR q-value =0, Normalized Enrichment Score =2.44) [54]. It should be 
noted that PPAR target genes cannot be separated according to PPAR isotype. 
Representation of the individual expression changes of the most highly ranked genes 
within “PPAR targets” in a heatmap reveals the pronounced and consistent induction of 
numerous PPAR targets by inulin (Figure 8B). These data suggest that gut microbial activity 
and resultant formation of SCFA leads to activation of PPARs.
Figure 8   Inulin feeding activates PPAR in colon
Mice were fed a diet enriched with inulin for 10 days. A) Lumenal concentration of SCFA in the colon 
as determined by gas chromatography.  Errors bars represent SEM. B) Gene expression changes in 
colon illustrated by heat map of genes belonging to the most significantly induced gene set “PPAR 
targets” . SLR: signal log ratio.
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Discussion 
Here we explored the mechanisms involved in regulation of ANGPTL4 synthesis in human 
colon. The two major findings are: 1) ANGPTL4 synthesis is highly stimulated by SCFA; 2) 
SCFA transactivate and bind to PPARγ, likely by serving as selective PPAR modulators. 
Overall, the data indicate that SCFA induce ANGPTL4 mRNA expression and protein 
secretion in colon cells by activating PPARγ. Butyrate was the strongest activator followed 
by propionate, whereas acetate only weakly stimulated PPARγ and ANGPTL4. 
Butyrate is a potent histone deacetylase inhibitor, which likely accounts for most of the 
observed effects of butyrate in colon adenocarcinoma cells as revealed by microarray. 
Indeed, a far larger number of genes was regulated by butyrate compared to rosiglitazone, 
suggesting that PPARγ activation is quantitatively a relatively minor pathway in gene 
regulation by SCFA, at least in T84 cells. 
Two previous studies have hinted at potential activation of PPARγ by butyrate [55,56], yet 
the concept has largely eluded recognition in the field. In contrast, long chain (unsaturated) 
fatty acids are well-known activators of PPARγ [57]. They activate PPARγ at concentrations 
in the low to medium micromolar range and thus serve as high affinity agonists of PPARγ. 
In contrast, concentrations of SCFA needed to activate PPARγ are in the high micromolar 
to low millimolar range. Due to the low affinity, the in vivo relevance of PPARγ activation 
by SCFA is likely insignificant in most human tissues, including adipose tissue. However, 
the situation is different in the GI-tract and in liver [58]. Indeed, SCFA concentration 
approaching or even exceeding 100 mM have been reported in human colon and caecum 
[59].  In mouse intestine we measured total SCFA concentrations of around 40 mM, which 
would result in substantial activation of PPARγ. Accordingly, we believe that activation of 
PPARγ by SCFA is physiologically only meaningful in human caecum and colon, and 
perhaps in liver.
Interestingly, medium chain fatty acids (MCFA, C8-C10) were recently shown to act as 
modulators of PPARγ [31]. Similar to the data reported here for SCFA, the MCFA decanoic 
acid bound and (trans)activated PPARγ, and contrary to synthetic PPARγ agonists and 
LCFA, decanoic acid inhibited adipogenesis. Furthermore, it was shown that the 
hydrocarbon tail of decanoic acid occupies a completely different pocket compared to 
the tail of LCFA or rosiglitazone. Remarkably, even though no specific orientational or 
positional restraints were used to guide the binding of butyrate in the large PPARγ binding 
site, the most favorable solution to the docking was very similar to that of decanoic acid. 
In general, the best solutions of the docking protocol displayed high quality interactions 
with the PPARγ receptor, with a slightly different orientation of the butyrate carboxylic 
acid group in the binding site compared to decanoic acid. The model shows that butyrate 
is stabilized in the binding site by interactions with protein side-chains. Since the buried 
surface area and interaction energy with the receptor are less than for decanoic acid, the 
affinity of the complex with butyrate is predicted to be weaker than with decanoic acid. 
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PPARγ has an antineoplastic effect in many different tumor types, yet its role in colorectal 
tumors remains controversial [60]. In contrast, the anti-inflammatory effect of PPARγ in the 
colon is well recognized [61]. PPARγ ligands were shown to suppress inflammatory gene 
expression in colonic cell lines by suppressing NF-κB and reduce inflammation in a mouse 
model of Inflammatory Bowel Disease [62,63]. In addition, PPARγ in colonic epithelial cells 
was shown to protect against experimental inflammatory bowel disease [49]. Similarly, 
SCFA, especially butyrate, seem to have broad anti-inflammatory properties by altering 
immune cell migration, adhesion, and cytokine expression, and by affecting cell proliferation 
and apoptosis [64]. Accordingly, it can be hypothesized that the anti-inflammatory 
properties of SCFA in the colon are at least partially conveyed by PPARγ [65].  
Based on data presented here, microbiota may be able to influence ANGPTL4 production 
via production of SCFA and subsequent activation of PPARγ. Backhed reported that 
colonization of the gut of germ free mice with microbiota reduces ANGPTL4 expression in 
mouse intestine [2]. In as much as SCFA stimulate ANGPTL4 expression, the suppressive 
effect of colonization on ANGPTL4 must be mediated by a mechanism other than SCFA. 
It has been suggested that alterations in intestinal ANGPTL4 expression may influence 
adipose LPL activity and thereby impact adipose mass [2]. SCFA may thus inhibit fat 
storage by stimulating release of ANGPTL4. Whether ANGPTL4 also has a functional role in 
the intestine is unclear. Since the intestine does not express LPL, the local role of ANGPTL4 
in intestine must extend beyond LPL inhibition. LPL-inhibition is conferred exclusively by 
the N-terminal domain of ANGPTL4, whereas the C-terminal fragment of ANGPTL4 acts as 
a ligand for integrins to alter cellular signaling [66-68].
In conclusion, we show that SCFA potently stimulate ANGPTL4 production in human 
colon cell lines via PPARγ. Our data point to activation of PPARs as a novel mechanism of 
gene regulation by SCFA in the colon, in addition to other mechanisms of action of SCFA.
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Supplemental Information
Supplemental Figure 1
Venn diagram showing overlap in gene induction by butyrate (1 mM or 8 mM) and rosiglitazone  (1 μM) 
in T84 cells based on Affymetrix microarray analysis. Only genes with signal intensity >20 and number 
of probesets >10 were included. Threshold for regulation was set at fold change of 1.8.
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Abstract
Dietary fibers are known to promote gastrointestinal homeostasis. Dietary fibers are 
fermented in the large intestine by microbiota to produce short-chain fatty acids (SCFA). 
SCFA, in particular butyrate, transactivate peroxisome proliferator-activated receptor 
(PPAR) γ. Studies with mice deficient in intestinal PPARγ suggested an important role for 
PPARγ in gastrointestinal homeostasis. Target genes of PPARγ were activated by dietary 
fibers that are fermented. 
Here we addressed the question which role PPARγ in the intestinal epithelium played in 
the fermentation of dietary fiber in mice. Mice lacking epithelial Pparγ (KO) in intestine (via 
cre-vilin) and wild type (WT) mice were fed the soluble dietary fiber inulin for 10 days. 
Subsequently, whole-genome gene expression of mucosal cells was analyzed by 
microarray analysis. The colonic content was analyzed for microbiota composition using 
mouse intestinal tract chip (MITChip) and metabolite level were measured by 1H-NMR 
spectroscopy. In addition, colonic crypt cells from both KO and WT mice were grown to 
organoids and subsequently treated with 1mM butyrate for 24hrs, followed by 
whole-genome gene expression analysis to identify butyrate mediated Pparγ-dependent-
ly regulated genes. 
We found that diet more than the genotype status of the mice coincides with variation in 
metabolite levels, microbiota composition and gene expression in colon. We identified 
Pparγ-dependent genes regulated by inulin indicating that Pparγ partially governs colonic 
response to fermentation. These genes clustered in biological processes related to 
oxidative stress response, catabolic metabolism, DNA repair, cell cycle, immune related 
processes, insulin signaling and gene transcription. In addition, Pparγ-dependent gene 
expression response to butyrate treated organoids was related to energy-generating 
processes, Nrf2 targets, amino acid and glucose metabolism. In conclusion, epithelial 
Pparγ partially mediates gene expression response to inulin and butyrate in colon.
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Background
Dietary fibers are known to promote gastrointestinal homeostasis [1-4]. Dietary fibers such 
as inulin are fermented by the intestinal microbiota. Fermentation results in the production 
of microbial metabolites among which short-chain fatty acids (SCFA) are the most 
abundant ones. Among the SCFA, acetate, propionate and butyrate are produced in high 
concentrations in the murine large intestine [5]. Beneficial effects of dietary fibers can in 
part be attributed to SCFA. Butyrate is thought to be the primary energy source for 
colonocytes [6]. Although propionate and acetate are mainly transferred and taken up by 
other organs than the large intestine, it has been demonstrated that they also impact 
colonic gene expression in mice [chapter 2]. Previously, it was found that dietary fibers 
that increased SCFA concentrations in the colonic luminal content of mice commonly 
increased the expression of Ppar target genes in murine colon [chapter 3]. Among the 
different dietary fibers, in particular inulin showed strongest activation of Pparγ as 
suggested by bioinformatics analyses. Additionally, it was reported that butyrate and to 
lesser extent propionate specifically transactivate the isoform PPARγ, as was shown with 
transactivation assays [7] using physiological concentrations of SCFA [chapter 3]. Hence, 
Pparγ was identified as potential regulator in the fiber fermentation process mediating 
effects of dietary fiber on gastrointestinal homeostasis. Only a few studies have been 
published that studied the role of PPARγ in the intestine. It is well known that PPARγ 
signaling is crucial for adipogenesis, insulin sensitivity and immunity [8]. Intestine-specific 
knock-out (KO) models of Pparγ have been described in literature and showed that Pparγ 
is important for maintaining intestinal homeostasis by affecting tumorigenesis [9] and 
mucosal immune response [10]. The role of PPARγ in the process of fermentation of dietary 
fiber is not known. 
Therefore, we used intestinal epithelial-specific Pparγ KO mice, which were fed with inulin 
for 10 days, followed by analyses of intestinal physiology including microbiota composition, 
SCFA, and whole-genome gene expression of mucosal cell scrapings to elucidate on the 
role Pparγ in fermentation process. To study Pparγ -dependent effects of butyrate on 
gene expression, colonic crypt cells derived from Pparγ KO or wild- type mice were grown 
ex vivo to form organoids [11] and treated with SCFA. 
Material and Methods
Mice 
Male C57BL/6J mice were housed in a light- and temperature-controlled animal facility of 
the University Medical Centre Groningen (light on from 7AM to 7PM, 21 °C) with free 
access to food and water. Intestine-specific Pparγ knock out (Pparγ ΔIEC) mice were 
generated from mice which had loxP-flanked exon 1 and 2 of the Pparγ gene (developed 
in Evans Laboratory and described in [12]). These mice were backcrossed with transgenic 
156
mice expressing Cre recombinase under control of the villin promoter. Mice (n=8 per 
genotype) were fed either low-fat diet (LFD) or inulin (IN) supplemented diets (10% of corn 
starch was replaced by IN) for 10 days (diet composition are given in chapter 3). The 
experiment was approved by the Ethics Committee for Care and Use of Laboratory 
Animals of the University of Groningen. On the day of sections, mice were fasted for 2hrs. 
Two hours later mice were anaesthetized with isoflurane, and the colon was excised. The 
adhering fat around the colon was carefully removed, and the colon was cut open 
longitudinally. The luminal content was sampled and the tissue was rinsed with ice-cold 
phosphate buffered saline. Subsequently, the epithelial lining of the colon was scraped 
off. Luminal content and scrapings were collected in tubes, which were immediately snap 
frozen in liquid nitrogen and stored at -80°C.
Organoids
From 3 WT and 3 Pparγ ΔIEC mice colon was isolated, washed with cold PBS, epithelial layer 
was gently scraped, the remaining tissue with intact crypts was washed several times with 
cold PBS and subsequently incubated for 1hr in 5mM EDTA in PBS to isolate crypt cells as 
previously described [11]. The washed and filtered crypt cells were embedded in Matrigel 
and seeded in a 24-well plates containing advanced DMEM/F12 supplemented with 
Penicillin/Streptomycin, 10 mM Hepes, Glutamax, Wnt, nAcetyl-cysteine, growth factors 
(Noggin, R-spondin, mEGF), B27, kinase inhibitor, Nicotinamide, A83 and  p38. 
Butyrate treatment. Organoids were treated with butyrate (1mM) for 24hrs. PBS served as 
control. After 24 hours organoids were harvested and stored in Trizol at -80C until RNA 
isolation.
MITChip 
Colonic content of 20 mice (n=5 per group) was used for microbiota composition analysis 
by MITChip following protocols and data analyses as described before [chapter 4]. 
1H-NMR spectroscopy 
Colonic and cecal content samples were collected, homogenized in 100mM phosphoric 
buffer solution (pH 8) and kept at -20 C. Samples were then diluted in phosphoric buffer 
with 1mM maleic acid as standard. Subsequently, 200 µL were transferred to a 3 mm NMR 
tube (Bruker match system). Samples were measured at 310 K (calibrated temperature) in 
an Avance III NMR spectrometer operated at 600.13 MHz as described in [13].
Microarray analysis and data processing 
Colonic scrapings (n=6 per diet group) were subjected to genome-wide expression 
profiling as described before [chapter 3]. After quality control 1 array from the control 
group had to be excluded from further analysis due to insufficient quality. The dataset was 
filtered to only include probe sets that were active (i.e. expressed) in at least 3 samples 
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using the universal expression code (UPC) approach (UPC score > 0.50). This resulted in 
the inclusion of 9,329 of the 21,187 probe sets. For organoid tissues, 9,354 of the 21,187 
probe sets were included. Differentially expressed probe sets were identified by linear 
models and an intensity-based moderated t-test [14,15]. Probe sets that satisfied the 
criterion of P < 0.01 were considered to be significantly regulated.
Statistical analysis
Statistical differences were determined with two-way ANOVA using GraphPad Prism 
version 5.04 Windows, GraphPad Software, San Diego California USA. Differences were 
considered significant at * P≤0.05 or ** P≤0.01. Data are presented as mean ± SEM.
Results
I. The role of intestinal, epithelial Pparγ on effects of inulin 
Physiological parameter
Feeding inulin and a LF control diet to WT and Pparγ ΔIEC mice did not lead to significant 
differences in cumulative food intake or body weight after the 10 days feeding period 
(Figure 1). The total cecum showed significantly higher weight in mice fed inulin for both 
genotypes, whereas for colon no significant differences between the groups were 
observed (S Figure 1).   
Figure 1
Food intake measured over 10 days feeding control diet (CON) (low fat diet) or inulin supplemented 
diet (IN) in wild type (WT) or KO (cre-vil Pparγ KO) mice and body weight at the end of the feeding 
period.
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Microbiota composition changes in colonic content 
To analyze the effect of inulin and intestinal Pparγ on microbiota composition, a MITChip 
analysis was performed. Microbiota composition in mice fed the same diet was more 
similar than mice with different genotype status (Figure 2). The four different experimental 
groups explained 22.3% of the total variation in composition. In addition, samples of Pparγ 
ΔIEC mice fed with IN showed a high variation. Although we can conclude a predominant 
role of diet on microbiota composition rather than epithelial Pparγ, there are also bacterial 
groups modulated in Pparγ ΔIEC mice indicating a role of Pparγ on composition. 
Figure 2
Redundancy analysis of colon microbiota from wildtype (WT) or Pparγ KO (KO) mice on a control or 
inulin diet. The variables were the different groups - WT on control diet (WT control); WT on inulin 
diet (WT Inulin); Pparγ KO on control diet and Pparγ KO on the inulin diet. These variables together 
accounted for 22.3% of the total variation, of which in this plot 92.2% is shown.
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Metabolomics changes in colonic content 
Metabolomics was used to determine compounds in luminal content of colon. After 
applying Partial Least Square –Discriminant Analysis (PLS-DA) on the 214 binned 
compounds measured by 1H-NMR, we observed clustering of samples from mice receiving 
inulin vs. control diets on the second and third component, independent of the genotype, 
not however on the first component (Figure 3A). SCFA levels were determined since 
these compounds are expected to be formed by fermentation and are known to activate 
PPARγ. Diet had a significant effect on acetate levels, whereas there was no significant 
genotype effect. Acetate and propionate levels were higher in mice fed IN compared to 
control diet fed mice for both genotypes (Figure 3B). For butyrate levels, however, there 
was a significant effect of interaction between diet and genotype. While levels were 
higher in Pparγ ΔIEC with IN fed mice, they were lower for WT mice. In addition, we noticed 
high variation between Pparγ ΔIEC mice fed IN. Taken together, our data suggest an effect 
of intestinal Pparγ on specific luminal metabolite peak integrals, in particular for butyrate, 
although overall the diet effect seemed to be larger than the genotype effect.  
Pparγ dependent gene expression changes induced by inulin
The 9,329 filtered genes were subjected to PLS-DA to compare gene expression profiles 
between mice. Overall, gene expression profiles were more comparable between mice 
fed the same diet than between mice from the same genotype indicating that the diet 
effect is more pronounced than the genotype effect (Figure 4A). To analyze the role of 
genotype effect, genes significantly regulated between IN and control fed WT and Pparγ 
ΔIEC mice, respectively were determined (P<0.01). In IN fed mice 449 genes were significantly 
regulated, while in Pparγ ΔIEC mice 171 genes were regulated suggesting that abolishing 
intestinal Pparγ dampened part of the effect of IN on the colonic transcriptome (Figure 4B). 
To determine IN induced changes mediated via Pparγ, Venn plots were used to calculate 
the number of genes only regulated in WT mice by IN and not in PPARγΔIEC mice. From the 
449 genes regulated by IN under WT conditions, 397 genes were regulated by IN only in 
the WT mice, whereas 52 genes were also regulated in the Pparγ ΔIEC mice and 119 genes 
were only regulated in Pparγ ΔIEC mice (Figure 4C). The large number of genes (~88%) 
regulated only in Pparγ WT mice indicated that Pparγ plays an important role in mediating 
IN induced effects on colonic transcriptome.
In addition, there were two sets of genes regulated with IN in WT mice but not in KO mice, 
suggesting Pparγ dependency. (1) Genes regulated by IN only in WT that were also 
regulated between WT and Pparγ ΔIEC mice fed the control diet (43 genes) suggesting 
additional mechanism. (2) The majority of genes that were regulated by IN only in WT 
mice were not regulated between WT and Pparγ ΔIEC fed the control diet (354 genes) 
suggesting direct Pparγ-dependent regulation. The highest regulated genes with IN vs. 
control diet from (1) were Reg3g (FC 4.09), Reg3b (FC 3.49) and from (2) Ly6g6c (P<0.01, FC 
2.69) and Wfdc18  (P<0.01, FC 2.13) (Figure 4D). 
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Figure 3
Metabolite level in content of colon measured with 1H-NMR; Partial least square analysis showing 
variation of mice based on integrals of components (A); Average with standard error of integrals of 
SCFA for (B), two-way ANOVA for diet effect (D), genotype effect (G), or interaction (I),* indicates 
significant difference between two groups with P<0.05;  WT=wild type, KO= cre-vil Pparγ KO, 
IN=inulin, CON=control diet
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Gene sets regulated by inulin
Using gene set enrichment analysis (GSEA), the potential role of Pparγ in mediating effects 
of IN on intestinal epithelial cells was further explored. Gene sets that were significantly 
regulated (P<0.001, FDR<0.05) in IN fed WT mice but were not regulated in Pparγ ΔIEC mice 
were selected and presented in an enrichment map (Figure 5). Among the biological 
Figure 4
Gene expression profile in colonic tissue scrapings measured with microarray; A) Partial least square 
analysis showing variation of mice based on gene expression; B) Number of genes activated and 
suppressed in inulin fed mice compared to control diet fed WT (wild type) and KO (cre-vil Pparγ KO) 
mice C) Venn plots comparing number of genes significantly regulated (P<0.01) D) Genes regulated 
between IN and CON fed mice and not regulated between WT and KO mice (upper) and genes also 
regulated between WT and KO mice
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processes that were enriched with Pparγ-dependent, activated genes were catabolic 
processes (TCA cycle, electron transport chain, redox reactions), phase I and II metabolism 
and Nrf2 target genes, DNA repair and cell cycle (Figure 5A). Processes enriched with 
Pparγ dependent suppressed genes encompassed immune related processes (interferon 
signaling, T cell signaling, cytokine metabolic process, antigen processing and presentation), 
insulin signaling and gene transcription (Figure 5B). The differentially regulated gene sets 
indicate a role for epithelial Pparγ in the activation of metabolic processes and suppression 
of immune-related processes mainly.  
II.  Pparγ dependent SCFA effects on colonic gene expression
It has been reported before that butyrate and to a lesser extend propionate transactivate 
Pparγ [7]. To analyse butyrate-induced Pparγ -dependent gene regulation, organoids 
were cultured from colonic crypt cells derived from Pparγ ΔIEC and WT mice, treated with 
butyrate and gene expression was measured using microarrays. To select Pparγ-dependent 
genes regulated by butyrate, Venn plots were created from genes differentially regulated 
between butyrate vs. control in WT and PparγΔIEC organoids, respectively (Figure 6A). 
From the differentially regulated genes in WT organoids, butyrate regulated 49% of genes 
Pparγ dependently. A much higher number, however, was regulated by butyrate in the 
Pparγ ΔIEC derived organoids indicating that butyrate regulated much more genes related 
to Pparγ deficiency. 
To hypothesize on biological implications of butyrate-induced genes that are Pparγ- 
dependent, gene sets significantly (P<0.001, FDR<0.05) enriched with genes regulated by 
butyrate in WT but not in Pparγ ΔIEC derived organoids were analysed. These gene sets 
encompassed metabolic, catabolic processes (lipid catabolism, fatty acid oxidation, TCA 
cycle, electron transport chain, redox reactions), Nrf2 targets, amino acid and glucose 
metabolism (Figure 6B) suggesting a role of butyrate and Pparγ for energy-generating 
and oxidative stress response. 
Pparγ mediated inulin and butyrate-induced genes
We next compared the Pparγ-dependent genes regulated with butyrate and IN. Genes 
only differentially regulated with butyrate (vs. control) in organoids derived from WT mice 
were selected and overlap with genes differentially regulated only in WT mice fed IN 
(vs. control) was calculated with Venn plots. The comparison revealed that only 6 out of 
233 genes that were regulated by butyrate were also regulated in mice fed IN in Pparγ 
dependent manner. 
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Discussion
Herein we report for the first time on the role of intestinal Pparγ on gene expression 
regulation in colon of mice fed with the dietary fiber inulin. We demonstrated with 
whole-genome gene expression analysis that epithelial Pparγ is associated with changes 
in genes related to metabolic, catabolic processes, cell cycle, and immune system in colon 
in response to fermentation of inulin. These results supports that epithelial PPARγ plays an 
important role for signaling between epithelial cell and immune system in keeping 
mucosal homeostasis [16]. Furthermore, we used an organoid model derived from KO and 
WT mice treated with butyrate to compare effects induced by inulin. PPARγ is transactivated 
by fiber fermentation products [7] but whole-genome gene expression profiles induced 
by butyrate in Pparγ-dependent manner have not been reported before. Herein, we 
report that Pparγ plays a role for gene regulation primarily related to energy metabolism 
and oxidative stress response (Nrf2) in butyrate treated colonic organoids. This result is in 
line with other studies showing that butyrate affect cellular energy metabolism by 
increasing fatty acid oxidation and mitochondrial respiration [18] and enhance phase II 
enzymes via Nrf2 [19]. Interplay and positive feedback loop between NRF2 and PPARγ in 
regulating oxidative stress response and anti-inflammatory activities has been suggested 
before [20]. Although the observed overlap of butyrate- and IN-induced, Pparγ-depen-
dent genes was relatively small, biological processes associated with Pparγ-dependent 
genes were largely comparable between IN and butyrate. These processes encompassed 
mainly energy generating processes and oxidative stress response (Nrf2). Although the 
expression changes in immune-related and Pparγ-dependent genes suppressed in mice 
fed inulin cannot be compared with the organoid model, this does not exclude the 
possibility that SCFA can be responsible for part of the immune-related changes seen in 
vivo [17]. 
Regulation of SCFA transport via Pparγ - Slc5a8
Notably, we observed higher integral levels for acetate, propionate and butyrate in KO 
mice fed inulin diet compared to WT mice fed control or inulin diet. This effect suggests 
that fermentation of dietary fiber and SCFA metabolism in epithelial, intestinal cells is 
blocked by abolishing Pparγ because Pparγ might have an effect on the absorption of 
SCFA, in particular butyrate. Butyrate is transported by Slc5a8/Smct1 into colonocytes 
(sodium-coupled monocarboxylate transporter 1) [21]. The mRNA levels of this SCFA 
transporter in cecum were significantly correlating with all three SCFA concentrations 
found in cecum in mice fed guar gum [22]. Gene expression of Slc5a8 was indeed 
significantly higher in IN fed WT mice, however, not in KO mice (fold change 1.23, P=0.01 
WT IN and 1.07, P=0.35 KO IN). Hence, the higher SCFA level in the KO mice fed inulin could 
indicate less uptake by Smct1 which might be dependent on intestinal, epithelial Pparγ. 
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Taken together, we demonstrated that Pparγ-dependent gene expression changes 
induced by butyrate are related to Nrf2 and energy metabolism in epithelial cells, which is 
comparable with the gene expression response seen in inulin fed mice. The abolished 
increase in SCFA transporter mRNA level in KO mice suggest a role of Pparγ in uptake of 
SCFA which might support the importance of butyrate in regulating the transcriptional 
response to inulin via Pparγ. Little overlap between IN and butyrate of the regulated Pparγ 
-dependent genes might suggest that other metabolites or different cofactors additionally 
play a role in mediating response to fiber fermentation. 
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Supplemental Information
Supplemental Figure 1
Weight of cecum and colon including content in mice after 10 days feeding inulin (IN) or control 
(CON) diet. Average ± SD weight is given per group of mice fed inulin or control diet in wild type 
mice (WT) or cre-vil Pparγ  KO mice (KO)
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Health is not merely the ‘absence of disease’ (WHO, 1948), the definition should also 
include the ability to adapt and self-manage [1]. Intestinal health includes criteria such as 
nutrition, intestinal microbiota, immune status, absence of gastro-intestinal illness and 
well-being [2]. Hence, to prevent diseases, understanding the interactions between food/
diet, microbiota, and host physiology is important [2]. 
Therefore, the work presented in this thesis aimed at characterizing the molecular 
relationships between dietary fibers and the large intestine, with focus on short-chain 
fatty acid-related transcriptional regulation in large intestine in mice. To comprehensively 
elucidate the underlying mechanisms, omics technologies were used to study both host 
and bacterial gene regulation and microbiota composition, which subsequently were 
integrated with multivariate statistics. To test the generated hypothesis, an intestine-spe-
cific knock out mouse models was used. 
The following main results were obtained in this thesis:
1. SCFA –related gene expression changes in large intestine differ between a low fat/
high carbohydrate and high fat/low carbohydrate diet (chapter 2)
2. Dietary fibers that are fermented induce a common transcriptional profile that is 
potentially governed by Ppar. The common gene expression changes were related to 
energy-generating processes and correlated with bacteria mainly belonging to 
Clostridium cluster XIVa, which encompass known butyrate producer. Furthermore, 
unique genes regulated by different dietary fibers were identified (chapter 3). 
3. Next to commonalities induced by dietary fibers, metatranscriptome analysis of cecal 
microbiota revealed that different fibers activate different bacterial families, which are 
related to distinct activities in the fermentation of fibers into SCFA (chapter 4).
4. SCFA, in particular butyrate, (trans)activate PPARγ and regulate ANGPTL4 in colonic 
cell line (chapter 5).
5. The transcriptional response to fermentation of inulin and butyrate is partially 
governed by epithelial Pparγ in colon (chapter 6).  
Pparγ in the large intestine
Next to adipose tissue, Pparγ is also highly expressed in the large intestine (http://biogps.
org). While PPARγ is known to play an important role in adipose tissue, e.g. for differentia-
tion [3], the function of PPARγ in colon, however, is less clear. Activation of Pparγ by its 
ligand troglitazone has been seen to be protective on malignant changes involved in 
colon cancer [4]. Whereas others found increased formation of colon polyps upon Pparγ 
activation by troglitazone and suggest that Pparγ plays a role in mediating effects of 
high-fat diet-induced colorectal tumorigenesis [5]. Both SCFA and dietary fibers are related 
to decreased cancer risk, and are inducing Pparγ targets (chapter 3 and 5). What the 
impact of high-fat diet is on protective effects of SCFA and dietary fibers via Pparγ should 
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be investigated. The type of ligand might also play a role for effects of Pparγ on colonic 
dysbiosis. 
In addition, we noticed many genes that were regulated independent of epithelial Pparγ 
in inulin fed mice in colon (chapter 6) indicating that other mechanisms may play a role 
including Pparγ in other cell types or related to the dysfunction of epithelial Pparγ as 
antagonist for other regulatory networks. In rosiglitazone treated cre-vil Pparγ KO mice 
reduced colonic inflammation was seen and hence independent of epithelial Pparγ [6]. 
Pparγ is also expressed in other immune related cell types such as T and B cell, macrophages, 
eosinophils or dendritic cells [7]. Hence, it can be speculated that activation of Pparγ 
expressed in other cell types might play a role for colonic response. 
Epithelial vs. immune-cell Pparγ in intestine
Studies with mice with experimental inflammatory bowel disease investigated the 
influence of immune cell and epithelial Pparγ KO (knockout) on mucosal homeostasis. 
Studies with epithelial Pparγ KO mice demonstrated a role of Pparγ for mucosal immune 
response possibly via lysosomal and antigen presenting pathways [8]. Studies with T cell 
specific Pparγ KO mice demonstrated regulation of genes in colonic mucosa that are 
related to adhesion dynamics, TCA cycle, ribosome and apoptosis [9]. Similarly, macrophage 
specific Pparγ KO showed increased expression of fatty acid oxidation and inflammatory 
genes in colonic mucosa and an influence on T cells [10], demonstrating the impact and 
the complex interaction of Pparγ in both epithelial and immune cell types for mucosal 
homeostasis. 
Nrf2 and Pparγ
Next to PPAR, Nrf2 (NF-E2-related factor 2) target genes were regulated in response to 
dietary fiber (chapter 3). Like Pparγ, Nrf2 target genes were commonly increased for dietary 
fibers that are related to higher SCFA concentrations. Compared to Pparγ KO mice, WT mice 
on control diet showed increased expression of Nrf2 target genes (GSEA, P<0.0001, 
FDR<0.026), indicating that Nrf2 acts in close relationship with PPARγ. Nrf2 and Pparγ are 
known to be in cross talk [11]. In addition, target genes of Nrf2 were not considered 
significantly regulated in inulin fed mice compared to control diet fed mice under KO 
conditions indicating that response to fermentation is also partially governed by Pparγ-Nrf2. 
Taken together, response to dietary fiber fermentation in colon is likely not only governed 
by epithelial Pparγ but is more complex and includes also other mechanisms that play an 
important role. 
High-fat/low carb diet induced changes in large intestinal physiology 
The transcriptional response to SCFA infusion was different between low fat/high carb 
(LFD) and high fat/low carb (HFD) diets (chapter 2). Therefore, high-fat diet induced 
changes in intestinal physiology will be discussed in the following paragraph. 
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Dietary fat is taken up in the small intestine. Hence, most studies on dietary fibers are 
rather focusing on the small intestine than large intestine. An excess of dietary fat as part 
of a high fat diet has influences on the intestinal physiology in particular in the more distal 
part [12] but also in the cecum and colon. The type of dietary fat also affects the fecal 
microbiota diversity and composition [13]. DeWit et al. [13] showed in this study that 
saturated fat (palm oil) deviated from all other dietary fat types in regulating gene 
expression in the distal part of the small intestine indicating an overflow of fat to the more 
distal parts after 2 weeks diet intervention. Hence, dietary fat might directly in even more 
distal parts, in large intestine, affect gut physiology. In line with this, it was shown that high 
fat diet induces changes in the large intestinal physiology (cecum), with respect to 
microbiota diversity, composition and metabolome as well as metaproteome [14]. 
Interestingly, it was demonstrated that changes in the diet induced more marked changes 
on the “chemical fingerprint” (unique metabolite pattern) than major perturbations in 
microbiota composition (e.g. by antibiotics treatment) which indicates the high impact of 
diet on intestinal physiological. The functional changes induced by HFD included shifts 
towards amino acid and steroid metabolism. The changes in amino acid metabolism with 
HFD might be due changes in ratio of protein to carbohydrates in HFD compared to 
LFD, which results in higher production of branched-chain fatty acids. In chapter 2 we 
observed regulation of genes related to branched-chain amino acids and other amino 
acids after propionate infusion on HFD, which might indicate the interference of 
propionate with HFD metabolites and hence might contribute to positive effects of 
dietary fiber. 
Furthermore, HFD are related to changes in bile acid metabolism induced by bacteria, 
which form secondary bile acids such as deoxycholic acid and lithocholic acid. In rat 
colon, deoxycholic acid and butyrate have antagonistic effects on proliferation along the 
crypt-villus axis [15]. Due to the lowering in pH by adding SCFA, the transformation of bile 
acids is inhibited [16] which might prevent cell damage and increased proliferative activity 
with detrimental health effects. Hence, possible bile acid related metabolites should be 
studied in relation to SCFA induced changes. 
G-protein coupled receptor (Gpr) 41 are receptors for SCFA. SCFA, however, have been 
reported to protect against diet-induced obesity independent of Gpr41 after HFD feeding 
[17]. Hence, other mechanism might play a role. HFD induces microbiota changes leading 
to inflammation via LPS-induced TLR4 activation [18]. TLR signaling and PPAR signaling 
respond differentially to changes in microbial activity related to different dietary fiber 
interventions as was seen from correlations between metatranscriptome and host 
transcriptome (chapter 4). It has been shown that activation of macrophage-specific 
PPAR gamma signaling is inhibited by activation of TLR4 in LPS–stimulated macrophages 
[19]. It can be speculated that activation of PPARγ by SCFA is related to and possibly 
counteracted by TLR4 signaling upon HFD feeding, a mechanism that should be further 
elaborated. 
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Taken together, the impact of the diet on the intestinal metabolome in influencing mucosal 
transcriptome response should be studied more comprehensively when investigating 
intestinal homeostasis. 
Dietary fiber-induced changes mediated via SCFA? 
Compared with the transcriptional profiles induced by SCFA, profiles induced by dietary 
fibers were different to SCFA infusions (mainly with respect to metabolic, catabolic gene 
sets) (chapter 2, 3). Several factors might play a role in this discrepancy. For example, it has 
been shown that individual SCFA can have opposite effects in metabolic pathways [20], 
[21]. Hence, the studied individual SCFA might act differently when applied in combination, 
as it is the case in more physiological conditions. Another point that can be taken into 
account for explaining differences between response to SCFA infusion and dietary fibers 
are fluxes of SCFA vs. snapshot concentrations. By measuring SCFA concentrations, 
production and uptake rates of SCFA remain unknown. It has been shown that actual 
concentrations of SCFA do less correlate with parameters of metabolic syndrome after 
feeding guar gum to mice than do flux measurements of SCFA [22]. Hence, different fibers 
can have similar SCFA concentrations but different uptake rates, which might lead to 
different effects. 
Role of concentration dependent effect of butyrate
Butyrate in different concentrations induced different sets of genes (chapter 5; 1mM vs. 
8mM) which points to other mechanism being involved at different concentrations. This is 
further supported by the fact that butyrate regulated also many genes Pparγ independently 
(243 genes regulated in both Pparγ WT and KO mice, chapter 6). It was shown that 
butyrate induced different mechanisms for concentrations > 5mM where HDAC inhibition 
takes place which is different at lower concentrations [23]. It is suggested that the different 
concentrations may play a role for cell turnover along the lumen-to-crypt axis of the colon 
[24]. At lower concentrations, which can be found at the crypt cells, butyrate induces 
proliferation of cells via usage as energy substrate and histone acetylation via acetyl-CoA. 
Whereas at the luminal site butyrate concentrations are higher, exceeding metabolic 
capacity of the cells and hence inducing apoptosis of cells via HDAC (histone deacetylase) 
inhibition. Hence, detailed mechanism about the different concentrations not only along 
the intestine, in small or large intestine, proximal or distal, but also along the crypt-villus 
axis should be studied in more detail. Experiments on the crypt or surface cells can reveal 
more evidence for the expected role of butyrate and also PPAR along the crypt-villus axis. 
Transcriptome analysis of crypt and surface cells isolated by laser capture microdissection 
can be used to dissect the molecular mechanism on the single cell level along crypt-villus 
axis [25]. 
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Furthermore, other metabolites formed during dietary fiber fermentation and degradation 
might explain differences in colonic gene expression response.
Intestinal metabolites
In general, intestinal metabolites modulated or produced by microbiota include bile acid 
derivatives, indole, choline metabolites, phenolic, benzoyl, phenyl derivatives, vitamins, 
polyamines, lipids [26]. During fermentation of carbohydrates mainly SCFA are formed, 
but also formate, hydrogen sulphide, ethanol, succinate and lactate. In chapter 6, besides 
SCFA, another metabolite (succinate) was found to be important for driving the intestinal 
metabolome after feeding mice inulin. Succinate is a di-carboxylic acid and an intermediate 
product of fermentation which is converted into propionate by luminal bacteria [27]. 
Metabolites such as succinate are rather used in the metabolic network of the gut bacteria 
to finally produce SCFA, propionate [28]. Succinate can be taken up by large intestinal 
mucosa [29]. Little is known about effects on gene expression in intestinal mucosa by 
succinate. Succinate can be metabolized in the TCA cycle. Succinate was further shown to 
be a signaling molecule in inflammation [30], [31] and linking TCA cycle dysfunction to 
oncogenesis [32]. In vitro studies showed that succinate can inhibit growth and proliferation 
of colon cancer cells and that some polyphenols can increase the cecal succinate levels in 
rats fed HFD [33]. Other products derived from carbohydrate degradation are less well 
studied with respect to host metabolism. 
Alternatives
What would be alternatives to study impact of SCFA in dietary fiber mediated effects? 
Germ free animal models can be applied to study the direct effects of dietary fibers on 
colonic mucosa without influences of SCFA, which are not produced in germ free mice. 
This model, however, has several marked disadvantages such as large differences between 
germ free and conventional mice with respect to immune cells, epithelial cell turnover, 
mucosal gene expression and metabolic functions [34] making it difficult to compare to 
physiological conditions. Also short-term antibiotics use to diminish the number of 
bacteria could be applied to study effects of dietary fiber without SCFA production [35]. A 
shift in the balance of microbial ecosystem [36], however, might influence the response to 
dietary fibers in the colonic epithelium. Furthermore, to test the causal effect of SCFA in 
dietary fiber induced gene expression profile one could use SCFA transporter knockout 
models. SCFA are taken up via transport proteins (monocarboxylic acid transporters), 
mainly by MCT1-4. Also sodium-coupled transporter SMCT1 has been found to transport 
SCFA. Fluxes of SCFA correlate with mRNA level of these transporters [22] implicating the 
importance of these transporters in uptake and subsequent metabolism of SCFA. Hence, 
blocking uptake of SCFA via knock out of these transporters might help to better 
understand the impact of intracellular SCFA metabolism. Next to SCFA, the monocarbox-
ylate transporter also transport other metabolites (lactate, pyruvate, nicotinate and ketone 
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bodies) [37]. Knock down of MCT1 and MCT4 by siRNA has been seen to lower both lactate 
and butyrate uptake into rat intestinal cells [35]. From these metabolites, lactate and 
pyruvate are formed as intermediary products by bacteria during carbohydrate 
fermentation, which are utilized by other bacteria to form SCFA. Hence, uptake of these 
metabolites by these transporters might play only a minor role for host response to 
fermentation. Besides uptake via transporters, however, diffusion of the protonated form 
of SCFA has also been suggested [38] and the primary transporter for butyrate on the 
apical site has not been unequivocally identified yet. Nevertheless, for answering the 
question in as how much SCFA are mediating the colonic response to fermentation of 
dietary fiber, Smct1 knock out might be most appealing since in chapter 6 we showed 
that mRNA level were significantly increased by dietary fibers in Pparγ dependent manner 
and might hence be important for mediating effects of dietary fiber.
Special case of resistant starch 
Resistant starches are starches included in the definition of dietary fiber since they are not 
digested in the small intestine and can be fermented in the large intestine. There are four 
types of resistant starch, type 1 (physical inaccessible), 2 (ungelatinized starch), 3 
(retrograded starch) and 4 (chemically modified starch). The RS used in our studies was 
tapioca starch, type 3. The same dietary fiber has been used previously in pigs fed RS for 
14 days [39]. In this study, the colonic gene expression changes to RS in pigs showed a 
comparable profile to mice fed inulin, FOS, guar gum or arabinoxylan supplemented diets 
fed for 10 days, but not to those of mice fed RS (chapter 3). In both cases, genes related to 
energy metabolism were differentially regulated and PPARγ was identified as potential 
upstream regulator. Similarly, SCFA levels were increased with RS in pigs as with the other 
fiber diets in mice. Both the gene expression changes and luminal SCFA level in RS fed 
mice were rather similar to control conditions in the mouse study. It can be speculated 
that in the mouse model RS is less efficiently fermented to SCFA and hence comparable to 
normal starch that still is present in the control diet condition. It was suggested that some 
obese mouse models do not ferment RS [40]. In humans, in a randomised, placebo 
controlled trial RS (type 2) was tested in carrier of hereditary colorectal cancer (Lynch 
syndrome) for 4 years. As a result, no protection of development of colorectal cancer was 
found with RS [41]. Similar no effect results were found by [42] and [43]. In the latter study, 
fecal total SCFA concentrations were measured and showed no change compared to 
control with RS2 or RS3. In conclusion, the results show that dietary fibers can act quite 
differently in different animal models and human studies. 
Which dietary fiber is the best?
The answer to this question depends on what is healthy. Production of SCFA is generally 
considered beneficial for gut health by serving energy to colonic mucosa, hence IN and 
GG-enriched diets are probably most healthy. The actual SCFA concentrations, however, 
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are less representative for host response as different uptake rates can be expected. From 
the definition mentioned before, studying gut health necessarily includes nutrition, 
intestinal microbiota and immune status. By comprehensively studying diet, microbiota 
and host response we identified potential mechanism related to health. FOS and AX were 
quite comparable in gene expression profile to IN and GG in activating PPAR target genes 
which is considered healthy for gut and hence health-related effects might be attributed 
to these fibers, too. Next to the common overlapping effects of fermentable fibers, we 
saw unique effects in gene regulation. What the consequences of the fine and unique 
effects of specific dietary fiber are in preventing disease should be studied in long-term 
studies and in combination with knock out models of specific, potential upstream 
regulators identified in chapter 3. Health definition should also include ability to adapt, 
self-manage [1]. From that perspective, however, we can speculate that a combination of 
different fibers might be even better since many unique genes are regulated by individual 
fibers possibly enhancing adaptability.  
Conclusion and Future direction
The definition of dietary fiber is the bottleneck in understanding its health benefits. As 
mentioned before, the definition includes complex carbohydrates and lignin that are not 
fermented in small intestine and can be fermented in large intestine. Considering that a 
variety of sources of dietary fibers with different chemical compositions exist, a wide array 
of specific and unique fiber-related microbial metabolites can be expected related to the 
identified specific genes and should be studied with respect to host metabolism. We 
showed that the diversity of dietary fibers can be studied comprehensively with omics 
tools to better understand these important food components. The plethora of other 
potential metabolites conferring health benefits, however, needs to be explored further. 
Metabolomics should be included when studying diet-host-microbe interactions as diet 
clearly has a large impact on the intestinal metabolome, which in turn is important for 
understanding host dynamics. Finally, to better understand the biological basis of the 
interactions of multi-omics data, one needs to test the generated hypotheses in 
subsequent studies.
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De gezondheid van de darm wordt bepaald door interactie tussen de voeding, de 
darmbacterien (microbiota) en de gastheer. Voedingsvezels staan erom bekend dat ze de 
darmgezondheid positief beïnvloeden. Voedingsvezels zijn de eetbare delen van planten 
en bestaan uit complexe koolhydraten en lignine. Een karakteristiek kenmerk van 
voedingsvezels is dat zij niet verteerd kunnen worden in de dunne darm. Er bestaan een 
groot aantal voedingsvezels die verschillen in koolhydraatsamenstelling en wijze van 
afbraak in darm. De afbraak van de voedingsvezels in de darm vindt plaats in het ceacum 
en colon door darmbacteriën. De afbraak van de voedingsvezels in de darm resulteert 
voornamelijk in de productie van metabolieten zoals korte-keten vetzuren (KKVZ) acetaat, 
propionaat en butyraat. KKVZ kunnen vervolgens door de gastheer worden opgenomen. 
Butyraat wordt voornamelijk gebruikt door de epitheelcellen en is belangrijk voor energi-
emetabolisme van de darmcellen. Daarnaast vermindert butyraat het risico op dikke 
darmkanker. Dit effect op dikke darmkanker wordt daarom gezien als één van de positieve 
effecten van voedingsvezels op de gezondheid. Propionaat en acetaat worden opgenomen 
en via het bloed getransporteerd naar andere organen van de gastheer. Propionaat wordt 
in de lever gebruikt als substraat voor glucose in lever en acetaat word verder getransporteerd 
naar anderen organen. Darmbacteriën spelen een belangrijke rol voor de gastheer. 
Onderzoekers schatten dat de mens uit 10 keer meer microbiële cellen bestaat dan uit 
lichaamscellen, wat de rol van de bacteriën in het lichaam verder onderstreept. Darm -
bacteriën beïnvloeden het energie metabolisme van de gastheer. Het is bijvoorbeeld 
aangetoond dat het eiwit Angptl4 die effecten van darmbacteriën op energiemetabolisme 
beïnvloed. In hoeverre KKVZ de expressie van Angptl4 beïnvloeden is nog niet duidelijk. 
Deze, net genoemde achtergrondinformatie staat gedetailleerd beschreven in hoofdstuk 1. 
Het doel van het onderzoek beschreven in dit proefschrift was om de mechanismen te 
ontrafelen die achter de effecten van voedingsvezels en KKVZ op de gastheer zitten. Daarbij 
hebben wij gebruik gemaakt van verschillende zogenoemde -omics technologieën. Deze 
-omics technologieën omvatten transcriptomics (het meten van de activiteit van alle 
genen genactiviteit middels mRNA van de gastheer), metatranscriptomics (het meten van 
de activiteit van alle genen in de darmbacteriën) en het meten van samenstelling van de 
bacteriën in de darm. 
In hoofdstuk 2 wordt beschreven wat de invloed is van KKVZ op de genexpressie in het 
colon. De KKVZ zijn in dit hoofdstuk rechtstreeks ingebracht in de dikke darm en de respons 
van de gastheer is bestudeerd middels de microarray technologie, wat een vorm van 
transcriptomics is. Door middel van deze experimenten hebben wij genen geïdentificeerd 
die enkel in expressie veranderen bij toediening van of acetaat, of propionaat of butyraat. 
In tegenstelling tot acetaat en butyraat die met name de activiteit van genen gerelateerd 
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aan vetmetabolisme veranderen, beïnvloedt propionaat juist genen die gerelateerd zijn 
aan het koolhydraat- en aminozuurmetabolisme Verder hebben KKVZ een effect op 
diverse processen gerelateerd aan het metabolisme en de celcyclus Tevens hebben wij 
onderzocht wat de invloed is van een dieet dat een laag of een hoog vetgehalte bevatte 
op de effecten van KKVZ. Hieruit bleek dat de invloed van propionaat op de genexpressie 
in de dikke darm grotendeels wordt bepaald door het dieet, maar voor acetaat en butyraat 
was dat niet het geval. 
Onderzoek beschreven in hoofdstuk 3 bestaat uit gedetailleerde analyses van de 
moleculaire effecten van verschillende voedingsvezels op de dikke darm. Uit het 
onderzoek bleek dat de voedingsvezels die worden afgebroken in de dikke darm en een 
verhoogde KKVZ concentratie in de dikke darm veroorzaken, vergelijkbare effecten 
hebben op de genexpressie profielen in de darmwand en de samenstelling van de 
darmbacteriën . De genen die veranderden door deze voedingsvezels waren gerelateerd 
aan energie metabolisme. Tevens correleerden deze genen met bacteriën die voornamelijk 
horen bij de Clostridium klasse XIVa. Uit de analyses bleek verder dat de voedingsvezels die 
worden afgebroken in de dikke darm een gemeenschappelijke genexpressieregulator 
hadden, namelijk de peroxisome proliferator-activated receptor (PPAR) γ. Tenslotte 
hebben wij ook door middel van verschillende -omics technologieën aangetoond dat de 
verschillende voedingsvezels unieke genexpressie profielen induceren, wat de diversiteit 
van de verschillende voedingsvezels onderstreept.    
In hoofdstuk 4 hebben wij onze resultaten van hoofdstuk 3 verder onderzocht,  In dit 
hoofdstuk hebben wij naast de samenstelling van de darmbacteriën ook de activiteit van 
de darmbacteriën gemeten. Dit hebben wij gedaan door het sequensen van monsters uit 
de caecum-inhoud van muizen die behandeld waren met de verschillende voedingsvezels 
uit hoofdstuk 3. Uit deze analyse bleek dat verschillende soorten bacteriën deelnemen 
aan de afbraak van voedingsvezels. Deze voedingsvezels zorgden allemaal voor een 
specifieke verhouding KKVZ. 
Hoofdstuk 5 beschrijft het onderzoek naar de regulatie van het eiwit Angptl4. Angptl4 is 
een mogelijke mediator tussen de darmbacteriën en het energie metabolisme van de 
gastheer. Uit het onderzoek in hoofdstuk 5 bleek dat Angptl4, dat wordt gereguleerd door 
PPAR, en wordt geactiveerd door blootstelling aan KKVZ in darmcellen. Tevens bleek uit 
deze studie dat de KKVZ vooral de PPAR isoform PPARγ activeren. 
Vervolgens wordt in hoofdstuk 6 beschreven welke invloed Pparγ in de darmcellen heeft 
op de afbraak van de voedingsvezel inuline. Om dit te bestuderen zijn knock-out muizen 
ontwikkeld die de transcriptie factor Pparγ missen in de epitheelcellen in de darm . Net als 
in hoofdstuk 3/4 hebben deze muizen 10 dagen inuline gegeten. Vervolgens is de 
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samenstelling van de darmbacteriën bepaald en de KKVZ concentraties en gen expressie 
in het darmepitheel gemeten. Uit deze analyses bleek dat de samenstelling van de 
darmbacteriën en het darm genexpressie profiel meer verschilde tussen de diëten dan 
tussen de genotypes. Verder hebben wij bepaald welke soorten darmbacteriën en welke 
genen beïnvloedt worden door Pparγ. Hieruit bleek dat de Pparγ afhankelijke genex-
pressieveranderingen gerelateerd aan de afbraak van inuline bestaan uit genen 
gerelateerd aan processen zoals immuun response, celcyclus, metabolisme, en oxidatieve 
stress.. Vervolgens hebben wij cellen geïsoleerd uit knock-out en wildtype muizen om 
zogenoemde darm-organoids (‘mini-darm’ die gekweekt is in het lab) te maken. Deze 
organoids werden daarna met butyraat behandeld en de genexpressie werd bepaald. 
Hieruit bleek dat butyraat een deel van Pparγ afhankelijke genexpressie beïnvloedt. Deze 
genen waren gerelateerd aan het energie metabolisme, cel cyclus, DNA herstel, en 
oxidatieve stress. 
In hoofdstuk 7 worden de resultaten uit hoofdstukken 2 tot en met 6 bediscussieerd.
 
Op basis van de resultaten van dit proefschrift wordt geconcludeerd dat dat voedingsvezels 
en KKVZ zowel gemeenschappelijke en uniek effecten hebben op de profielen die wij 
hebben verkregen door middel van –omics technieken. Deze genexpressie en darmbac-
terie-profielen zijn cruciaal voor de regulatie van de darmfysiologie. Tevens is gebleken 
dat de effecten van KKVZ op het darmepitheel sterk afhankelijk zijn van het dieet waaruit 
de KKVZ worden geproduceerd en dat Pparγ waarschijnlijk een regulerende rol heeft in 
de regulatie van de gen expressie responses van de gastheer.
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